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ABSTRACT
Osteoarthritis (OA) is the most common type of arthritis, with prevalence estimates 
expected to increase dramatically worldwide due to ageing and increasingly obese 
populations. The knee is the most commonly affected joint, leading to pain, loss of 
function and disability. Magnetic resonance imaging (MRI)-detected bone marrow 
lesions (BMLs) and osteophytes (OPs) are types of subchondral bone abnormalities 
whose aetiology and predictive value are uncertain. The aims of this thesis are to 
investigate associations between local cartilage morphology, systemic inflammatory 
cytokines and knee BMLs, and the predictive value of MRI-detected OPs on knee OA 
structural and symptomatic changes. 
Two data sources were used in this thesis. The first was a population-based study of
older adults aged 50-80 years (mean age: 62 years; 51% female). Participants were 
randomly selected from the electoral roll in Southern Tasmania (population 229, 000) 
using sex-stratified random sampling. Follow-up measurements were performed at 
about 2.6 years later and again for questionnaire data at about 5.0 years later. MRI scans 
of the right knees were conducted at baseline and first follow-up. Knee cartilage 
defects, cartilage volume, tibial bone area, BMLs, effusion synovitis, infrapatellar fat 
pad and OPs were measured or scored based on MRI images. A standing 
anteroposterior semi-flexed view right knee with 15° of fixed knee flexion was 
performed at baseline with joint space narrowing (JSN) and radiographic OPs scored 
according to the Osteoarthritis Research Society International (OARSI) atlas. Knee 
pain was assessed using the Western Ontario McMaster Osteoarthritis Index 
(WOMAC) at all phases. 
The second was a randomized, multi-centre, placebo-controlled and double-blinded
clinical trial that was designed to evaluate the effect of vitamin D supplementation on 
knee OA. Eligible participants were aged 50 to 79 years who had symptomatic knee 
OA (according to American College of Rheumatology criteria) for at least 6 months, 
and had pain of 20 to 80 mm on a 100-mm visual analog scale (VAS). Additionally,
participants’ serum 25OHD levels were >12.5 nmol/L and < 60 nmol/L. Knee cartilage 
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defects, cartilage volume, BMLs and OPs were measured or scored based on MRI 
images at baseline and after 24 months. WOMAC knee pain, serum levels of 
inflammatory cytokines were assessed at baseline and after 24 months using enzyme-
linked immunosorbent assay. 
This thesis encompasses five studies. In the first study, the natural history of 
patellofemoral joint (PFJ) BMLs over 2.6 years was described and associations 
between PFJ BMLs, knee pain and knee cartilage morphology were evaluated in a 
population-based sample of older adults. 109 (27%) of 406 participants who completed
follow-up had PFJ BMLs at baseline. Of these participants, 49 (45%) of these 
participants’ PFJ BMLs persisted in the same grade, 26 (24%) increased in grade, and 
34 (31%) decreased in grade. Change in PFJ BMLs over 2.6 years was deleteriously 
associated with change of knee pain when going up/down stairs over 5 years. Baseline
PFJ cartilage morphology predicted increases in PFJ BMLs over 2.6 years.
In the second study, cross-sectional and longitudinal associations between serum high 
sensitivity C reactive protein (hs-CRP), knee BMLs and knee pain were investigated in 
a sample of knee OA patients. In these patients, serum hs-CRP is associated with knee 
BML scores and pain both cross-sectionally and longitudinally, suggesting 
inflammation is linked with BMLs and their associated pain. 
The third study described cross-sectional and longitudinal associations between serum 
levels of IL-17A, IL-17F, IL-23, IL-6 and knee BMLs in patients with knee OA. 
Baseline IL-6 were significantly associated with total knee BMLs as well as increased 
knee BML scores in both females and males. Baseline IL-17F and IL-23 predicted 
increased BML scores in females only. 
In the fourth study, MRI-detected OPs were measured and the cross-sectional and 
longitudinal association with knee structural abnormalities and knee pain were 
examined in older adults. Baseline MRI-detected OPs were significantly, 
independently and site-specifically associated with increases in cartilage defects, BMLs 
and loss of cartilage volume over 2.6 years. Medial tibiofemoral and total OP scores 
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were dose-dependently associated with total knee pain change over 2.6 and 5 years but 
these became non-significant after further adjustment for cartilage defects and BMLs. 
In the fifth study, the prevalence of MRI-OPs detected only by MRI but not by standard 
x-ray was described, and the longitudinal associations with knee pain and structural
changes were investigated in a population-based older adult sample. The prevalence of 
MRI-OPs was about 75%. Compared with participants without any OPs, participants 
with MRI-OPs had greater cartilage volume loss and increased cartilage defects and 
BMLs. MRI-OPs and established-OPs both predicted progression of knee structural 
abnormalities, but the associations for MRI-OPs were not as prominent as those for 
established-OPs. This suggests MRI-OPs may have a role to play in knee early-stage 
osteoarthritic progression.
In conclusion, this series of studies indicate that BMLs are not static and changes in
BMLs are clinically relevant. Systemic inflammation is important in the aetiology of 
BMLs in OA. MRI-detected OPs can predict knee OA structural and symptomatic 
progressions. MRI-OP detected only by MRI but not by standard x-ray can also lead to
OA progression, suggesting MRI-OP, which largely represent early OP formation, can 
also serve as a biomarker to predict knee structural progression over time.
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1.1 Overview of osteoarthritis 
1.1.1 What is osteoarthritis 
Osteoarthritis (OA) is a progressive disorder of joints that results from breakdown of 
joint cartilage and subchondral bone [1]. OA is the most common form of arthritis and 
a leading cause of pain and disability among the elderly [2]. Although OA can damage 
any joint, the disorder most commonly affects knees, hips, spine and hands. 
The disease manifests first as a molecular derangement, followed by anatomic, and/or 
physiologic derangements characterized by cartilage degradation, bone remodelling, 
osteophyte formation, joint synovities and joint function limitation [3]. The chronology 
of the OA trajectory from molecular disease to illness is still largely unknown, and it 
usually takes decades from clinical manifestations to organ failure when joint 
replacement is required [3].  
OA is a progressive disease with many pathological changes in many structures, such 
as subchondral bone, cartilage, ligament, meniscus, periarticular muscle, synovium, 
nerves and periarticular fat [4]. It is considered highly heterogeneous in terms of sites, 
risk factors and syndromes, but eventually leads to common clinical manifestations [5, 
6]. It is crucial to acknowledge that OA is far from a static disease. Several OA 
phenotyping systems have been proposed based on modern imaging [4], or 
pathophysiological mechanisms [5]. Those well-received subtypes include the 
following: metabolic OA [7], traumatic OA [8], atrophic/hypertrophic OA [9], 
inflammation-driven OA [10] and subchondral bone turnover- driven OA [11]. 
Developing personalized treatments targeting a particular disease phenotype with the 
etiologically appropriate therapy should result in far better therapeutic efficacy. 
Therefore, it is important to enhance our ability to identify factors that can more 
precisely classify various phenotypes of OA.  
1.1.2 Osteoarthritis epidemiology  
The prevalence of OA varies greatly depending on definitions used, specific joint, age 
group, gender and geographical area investigated. Generally, the incidence of knee, hip 
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and hand OA increases with advancing age, especially after age of 50 years, and 
females have higher risks than males [12]. A decreased incidence occurs around the 
age of 80 years possibly due to many people having the disease by that time [13]. In 
the Framingham Study, 19.2% radiographic knee OA was observed in adults aged ≥ 45 
years, while in Johnston County Osteoarthritis Project it was 27.8% [14]. The third 
National Health Nutrition Examination Survey (NHANES III) estimated the prevalence 
of radiographic knee OA in the United States [15] was about 37% in adults aged >60 
years. Murphy et al. reported the lifetime risk of developing symptomatic knee OA is 
about 40% in males, and 47% in females [16]. The prevalence of symptomatic knee 
OA was about 5% in Framingham participants aged ≥ 26 years, while it was 17% in 
participants aged ≥ 45 in the Johnston County Osteoarthritis Project [14]. In Australia, 
9% of adults sefl-reported having OA, totalling 2.1 million Australians affected in 
2014-2015 [17].  
OA is the third-largest contributor to life-years lost due to disability in Australia [18]. 
OA has contributed to an estimated 60 000 disability-adjusted life-years (DALYs) lost 
in 2000 alone [19]. The Australian Institute of Health and Welfare (AIHW) reported 
that there are more than 40 000 new cases of radiological OA each year, which will 
continue grow as population ages [20], causeing a significant economic burden to 
society [18]. About $2.1 billion medical costs were attributed to OA from Australia 
healthcare budget in 2007 [21]. The leading component costs were hospitalisation, 
predominantly for joint replacement surgery (43%), clinic consultations (13%), 
medication (9%), and allied healthcare (6%). OA composes 63% of hospital inpatient 
expenditure, comparing to rheumatoid arthritis just 3.5% [22]. The group aged 45 and 
over, who is the most commonly affected by OA, is where most of the expenditure 
occurs, and the expenditure peaks in the 65-74 age group.  
1.1.3 Diagnostic criteria 
Clinical  
The clinical diagnostic classification criteria developed by the American College of 
Rheumatology (ACR) remains a popular method for clinical and epidemiological 
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studies to diagnose OA [6]. Pain, stiffness, crepitus and Erythrocyte Sedimentation rate 
(ESR) are the key factors to consider in the diagnosis of OA using ACR clinical 
classification criteria, despite the fact that the natural history of OA most commonly 
begins long before any clinical symptoms are present.  
Pain is usually the primary symptom of OA, with reduced range of motion and crepitus 
commonly present. Initially, pain may be relieved by rest or medications. But as OA 
progresses, pain may become more prominent and not respond to medications. The pain 
usually happens around the affected joint but in some cases, pain can also be referred 
to other areas. For instance, radiographic hip OA can manifest as knee pain [23]. 
Another common symptom of OA is stiffness. The morning stiffness of OA usually 
resolves within 30 minutes of rising, however, it can recur during the day through 
periods of inactivity [24]. Movement of OA joints may cause a crackling sound or 
grating sensation termed crepitus. Crepitus is presumably casused by roughening of the 
normally smooth joint surface [25]. ESR detects non-specific inflammation in the body. 
It is increased in rheumatoid arthritis (RA) but not in OA [24], and ESR < 40mm/hour 
is another ACR criteria. However, there is a growing consensus that low-grade systemic 
inflammation is related to OA development [26], but there are no consistent and reliable 
biomarkers thus far.  
Recently, studies have argued that the ACR clinical criteria may reflect more advanced 
disease, and may be difficult to evaluate reliably [27-29]. There is an increasing 
awareness on the importance in identifying early or mild phases of OA degenerative 
process when there might still be some regenerative ability of cartilage and subchondral 
bone. This will allow to better design trials with increased benefit and reduced risks on 
disease-modifying anti-OA drugs (DMOADs) and lead to improved treatment 
algorithms in specific patient population.  
Radiographic 
Confirmation of the diagnosis can be made with radiography. Despite the development 
of advanced imaging techniques, conventional radiographs still are the gold standard 
for radiographic OA (ROA) diagnosis. The first criteria for ROA definition was 
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proposed in 1957 by Kellgren and Lawrence [30] and was embraced by the World 
Health Organization as standard criteria in 1961. The Kellgren and Lawrence (K/L) 
grading system has been extensively used in clinical research ever since. It offers an 
ordinal 5-point scoring scale to assess the severity of ROA based on the measurement 
of joint space narrowing (JSN) and osteophytes (OPs). Table 1 displays the K/L grading 
system in detail.  
Table 1 Criteria of Kellgren and Lawrence (K/L) grading system 
Grade – Changes Description 
Grade 0- None No change 
Grade 1 –Doubtful Doubtful narrowing of joint space and possible osteophyte lipping 
Grade 2 – Minimal Definite osteophytes, definite narrowing of joint space 
Grade 3 – Moderate Moderate multiple osteophytes, definite narrowing of joint space, 
some sclerosis and possible deformity of bone contour 
Grade 4 - Severe Large osteophytes, marked narrowing of joint space, severe sclerosis 
Apart from the K/L grading system, alternative scoring systems that evaluate individual 
radiographic features have also been developed to screen patients for the diagnosis and 
staging of OA, particularly for clinical trials [31-33]. The Osteoarthritis Research 
Society International (OARSI) atlas classification score was established in 1996 [31], 
and later revised in 2006 [34]. Unlike the K/L grading system, the OARSI atlas uses 
semi-quantitative separate scoring for JSN and OPs (grading 0-3) in the medial 
tibiofemoral and lateral tibiofemoral compartment separately. The atlas has enabled 
standardisation of grading of OA from radiographs. Table 2 displays the OARSI atlas 
grading system details for the knee.  
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Table 2 Criteria of OARSI atlas grading system for knee 
Site & feature Description 
Osteophytes     
Medial femoral 0 (normal) 1 (mild) 2 (moderate) 3 (severe) 
Medial tibial 0 (normal) 1 (mild) 2 (moderate) 3 (severe) 
Lateral femoral  0 (normal) 1 (mild) 2 (moderate) 3 (severe) 
Lateral tibial  0 (normal) 1 (mild) 2 (moderate) 3 (severe) 
     
Joint space narrowing     
Medial compartment 0 (normal) 1 (mild) 2 (moderate) 3 (severe) 
Lateral compartment 0 (normal) 1 (mild) 2 (moderate) 3 (severe) 
     
Other      
Medial tibial attrition 0 (absent) 1 (present) 
Medial tibial sclerosis 0 (absent) 1 (present) 
Lateral femoral sclerosis 0 (absent) 1 (present) 
Several additional grading systems are also available for assessing OA and its severity 
[35, 36].  
Different scoring systems for ROA give markedly different prevalence estimates.  For 
example, prevalence estimates for tibiofemoral OA using the OARSI atlas criteria are 
almost double than obtained using the K/L grading system [37]. This discrepancy may 
be a major reason for the variability of OA prevalence reported in the literature. 
However, the recent development of imaging technologies has revealed a number of 
inherent limitations of radiographs as an imaging tool for visualising OA [38], 
including poor sensitivity to follow-up changes; inability to delineate articular 
cartilage, meniscus, effusion synovitis, BMLs; effect of differences in knee positioning 
during imaging and lack of reproducibility [39].  
1.1.4 Knee osteoarthritis 
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Knees are one of the joints most commonly affected by OA. Prevalence of symptomatic 
knee OA is 10% in men and 13% in women aged 60 years or older [40]. The prevalence 
of knee ROA (defined as KL grade 2 or higher) among elderly in United Stated is 30%-
40% [41]. Risk factors for knee OA include previous injury, family history, female 
gender and obesity, but the most important risk factor is age. Knee OA is the most 
frequent cause of knee pain in adults aged > 50 years. Thus, knee OA needs to be taken 
seriously not only due to its high prevalence rate compared with other sites of OA but 
also for its occurrence at earlier age groups espacially in younger obese women [42].  
1.1.5 PFJ osteoarthritis 
The knee joint is usually considered as tri-compartmental: medial, lateral tibiofemoral 
and patellofemoral compartments. Traditionally, knee OA has been seen as a disorder 
of the tibiofemoral joint (TFJ) principally because radiographic assessment has focused 
on the anteroposterior X-ray, which does not image the patellofemoral joint (PFJ) [43]. 
As technological advances have enabled development of more sophisticated imaging 
tools, so too has awareness of PFJ OA. This is timely because PFJ OA is one of the 
most important source of pain and function limitation in knee OA [44-46]. 
Radiographic OPs in the PFJ are more common than the TFJ compartment in the 
community-based population [47]. The most common radiographic presentation in 
people with knee OA is combined TFJ and PFJ OA, followed by segregated PFJ OA, 
with segregated TFJ OA comprising only a very small proportion of participants (4% ) 
[48]. Despite the high prevalence and clinical relevance of PFJ OA, relatively little 
research has been done on this specific compartment, especially the natural history of 
OA features in this compartment has not been described.  
1.1.6 Viamint D and osteoarthritis  
Both vitamin D deficiency and OA are highly prevalent in the adult population of over 
50 years of age [49]. The prevalence of OA and vitamin D deficiency increases with 
age and is higher in the obese people and in women [50]. A systematic review of 13 
observational studies concluded that low levels of 25-(OH)D were associated with 
increased progression of radiographic knee OA. However, there was limited evidence 
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to support the association between 25-(OH)D levels and symptomatic OA [51]. Despite 
wide-ranging health benefit claims for vitamin D in OA, the randomised clinical trials 
(RCTs) conducted to explore the effect of vitamin D supplementation on OA have not 
found reduced knee pain or cartilage volume loss [52, 53]. As vitamin D insufficiency 
is common in OA populations, future research should address whether vitamin D 
supplementation over the long term is effective in OA patients with vitamin D 
deficiency. 
1.2 Subchondral bone abnormalities 
1.2.1 Preface 
Subchondral bone abnormalities are primary players in the pathogenesis of OA [54]. 
Bone marrow oedema/lesions [55, 56], tibial bone size [57], bone attrition [58], bone 
mineral density [59], trabecular bone morphometry [60], bone cysts [61], bone shape 
[62] and osteophyte (OP) [63] are typical subchondral bone abnormalities that have 
been linked to OA symptoms and structural changes.  
The subchondral bone has long been viewed as intimately associated with cartilage 
damage in the joint. Recent epidemiological studies with MRI have revealed that bone 
changes are evident in early disease stage, even prior to cartilage lesions [64]. This 
section summarizes the current knowledge of the role of two most well investigated 
bone changes in OA: BMLs and OP.  
1.2.2 Bone marrow lesions 
Bone marrow lesions (BMLs), previously known as bone marrow oedema, is described 
as ill-defined area of high signal intensity area in T2-weighted, fat-saturated MR images 
or in short tau inversion recovery (STIR) sequences. It usually cannot be visualized by 
x-ray, ultrasound or computed tomography (CT) [65, 66]. Histologically, BMLs 
consisted of a wide range of abnormalities such as abnormal trabeculae, bone marrow 
necrosis/remodelling, contusion and marrow fibrosis [67, 68]. In knee OA patients, the 
BML size fluctuates over time [69, 70], and the prevalence estimates have been found 
to vary from study to study [71, 72]. BMLs may decrease or increase in size in as little 
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as 6 weeks [73], resolve completely, or new BMLs may develop [74]. Figure 1.1 
illustrates changes in BML size from time to time.  
 
Figure 1.1 Changes in BML size. a, BML increase from baseline to 2.7-year follow-up. b, 
BML decrease from baseline to 2.7-year follow-up 
Source: Dore et al. “Natural history and clinical significance of MRI-detected bone marrow 
lesions at the knee: a prospective study in community dwelling older adults.” In: Arthritis 
Research & Therapy, 12.6 (2010),1186/ar3210. 
BMLs are strongly related to knee pain [75, 76], OA incidence [77] and progression 
[78]. Moreover, BMLs can predict knee JSN on x-ray [79], cartilage defect progression 
[55], cartilage volume loss on MRI [80] and total knee replacement [81]. Thus, BMLs 
are hallmarks of knee OA on MRI [65]. 
BMLs are associated with knee pain in most cohort studies [82], with estimated OR 
ranging  from 2.0 [83] (adjusted for effusion and synovitis) to 5.0 (unadjusted) [84]. 
Hunter et al. [85] found that increased BML score was significantly associated with 
worsening of cartilage degradation. A cohort study suggested BML as a risk factor for 
rapid cartilage loss for both global knee and medial compartments [80]. The presence 
of BML predicts knee replacement independent of age, and patients with BMLs were 
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about 9 times more likely to have knee arthroplasty within 3 years compared with those 
without BMLs [86].  
Despite associations with knee pain and structural changes, the aetiology of BML 
formation remains largely unknown. Suggestions include local inflammatory reactions 
to cartilage breakdown products [87]. However, evidence linking systematic 
inflammation and knee BMLs is lacking, especially in knee OA patients.  
1.2.3 Osteophytes 
Osteophytes (OPs) are bony growths or deposits, also referred to as bone spurs, 
osteochondral nodules, osteochondrophytes, or chondro-osteophytes. They are bony 
projections that form along joint margins, initially as cartilage outgrowths and 
subsequently endochondral ossification [88] and are a defining feature of OA [6]. OPs 
usually develop as a reparative response by the remaining cartilage in a damaged joint, 
correlating with cartilage loss elsewhere in the joint. However, the initial stimuli for 
OP formation are still not well understood, but humoral [89] and mechanical [90] 
factors are believed to be involved. Studies also found that growth factors such as 
transforming growth factor beta (TGFβ), bone morphogenetic protein (BMP) and 
insulin like growth factors (IGF-1) can potentiate OP development [91-93]. Meanwhile, 
joint instability has been introducedd as a biomechanical trigger to OP formation [94]. 
The formation of OPs has been interpreted as an adaptation of the joint to the altered 
biomechanics of OA joints [95, 96], and to cope with instability and protect articular 
cartilage by playing a compensatory role in the redistribution of forces to protect 
articular cartilage [97]. A previous study reported that removing OPs from the arthritic 
joint seriously increased the varus-valgus motions [98], indicating that OPs may serve 
some purpose in stabilising an osteoarthritic joint.  On the other hand, OPs of the knee 
predict pain more accurately than the JSN in radiological views [99], suggesting a 
detrimental effect of OP.  Thus, it is still debatable of the role that OPs play in the 
progression of OA. Overall, the role of OPs in OA progression remains unclear. 
X-ray OPs  
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Despite of the widespread use of tomographic imaging tools, conventional radiographs 
remain the current standard for establishing a radiographic diagnosis of osteoarthritic 
changes in the knees. JSN and OP formation are two radiographic hallmarks of OA. 
Radiographic OPs are most prominent medially. On a typical plain x-ray image, they 
are usually seen anteriorly and medially at the distal femur and proximal tibia, and 
posteriorly at tibia and patella [100]. 
Higher OP scores are modestly associated with greater risk of OA progression [101], 
but the association disappears after further adjustment for limb alignment. OPs are a 
weaker predictor of OA progression than JSN [102], which is a strong predictor of OA 
progression in more than 1500 patients. Several studies concluded that there are only 
modest correlations between knee radiographic OPs and clinical features [47], and 
radiographic OPs may not be a favorable surrogate for clinical outcome in established 
OA [103]. Figure 1.2 shows an example of x-ray OPs from our study population.   
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Figure 1.2 Sample of X-ray OPs 
 
MRI OPs 
Magnetic resonance imaging (MRI) is a non-invasive multiplanar tomographic tool 
which provides high-resolution visualization of menisci, synovium, BMLs, articular 
cartilage, subchondral cysts, intra-articular ligaments and intra-articular lesions that are 
not detectable by conventional radiographs [104]. MRI assesses OPs in locations that 
are not easily visualised by conventional radiographs [105], and have higher sensitivity 
than conventional radiographs for early OP detection [106]. One study revealed that 
nearly 74% of MRI-detected OPs were present in radiographically normal knees [107]. 
In contrast, the prevalence of radiographic OPs was approximately 10% in a generally 
older population (mean age 61 years) [108]. These figures were largely in line with our 
own dataset which was a population-based older adult cohort study. In our sample, 85% 
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had MRI-detected OPs at baseline, whereas less than 10% had radiographic OPs [109]. 
This indicates that MRI is far more sensitive than X-ray to detect OP at early formation 
and can pick up OPs in locations that not easy to be observed by radiographs. It is 
important to detect preclinical OA as early interventions could then be introduced to 
prevent disease progression. Considering that OP formation is one of the criteria for 
OA, and radiography misses out a large proportion of early OP formations which can 
be detected by MRI, there must be a large number of early OA patients who have MRI-
early OPs but are misclassified as normal on conventional radiographs. To date, the 
relevance of MRI-early OPs for the development of structural and clinical 
abnormalities is still uncertain. If MRI-early OPs are proved to be related to future OA 
progressions, then detections of MRI-early OPs and interventions targeting them are 
essential and necessary. Figure 1.3 gives an example of an OP that was visible on MR 
imaging but not on radiography.  
 
Figure 1.3 Example of an osteophyte that was not visible on radiographic but was on MRI 
Source: Hayashi et al. “Pre-radiographic osteoarthritic changes are highly prevalent in the 
medical patella and medial posterior femur in older persons: Framingham OA Study”. In: 
Osteoarthritis and Cartilage, 22.1(2014), 76-83. 
Larger MRI-detected OPs are associated with higher K/L score cross-sectionally [63] 
and increased knee pain longitudinally [110], and cross-sectional studies suggest that 
increasing size and presence of MRI-detected OPs were associated with severity of 
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knee OA [9, 63, 111]. However, there are only two longitudinal studies, which report 
inconsistent results [110, 112]. The first did not find any significant associations 
between MRI-detected OPs and knee structural progression [110]. The second was a 
nested case-control study reporting that subjects with 6 or more locations affected by 
OPs had 4.4-fold increased odds of being both radiographic and pain progression 
compared with 0-2 locations affected [112]. The reasons for the discrepancy in the 
findings are unknown, but more longitudinal studies are needed to elucidate the 
relationship between MRI-detected OPs and clinical changes of OA.  
1.3 Cartilage abnormalities 
1.3.1 Cartilage volume  
High-resolution MRI has been used to quantify cartilage volume in OA [113, 114]. The 
most common technique involves estimation of the volumes of individual cartilage 
plates by manually drawing cartilage contours around the cartilage boundaries section 
by section, which are then reassampled by means of bilinear and cubic interpolation to 
give a total volume. Examples of segmentation are illustrated in Figure 1.4 
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Figure 1.4 Sample of cartilage volume segmentation 
Source: Grau et al. “Improved watershed transform for medical image segmentation using 
prior information”. In: IEEE Trans Med Imaging 23.4 (2004), pp. 447-458 
The relationship between cartilage volume and radiographic grade of OA has been 
reported broadly but longitudinal associations are uncertain. Cicuttini et al. [115] found 
that the inverse association between JSN  score and cartilage volume was stronger than 
that between OPs score and cartilage volume. Jones et al. [116] reported similar 
findings in the lateral tibia and patella compartments. In the patellofemoral (PF) joint, 
significant inverse associations were also found on lateral and skyline PF radiographs 
[117]. However, only few longitudinal studies directly compared cartilage volume 
change to quantitative measurements of radiographs, which generated controversial 
findings. Bruyere et al. [118] reported a significant association between changes in JSN 
and changes in cartilage volume in knee joint. In contrast, Gandy et al. [119] described 
no statistical correlation between cartilage volume loss and radiographic changes in any 
of the knee compartments. In general, a systematic review concluded that there is 
moderate association between cartilage volume loss and reduced radiographic joint 
space [120].  
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The link between cartilage volume and clinical symptoms is also widely reported and 
associations are consistent. Hunter et al. [45] found a significant negative association 
of patellar cartilage volume with the total WOMAC knee pain in a cross-sectional study 
of community-based population. Wluka et al. [121] observed a moderate correlation 
between tibial cartilage volume and symptoms in a cross-sectional study of early 
symptomatic knee OA. On the other hand, Raynauld et al. [119] reported no association 
between cartilage volume loss and worsening of symptoms. One study revealed that for 
each 1% increase rate of tibial cartilage volume loss, there was a 20% increase risk of 
knee replacement four years later [122]. Overall, the measurement of cartilage volume 
using MRI can provide longitudinal quantification of cartilage loss and assess clinical 
progressions of OA [123].  
1.3.2 Cartilage defects 
MRI can also visualize knee cartilage defects directly. There are several grading 
systems to assess the severity of cartilage defects using MRI, such as Whole Organ MR 
Scoring (WORMS) systems and Boston-Leeds Osteoarthritis Knee Scoring (BLOKS) 
[124, 125]. Our previous studies graded cartilage defects using a validated classification 
system that based on following criteria. Grade 0, normal cartilage; grade 1, focal 
blistering and intracartilaginous low signal intensity area with an intact surface and 
bottom; grade 2, irregularities on the surface or bottom and loss of thickness of less 
than 50%; grade 3, deep ulceration with loss of thickness of more than 50%; grade 4, 
full-thickness cartilage wear with exposure of subchondral bone [126-128].  A cartilage 
defect had to be present in at least two consecutive slices. This grading system is also 
used in current thesis. Figure 1.5 illustrated examples of cartilage defect grading.  
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Figure 1.5 Representative sagittal T1-weighted fat-suppressed 3-dimensional magnetic 
resonance images illustrating cartilage defects grading  
A, normal patellar cartilage but with cartilage defect of grade 1 at tibial (up arrow) and 
femoral (down arrow) sites. B, Cartilage defects of grade 2 at tibial site (up arrow), of grade 1 at 
femoral site (down arrow), and of grade 3 at patellar site (left arrow). C, cartilage defects of grade 3 at 
tibial (up arrow) and femoral (down arrow) sites. D, cartilage defects of grade 4 at tibial site (up arrow) 
and of grade 2 at femoral site (down arrow). 
Source: Cicuttini et al. “Association of cartilage defects with loss of knee cartilage in healthy, 
middle-age adults: a prospective study”. In: Arthritis & Rheumatology, 52.7 (2005), 2033-9. 
Cartilage defects are common and highly variable. In a cohort study of predominantly 
non-osteoarthritic adults, about 20% of participants had increased cartilage defects in 
total knee compartment over 2 years [129], while in older healthy participants, about 
two-thirds had increased cartilage defects over 2 years [128]. In patients with 
symptomatic OA, 46% had increased cartilage defects in the medial tibiofemoral 
compartment and 22% had increased cartilage defects in the lateral tibiofemoral [130]. 
Interestingly, other studies report reduction in cartilage defect grade over time [128, 
129, 131]. It is unclear if this is physiological or whether related to other factors such 
as measurement error. Two high-quality cohort studies of healthy, community-based 
participants reported an inverse relationship between physical activity and cartilage 
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defects, indicating beneficial effects of physical activity [132, 133]. According to a 
study that investigated the natural history of cartilage defects among knee OA patients, 
the factors related to cartilage defect change over 2 years included age, sex, BMI, 
baseline cartilage defect score and baseline tibial plateau bone area. Height, weight 
were not related to cartilage defect change [134].   
Many studies have examined the predictive value of cartilage defects to MRI-detected 
OA progression. One reported that baseline cartilage defect scores at all knee 
compartments had a dose-response relationship with change of cartilage volume at the 
corresponding site [127]. Additionally, decreased knee cartilage defect score was 
associated with increased cartilage volume at all compartments [135].  Another study 
revealed that increased cartilage defect score was significantly related to baseline 
tibiofemoral OP, tibial bone area, and medial tibiofemoral and patellar cartilage volume 
[129]. Prevalent knee cartilage defects were also correlated to BMLs [136, 137], 
meniscal tears [136] anterior cruciate ligament tears [131], and synovial thickening 
[138]. These studies suggested that cartilage defect is a solid predictor of MRI-detected 
structural progression of OA overtime. 
There is consistent evidence showing that cartilage defects are significantly associated 
with pain, and this is largely independent of other structural features [23, 67, 84, 139]. 
In a population-based cohort study, medial tibial cartilage defects scores were 
independently associated with severity of knee pain [23]. Moreover, a dose-response 
relationship was also found between knee pain severity and the number of sites having 
grade 3 or 4 cartilage defects [23]. The majority of associations were independent of 
radiographic OA and BMLs [23, 111]. Knee cartilage defects also predict total knee 
replacement (TKR). In a cohort of 117 subjects with symptomatic knee OA, higher 
total cartilage defect scores conferred a 6-fold increased risk of TKR over 4 years 
compared with those lower scores [140]. Data from the Osteoarthritis Initiative (OAI) 
showed that baseline cartilage defect scores were the strongest independent predictors 
of subsequent knee replacement [141]. In general, these studies suggested that cartilage 
defect can serve as a promising biomarker to identify OA patients at risk for disease 
progressions.  
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1.4 Systematic inflammation 
1.4.1 Interleukins  
Despite OA being traditionally regarded as a non-inflammatory arthritis, growing 
evidence has shown that the clinical course of OA may be largely driven by systemic 
and localized inflammation [26, 142], albeit at much lower levels than the recognized 
inflammatory arthropathies [10, 143]. Cytokines such as interleukin 1(IL-1), IL-6, IL-
8 and TNF-α are related to morphological changes including cartilage erosion and 
synovial inflammation [144-146]. Moreover, a relatively insufficient production of 
natural antagonist of IL-1 receptor in OA synovium could be associated with over 
production of nitric oxide in OA tissues [147]. In the pathophysiology of OA, 
interleukins play important roles in synovitis, cartilage destruction and pain [148, 149]. 
IL-6 is a 184 amino acid residue protein [149] which has both pro- and anti-
inflammatory effects both inside and outside of the joint [150, 151]. Although emerging 
evidence suggests that low-level systemic inflammation is involved in OA pathogenesis 
[26, 152], so far the role of IL-6 in OA process remains debatable. In a spontaneous 
ageing model of OA, mice deficient in IL-6 have higher levels of cartilage loss, 
suggesting a potentially protective role of IL-6 in the development of OA [153]. By 
contrast, higher serum IL-6 concentrations were related to higher prevalence of OPs in 
older adults [142] and circulating levels of IL-6 have been related to prevalence of knee 
OA [143].  
On the other hand, some interleukins have anti-inflammatory effects. IL-4, IL-10 and 
IL-13 are among those interleukins that can modulate various inflammatory processes 
[154, 155]. Their anti-inflammatory properties appear to largely depend on the target 
inflammatory cytokines. For example, IL-4 can surpress synthesis of both TNF- α and 
IL-1β in the same manner as low-dose dexamethasone [156]. Similarly, IL-10 can 
inhibit the synthesis of TNF-α and IL-1 [157], and IL-13 significantly inhibits 
lipopolysaccharide (LPS)-induced TNF- α production by mononuclear cells from 
peripheral blood, but not in cells from inflamed synovial fluid [158]. Although the 
applicability has yet to be proven, these anti-inflammatory interleukins can have 
potential for OA treatments.  
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T-helper 17 (Th-17) cells have been identified as a subset of CD4 (+) T helper (Th) 
cells that is differentiated from Th1 and Th2 cells [159, 160], and involved in a number 
of inflammatory and autoimmune diseases such as multiple sclerosis, rheumatoid 
arthritis (RA), psoriasis and inflammatory bowel disease [161, 162].  IL-17A and IL-
17F are the prototypical members of the IL-17 cytokine family, which are produced by 
Th-17 [163]. They share the most homology at the amino acid level and have 
overlapping but also distinct effector functions on autoimmune diseases [164, 165]. 
Cytokines such as IL-1, IL-6, IL-23 and TGF-β can promote the differentiation of CD4 
(+) cells, leading to the expression of IL-17A, IL17F and IL-6 [166, 167].  
Apart from playing critical roles in the aetiology and progression of autoimmune 
diseases, these Th-17 family interleukins also play crucial roles in the initiation of local 
inflammatory reaction [168] and cartilage destruction [169]. Previous studies revealed 
that IL-17A induces production of IL-1β, IL-6 and TNF-α, the major pro-inflammatory 
cytokines in OA [170]. Chen et al. [171] reported a positive association between knee 
OA severity and IL-17 concentration in synovial fluid, but not in serum. Liu et at [172] 
demonstrated that synovial IL-17 level was correlated with severity of knee pain, but 
not with ROA severity. These studies have limitations such as cross-sectional design, 
small sample size and lack of adjustment for potential confounders. A recent case-
control study reported that increased serum level of IL-17A and IL-23 were related to 
increased pain in OA patients [173]. To date, however, longitudinal studies looking at 
the roles of Th-17 family interleukins on OA aetiology are still rare.  
1.4.2 hs-CRP 
C-reactive protein (CRP) is a circulating marker of systemic inflammation. It is 
synthesized by hepatocytes and adipocytes and can be regulated by pro-inflammatory 
cytokines [174]. In 1992, an immunoassay was introduced by Montagne et al. to 
perform high sensitive CRP (hs-CRP) measurement [175], which reflected low grade 
systemic inflammation and was not able to be detected using previous method. Only 1 
year later, a study reported that CRP concentrations are elevated in OA patients but to 
a lesser extent than in RA patients [176]. Since then, numerous studies have explored 
the relationship between systemic or local level of CRP and OA onset using multiple 
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methodologies. Studies have found that comparing with healthy controls, circulating 
levels of hs-CRP are significantly higher in OA patients [177-179]. A meta-analysis 
concluded that there was a moderate but statistically significant association between 
hs-CRP levels and increasing pain score, and worsening physical function; however, 
this meta-analysis concluded hs-CRP level was not associated with K/L scores or JSN 
[180].  
With regards to the predictive value of hs-CRP for OA progression, the findings from 
studies are controversial. The study by Sharif et al. [181] revealed higher serum level 
of CRP in participants with progression of knee OA compared with controls. This was 
not supported by Rotterdam Study with a much bigger dataset, which showed lower 
serum levels of CRP in participants with progression of knee OA, compared with 
controls [182]. Sower et al [183] evaluated CRP concentration as a potential biomarker 
of prevalence and incidence of knee OA, and found that women with knee OA onset 
over 2.5-year had significantly higher CRP concentrations; however, its high 
dependence on obesity limits its utility as an exclusive biomarker for knee OA. Kerkhof 
et al. [184] conducted another meta-analysis and concluded no evidence of links 
between serum CRP concentrations and OA independent of BMI.  
Studies regarding associations between CRP and BMLs are rare. One cross-sectional 
study with a limited sample size (n=30) found no significant differences in hs-CRP 
levels between patients with and without BMLs, but this may be due to type 2 errors 
from that small sample size [185]. Another cross-sectional study with 194 participants 
involved showed that in patients with the highest quartile of hs-CRP, IL-17 was 
positively associated with BMLs at femoral compartment [186]. Therefore, 
longitudinal studies are required to determine the associations between CRP and BMLs 
in the development and progression of OA.  
1.5 Summary 
OA is one of the leading cause of pain, loss of function and disability amongst the 
elderly. Knees are the most commonly affected joints [2]. OA constitutes 63% of 
hospital inpatient expenditure while RA just 3.5%. Moreover, OA account for 30% of 
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hospital outpatient expenditure, in contrast of 16.3% attributed to RA. It is predicted 
that 7 million Australians will suffer from arthritis by 2050, among which OA 
contributes the largest proportion [187].  
 
Emerging evidence suggests that subchondral bone changes play vital roles in the onset 
and progression of OA. BMLs and OPs are typical subchondral bone changes that are 
pathological and related to OA [109]. There are very few clinical studies examining 
BMLs at the specific site of PFJ, and the natural history of PFJ BMLs has not yet been 
described. Additionally, whether systemic inflammation involved in the aetiology of 
BMLs in OA patients is unknown. OPs visible on radiographs have been viewed as a 
hallmark and defining structural feature of OA since 1950s; however, the predictive 
value of radiographic OPs on OA symptomatic and structural progression is poor, with 
only modest correlations between knee OPs and clinical features of OA [47, 103]. On 
the other hand, MRI-detected OPs can assess OPs in locations that are not easily 
visualised by radiographs [105, 188], and have higher sensitivity than conventional 
radiographs for detection of early OP formation [104]. 
 
The following chapters describe the natural history of BMLs at the rarely studied PFJ 
compartment and evaluate the role of systemic inflammations in the aetiology of BMLs. 
Furthermore, cross-sectional and longitudinal relationships between MRI-detected OPs 
and knee structural abnormalities as well as knee pain change are investigated in the 
following chapters.  
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The following research questions are summarised based on background and rationales 
introduced in Chapter 1 of this thesis. 
 
1. To describe the natural history of patellofemoral joint (PFJ) BMLs over 2.6 years and 
longitudinal associations between change in PFJ BMLs over 2.6 years, knee pain 
change over 5 years and baseline knee cartilage morphology in older adults. 
a) Is BML at PFJ static or variable over 2.6 years? 
b) Do changes in PFJ BMLs over 2.6 years correlate with knee pain changes over 5 years?  
c) Can baseline cartilage morphology predict PFJ BMLs changes over 2.6 years? 
 
2. To evaluate the cross-sectional and longitudinal associations between serum level of 
high sensitivity C reactive protein (hs-CRP) at baseline, knee BMLs and knee pain in 
patients with knee OA at baseline and changes over 2 years. 
a) What are the cross-sectional and longitudinal associations between baseline serum hs-
CRP and baseline as well as change of knee BMLs over 2 years in patients with 
symptomatic knee OA? 
b) What are the cross-sectional and longitudinal associations between baseline serum hs-
CRP and baseline as well as change of knee pain in patients with symptomatic knee 
OA? 
 
3. To examine the cross-sectional and longitudinal associations between serum levels of 
interleukin (IL)-6, IL-17A, IL-17F, IL-23 and knee BMLs in patients with knee OA.  
a) What are the cross-sectional and longitudinal associations between baseline serum 
autoimmunity-related interleukins and baseline as well as change of knee BMLs in 
patients with symptomatic knee OA? 
 
4. To investigate the cross-sectional and longitudinal associations between baseline MRI-
detected OPs and knee structural abnormalities over 2.6 years as well as knee pain over 
5 years in older adults.  
a) What is the prevalence and distribution of MRI-detected OPs in generally older 
population? 
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b) Can baseline MRI-detected OPs predict structural and symptomatic progression of OA 
over 2.6 years? 
 
5. To describe the prevalence of MRI-OPs that can be detected by MRI but not by x-ray, 
and to evaluate the longitudinal associations with knee pain change over 5 years and 
structural changes over 2.6 years.  
a) Is MRI-OPs common in a generally older population?  
b) Can MRI-OPs serve as a biomarker that predicts progression of OA over time? 
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3.1 Prelude 
 This chapter delineates the study population and design for the Tasmania Older Adult 
Cohort (TASOAC) and Vitamin D Effect on Osteoarthritis (VIDEO) studies as well as 
protocols of exposure and outcome measurements. These measurements are common 
in the subsequent chapters. Chapter 4, 7 and 8 stemmed from analyses using the data 
from TASOAC study. Chapter 5 and 6 arose from analyses using the data from VIDEO 
study. Data chapters are presented in the form in which they were submitted to, or 
accepted by peer-reviewed journals for publication. Due to requests from journal 
reviewers, there were some differences in the presentation of methods, analyses, results, 
and interpretations throughout these chapters.  
 
3.2 Tasmanian Older Adult Cohort (TASOAC) Study design 
3.2.1 Study design  
The TASOAC study is an ongoing, prospective, population-based cohort study that 
aims at identifying the genetic, environmental, and biochemical factors associated with 
the development and progression of OA. Baseline data collection were ascertained from 
April 2002 to September 2004. The follow-up study was carried out at 2.7 years later 
(range 2.6-3.3 years), with pain assessment performed also at a second follow-up at 
about 5 years later (range 5.3-6.8 years).  
3.2.2 Ethics  
The Southern Tasmanian Health and Medical Human Research Ethics Committee 
approved the study (Ethics Approval Number: H6488). Written informed consent was 
obtained from all participants.  
3.2.3 Study population  
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TASOAC consisted of older adults between the ages of 50 and 80 (mean: 62 years; 
standard deviation (SD): 7 years). Participants were randomly selected from the 
electoral roll of Southern Tasmania. The electoral roll represents the most complete 
population listing of Australian adults available, as voting is compulsory in state and 
federal elections. Sex stratified simple random sampling was used to provide equal 
number of males and females in the final cohort. Equal distribution was also drawn 
from rural and urban regions in Southern Tasmania. Institutionalized older adults were 
excluded as TASOAC study was designed to investigate community dwelling older 
adults. Participants with contraindications for MRI (including iron filings in the eye, 
claustrophobia, metal suture and presence of shrapnel) were also excluded. 2135 
eligible participants were identified initially, from which 1100 participants were 
enrolled in the study. The MRI scanner was decommissioned halfway through the phase 
2 follow-up period, resulting in only about half of the phase 2 participants with follow-
up MRI images. 
3.2.4 Demographic characteristics  
Age, gender, race, education and occupation were recorded and collected by 
questionnaires at baseline.  
3.2.5 Anthropometrics 
Weight was measured with shoes, socks and bulky clothing removed using electronic 
scales (nearest 0.1kg). Height was measured with shoes, socks and headgear removed 
using a stadiometer (nearest 0.1cm). Body mass index (BMI) was calculated using 
height and weight (kg/m2). 
3.2.6  Radiographic measurements 
A standing anteroposterior semiflexed view of the right and left knee was performed 
with 15°of fixed knee flexion was performed in all subjects at baseline and scored 
individually for osteophytes (OPs) and joint space narrowing (JSN) on a scale of 0-3 
(0=normal and 3=severe) based on the Altman atlas as previously described [189]. 
Medial tibiofemoral or lateral tibiofemoral JSN was scored separately. OPs were scored 
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at each site of medial tibia, medial femur, lateral tibia and lateral femur. Each score was 
determined by consensus of two readers who simultaneously assessed the radiograph 
with immediate reference to the atlas. The prevalence of medial or lateral tibiofemoral 
JSN or OPs was defined as the presence of radiographic osteoarthritis (ROA) [190].  
3.2.7 MRI measurements 
Magnetic Resonance Imaging 
MRI scans of the right knees were performed on two phases (baseline and 2.6 years 
later) and scanned in the sagittal plane on a 1.5-T whole body magnetic resonance unit 
(Picker, Cleveland, OH, USA) using a commercial transmit-receive extremity coil. The 
image sequences were used as follow: (1) T1-weighted fat saturation 3D gradient recall 
acquisition in the steady state; flip angle 30°; repetition time 31 ms; echo time 6.71 ms; 
field of view 16 cm; 60 partitions; 512×512 matrix; acquisition time 11 min 56 s; one 
acquisition. Sagittal images were obtained at a partition thickness of 1.5 mm and an in-
plane resolution of 0.31×0.31 (512×512 pixels). (2) a T2-weighted fat saturation 3-D 
fast spin echo, flip angle 90, repetition time 3067 ms, echo time 112 ms, field of view 
16 cm, 15 partitions, 228x256-pixel matrix; sagittal images were obtained at a partition 
thickness of 4 mm with a between-slices gap of 0.5 to 1.0 mm. The image database was 
transferred to a computer workstation using the software program Osirix (University of 
Geneva, Geneva, Switzerland) as previously described [116, 191]. 
 
Cartilage defects 
Knee cartilage defects were measured by a trained observer on T1-weighted MR image 
at baseline and 2.6-year follow-up according to previously described criteria [126, 192]. 
Grade 0, normal cartilage; grade 1, focal blistering and low-signal intensity change with 
an intact surface and bottom; grade 2, irregularities on the surface or bottom and loss 
of thickness of less than 50%; grade 3, deep ulceration with loss of thickness of more 
than 50%; grade 4, full thickness cartilage loss with exposure of subchondral bone 
[126]. The worst score of each individual site in the relevant compartment (or whole 
knee) was regarded as the cartilage defect score in that compartment (or whole knee). 
The reader was blinded of the initial results at the time of the second reading. The 
presence of cartilage defects was defined as a cartilage defect score of ≥2 at any site. 
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An increase in cartilage defects was defined as a change of cartilage defect score ≥1. 
Intra-observer reliability (expressed as ICC) was 0.89-0.94 and inter-observer 
reliability was 0.85-0.93 [126]. 
 
Cartilage volume 
Knee cartilage volume was measured on T1-weighted images by a single trained 
observer [126]. The volumes of individual cartilage plates (medial tibial, lateral tibial, 
medial femoral, lateral femoral, patellar and trochlear) were isolated from the total 
volume by manually drawing disarticulation contours around the cartilage boundaries 
on a section by section basis. These data were then reassembled by means of bilinear 
and cubic interpolation (area of 312×312 um and 1.5 mm thickness, continuous 
sections) for the final 3-dimentional rendering. The volume of patellofemoral and 
tibiofemoral compartments were obtained by summing the pertinent cartilage plates 
within compartments. Changes in cartilage volume were calculated as: percentage 
change per annum= [(follow-up volume-baseline volume)/baseline cartilage 
volume]/time between 2 scans in years×100. The coefficient of variation (CV) for 
cartilage volume assessments was 2.1% to 2.6% [193, 194].  
 
Subchondral BMLs evaluation 
Subchondral BMLs were defined as discrete areas of increased signal adjoining to the 
subchondral bone on T2-weighted MR images and were scored at medial tibial, lateral 
tibial, medial femoral, lateral femoral, medial patellar and lateral patellar regions using 
Whole-Organ Magnetic Resonance Imaging Score (WORMS) [125]. Grade 0, absence 
of BML; grade 1, area smaller than 25% of the region; grade 2, area between 25% to 
50% of the region; grade 3, are larger than 50% of the region. Each BML was scored 
according to the maximal percentage of bone are that the lesion occupied on the slice. 
The worst score of each individual site in the relevant compartment (or whole knee) 
was regarded as the BML score in that compartment (or whole knee). PFJ compartment 
BMLs were calculated by summing BML scores of patella and trochlea (anterior 
femoral). An increase in BMLs was deemed as a change in BMLs of ≥1 from baseline 
to follow-up at certain compartment. The inter-reader reliability of current BML 
scoring system was excellent [71, 195].  
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Osteophytes  
MRI-detected osteophytes (OPs) were measured according to the Knee Osteoarthritis 
Scoring System [196] where OPs are defined as focal bony excrescences, seen on 
sagittal, axial or coronal images, extending from a cortical surface. OPs were assessed 
using the following scale: grade 0, absent; grade 1, minimal (<3 mm); grade 2, moderate 
(3-5 mm); grade 3, severe (> 5 mm). Size was measured from the base (distinguished 
from that of adjacent articular cartilage with a normal MRI appearance) to the tip of OP 
[188] at each of the following 14 sites: the anterior (a), central weight-bearing (c) and 
posterior (p) margins of the femoral condyles and tibial plateaus, and the medial (M) 
and lateral (L) margins of the patella [125]. The worst score of each individual site in 
the relevant compartment (or whole knee) was regarded as the OP score in that 
compartment (or whole knee). MRI-detected OP was considered as present if OP score 
of ≥ 1. Intra-rater reliability (expressed as ICC) was 0.94-0.97 and inter-rater reliability 
was 0.90-0.96.  
 
 
Figure 3. 1 Examples of osteophytes assessed at different sites on MRI 
 LAF=lateral anterior femoral (grade 1); LAT=lateral anterior tibial (grade 2); MAF=medial 
anterior femoral (grade 1); MAT=medial anterior tibial (grade 0); LCF=lateral central femoral (grade 
3); LCT=lateral central tibial (grade 1); MCF=medial central femoral (grade 1); MCT=medial central 
tibial (grade 1); LP=lateral patella (grade 3); MP=medial patella (grade 0). 
 
Meniscal damage 
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Meniscal damage was measured on T1-weighted MR images as previously described 
[197]. For meniscal tears, the following scale was applied: 0 = no damage; 1 = one of 
three meniscal areas involved (anterior, middle, and posterior horns); 2 = two of three 
areas involved; 3 = all three areas involved. For meniscal extrusions, the extent of 
meniscal extrusion on the medial or lateral edges of the tibiofemoral joint space, not 
including the osteophytes, was evaluated for the anterior, middle, and posterior horns 
of the mensci in which 0 = no extrusion, 1 = partial meniscal extrusion, and 2 = 
complete meniscal extrusion with no contact with the joint space. Anterior, posterior 
and middle scores were summed to get medial and lateral meniscal tear/extrusion 
scores. The worst meniscal tear/extrusion score of medial or lateral compartment was 
regarded as total meniscal tear/extrusion score. The intra- and inter- rater correlation 
coefficient ranged from 0.86 to 0.96 for meniscal tear and 0.85 to 0.92 for meniscal 
extrusion [198].  
 
Bone size 
Knee tibial plateau bone areas were assessed from T1 MRI using an independent work 
station and the software program Osiris unpaired and unblinded to sequence [116]. 
Medial and lateral tibial plateau bone areas were uniform in nature and thus can be 
measured directly from the reformatted axial images. The CVs for these measures are 
2.2-2.6% [189]. 
3.2.8 WOMAC pain assessment  
Knee pain was measured at knee level using Western Ontario McMaster Osteoarthritis 
Index (WOMAC) [23]  using a 10-point scale from 0 (no pain) to 9 (most severe pain) 
at baseline, 2.6 and 5 years later. The 5 subscales (walking on flat surface, going 
up/down stairs, at night, sitting/lying and standing upright) were assessed separately 
and summed to create a total pain score (0 to 45). Change in knee pain score was 
calculated as follow-up value – baseline value. An increase in total WOMAC pain was 
defined as a change in WOMAC pain score of ≥ 1.  
 
3.3 Vitamin D Effect on Osteoarthritis (VIDEO) Study design 
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3.3.1 Study design  
VIDEO is a multicentre, parallel group randomised, placebo-controlled and double-
blinded clinical trial which aims to examine the effects of vitamin D supplementation 
on knee pain and structural changes in patients with symptomatic knee OA and low 25-
hydroxyvitamin D (25OHD) level. The inclusion and exclusion criteria are listed as 
follows: 
 
Inclusion criteria: 
a) Age 50-79 years old; 
b) Meet the American College of Rheumatology (ACR) criteria [6] of symptomatic knee 
OA diagnosis by an experienced rheumatologist;  
c) Men and women with symptomatic knee OA for at least 6 months with a pain visual 
analogue scale (VAS) of at least 20 mm;  
d) Relatively good health (0-2 according to the investigators global assessment of 
disease status on a 5-point Likert scale, range 0[very well] to 4 [very poor]);  
e) An ACR functional class rating of I, II and III [199]; 
f) Serum vitamin D level of >12.5 nmol/L and <60 nmol/L 
 
Exclusion criteria: 
a) Severe knee ROA (grade 3 according to Altman’s atlas [34]); 
b) Severe knee pain (more than 80 mm on a 100-mm VAS); 
c) With hypersensitivity to vitamin D; 
d) With rheumatoid arthritis, psoriatic arthritis, lupus, or cancer; 
e) With severe cardiac or renal function impairment; 
f) With any condition possibly affecting oral drug absorption (gastrectomy or clinically 
significant diabetic gastro-enteropathy);  
g) Significant trauma to the knees including arthroscopy or significant injury to 
ligaments or menisci of the knee within 1 year preceding the study; 
h) Having taken vitamin D supplementation in last 30 days; 
i) Need for knee or hip surgery in the next 2 years; 
3.3.2 Study population  
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The VIDEO study was conducted in Melbourne and Hobart, Australia. Sample size 
calculation had been done before patient recruitment and 200 patients in each arm 
(allowing fo a 20% dropout over 2 years) were calculated to be sufficient to detect the 
differences between treatment groups [52, 200]. Sample size calculation assumed 
α=0.05 and β=0.20, and was performed using the Cohen formula [201]. Participants 
were recruited using various strategy, including collaboration with general 
practitioners, specialist rheumatologists, and orthopaedic surgeons. A total of 599 
participants were screened for from 5 Jun 2010 to 1 Dec 2011, with 413 participants 
recruited for randomization. Figure 3.2 illustrates outlines of participant recruitment 
and withdrawal during study period.  
 
192 participants (mean 63 years, range 49-79 years, female 53%) in Hobart were 
selected from VIDEO study population to have hs-CRP and other inflammatory 
interleukins measurements.  
3.3.3 Ethics  
The Tasmania Health and Human Medical Research Ethics Committee (reference 
number H1040) and Monash University Human Research Ethics Committee (reference 
number CF10/1182-2010000616) approved this study. Informed written consent was 
obtained from all participants.  
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Figure 3. 2 Flow chat of participant recruitment in VIDEO study 
Source: Jin et al “Effect of vitamin D supplementation on tibial cartilage volume and knee pain among 
patients with symptomatic knee osteoarthritis” in JAMA 315.10 (2016), 1005-13 
3.3.4 25OHD assays  
In the original RCT study, after randomisation, participants in the intervention and 
control groups were given a monthly capsule of 50,000 IU (1.25 mg) vitamin D3 
(cholecalciferol) and placebo, respectively, for 24 months in total [202]. Serum 25OHD 
was assayed by Liaison method utilizing a direct competitive chemiluminescent 
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immunoassays (DiaSorin Inc, Stillwater, Minnesota, USA) at screening, month 3 and 
month 24, The intra-assay and inter-assay coefficients of variation were 3.2% and 
6.0%.  
3.3.5 Serum inflammatory markers measurements  
Hs-CRP 
Serum levels of hs-CRP were assayed at baseline and after 24 months using enzyme-
linked immunosorbent assay [203]. The minimal detectable concentration is around 
0.02 ug/ml. The coefficients of variation (CVs) in our hands was 5.8%-6.3%. Change 
in serum levels of hs-CRP was calculated as: follow-up value – baseline value.  
  
Interleukins  
Serum levels of IL-6, IL-17A, IL-17F and IL-23 were assayed at baseline and after 24 
months using enzymelinked immunosorbent assay [10]. The limits of detection are 0.49 
pg/ml, 1.84 pg/ml, 14.6 pg/ml and 34.4 pg/ml respectively. The coefficients of variation 
(CVs) were 5.8%-6.3%.  
3.3.6 Anthropometrics 
Height and weight were measured as described in section 3.2.4, and body mass index 
(BMI) was calculated accordingly (weight/height2).  
3.3.7 Demographic characteristics  
Age and gender were recorded.  
3.3.8 WOMAC knee pain assessment 
Knee pain was assessed using the WOMAC questionnaire [204] at baseline and 24 
months later. Five items were used to assess pain: walking on flat surface, when 
standing upright, when going up/down stairs, at night in the bed and when sitting/lying. 
In contrast with TASOAC study, these items were assessed using 100 mm visual 
analogue scales in VIDEO study. Total pain score (range 0-500) was obtained by 
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summing up all items. Change in total knee pain was calculated as (follow-up value-
baseline value of total pain scores).  
3.3.9  BMLs assessment  
Subchondral BMLs were defined as discrete areas of increased signal adjoining the 
subchondral bone on T2-weighted MR images and scored at medial tibial, lateral tibial, 
medial femoral, lateral femoral, medial patellar and lateral patellar regions using a 
modified version of Whole-Organ Magnetic Resonance Imaging Score (WORMS) 
[125]. Grade 0, absence of BML; grade 1, area smaller than 25% of the region; grade 
2, area between 25% to 50% of the region; grade 3, are larger than 50% of the region. 
In the modified WORMS, the medial and lateral tibial and femoral compartments are 
divided into three sub-regions (anterior, central, posterior), and the tibia has an 
additional spinous sub-regions which represents the portion of the tibia beneath the 
tibial spines. Each BML was scored according to the maximal percentage of bone area 
that the lesion occupied on the same slice. The worst score of each individual site in 
the relevant compartment (or whole knee) was regarded as the BML score in that 
compartment (or whole knee). An increase in BMLs was defined as a change in BMLs 
of ≥1 from baseline to follow-up at certain compartment. The intra-rater reliability 
(ICC=0.93-0.98) and inter-rater reliability (ICC=0.91-0.97) were excellent.  
 
3.4  Statistical Analysis 
T-tests or χ2 tests were used to compare means or proportions as appropriate. Standard 
diagnostic checks of residuals and model fit comparisons were performed routinely. A 
p value less than 0.05 (two-tailed) was considered statistically significant. All statistical 
analyses were performed on Stata12.0 for Windows (Stata Corporation, TX, USA) 
Detailed statistical analyses descriptions are presented in each chapter. 
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Chapter 4: 
Patellofemoral bone marrow lesions: natural history and 
associations with pain and structure  
This manuscript has been published (Zhu et al Arthritis Care & Research. 2016; 68(11)). 
The typeset version of the manuscript as it appeared in the journal is in Appendix 1. 
The text of this chapter is the same as the published version, except where changes have 
been requested by the examiners. Thus, there is some repetition of the methods. 
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4.1 Introduction 
Structural abnormalities in the subchondral bone are key players in the pathogenesis of 
OA [54]. BMLs are ill-defined hyperintense features seen on magnetic resonance (MR) 
images. In the whole knee, they precede cartilage pathology, including cartilage defects 
and cartilage volume loss [85, 126]. BMLs are associated with knee pain [75]and 
predict disease progression [78, 79]. Incident BMLs and increases in BML size are 
linked to the development of knee pain in pain-free subjects [76]; and increases in BML 
size are associated with increasing knee pain over time [77]. Kothari et al. [61]and 
Aitken et al. [205] reported that baseline BMLs were associated with cartilage loss in 
the same subregion. Raynauld et at. [71] Found that an increase in BML size was 
associated with cartilage volume loss in the medial but not in lateral compartment.  
The natural history of BMLs has been reported in some longitudinal studies. The 
MOST (Multi-centre Osteoarthritis) study [72]showed the one-third of knees without 
baseline BMLs developed new lesions at follow-up, 50% of the prevalent BMLs either 
regressed or resolved. Previous analyses from our cohort [74] assessed knee joint BMLs 
at four sites (medial tibial, media femoral, lateral tibial, and lateral femoral sites). This 
showed that 43% of participants had BMLs, of these 25% decreased in size and 24% 
increased in 2.7-year follow-up.  In a younger cohort, Foong. et al followed 198 patients 
over eight years and found that knee BML size remained stable in over half of the 
participants [206]. However, both of these studies reported BMLs in the tibiofemoral 
compartment or total knee BMLs, and did not report patellar BMLs. The patellofemoral 
joint (PFJ) is a common site of pain [207] and contributes to functional limitation 
among OA patients [208]; thus, it is important to assess patellar sources of knee pain. 
Despite the high prevalence of PFJ OA, there are very few clinical or epidemiological 
studies that investigate PFJ OA particularly and the natural history of PFJ BMLs had 
not yet been described.  
The aim of this study was, therefore, to describe the natural history of MRI-detected 
PFJ BMLs over 2.6 years and evaluated the association between increases in PFJ 
BMLs, knee pain and knee cartilage morphology in older adults.  
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4.2  Materials and Methods 
4.2.1 Subjects  
This study was performed as part of the Tasmanian Older Adult Cohort (TASOAC) 
study, a population-based study that was designed to identify the genetic, 
environmental, and biochemical factors associated with the development and 
progression of OA at multiple sites. Subjects between 50 and 80 years old were 
randomly selected from the electoral roll in Southern Tasmania (population 229,000), 
with an equal number of males and females.  Baseline examinations were first taken in 
2002 and follow-up measures were taken at approximately 2.6 years later. This study 
was approved by the Southern Tasmanian Health and Medical Human Research Ethics 
Committee. Written informed consent was obtained from all subjects. 
4.2.2 Anthropometrics 
Weight was measured with shoes, socks and bulky clothing removed using electronic 
scales (nearest 0.1kg). Height was measured with shoes, socks and headgear removed 
using a stadiometer (nearest 0.1cm). Body mass index (BMI) was calculated using 
height and weight (kg/m2). 
4.2.3  Magnetic Resonance Imaging 
MRI scans of the right knees were performed on two occasions and imaged in the 
sagittal plane on a 1.5-T whole body magnetic resonance unit (Picker, Cleveland, OH) 
using a commercial transmit-receive extremity coil.  The image sequences used are 
listed as follows: (1) a T1-weighted fat saturation 3D gradient recall acquisition in the 
steady state; flip angle 30°; repetition time 31 ms; echo time 6.71 ms; field of view 16 
cm; 60 partitions; 512×512 matrix; acquisition time 11 min 56 s; one acquisition. 
Sagittal images were obtained at a partition thickness of 1.5 mm and an in-plane 
resolution of 0.31×0.31 (512×512 pixels). (2) a T2-weighted fat saturation 3-D fast spin 
echo, flip angle 90, repetition time 3067 ms, echo time 112 ms, field of view 16 cm, 15 
partitions, 228x256-pixel matrix; sagittal images were obtained at a partition thickness 
of 4 mm with a between-slices gap of 0.5 to 1.0 mm. The image database was 
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transferred to an independent computer workstation using the software program Osirix 
(University of Geneva, Geneva, Switzerland) as previously described [116, 191].  
4.2.4  Subchondral BML evaluation 
Subchondral BMLs were measured by one observer (ZZ) trained by readers with long 
experience in scoring knee MRIs (CD) on T2-weighted MR images and were defined 
as increased signal areas adjoining to the subchondral bone at the patellar and trochlear 
sites of knees. The MRI slice with the greatest BML size were selected and scored using 
Whole-Organ Magnetic Resonance Imaging Score (WORMS) method [125]. Baseline 
and follow-up MRIs were scored in pairs in chronological order to minimise 
measurement error [74] (Figure 1). PFJ compartment BMLs were obtained by summing 
the BML scores of patella and trochlea (range 0-6). Each BML was scored according 
to the maximal percentage of bone area that the lesion occupied on the slice. We scored 
grade 0 if no bone marrow lesions were present; grade 1 if lesion size ≤25% of the 
region on the same slice; grade 2, 25% to 50% of the region on the same slice; grade 3, 
>50% of the region on the same slice [125]. The inter-rater reliability of this BML 
scoring system is excellent, as reported previously [71]. The intraclass correlation 
coefficient (ICC) was 0.94 for intra-observer repeatability. An increase of 1 or more 
grade on the 0 to 3-point scale from baseline to follow-up in BMLs was defined as an 
increase in BML. Those whose scores remained the same or decreased by 1 or more 
grade were regarded as stable or having regressed. 
4.2.5  Cartilage defects assessment 
Cartilage defects were assessed by a trained observer (CD)  on T1-weighted MR image 
according to previously described criteria [126, 192]: grade 0 = normal cartilage; grade 
1 = focal blistering and intracartilaginous low-signal intensity area with an intact 
surface and bottom; grade 2 = irregularities on the surface or bottom and loss of 
thickness less than 50%; grade 3 = deep ulceration with loss of thickness more than 
50%; grade 4 = full-thickness chondral wear with exposure of subchondral bone. The 
worst grade was used if more than one defects existed at one site. Medial tibial, lateral 
tibial, medial femoral, lateral femoral, trochlear and patellar compartments were 
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measured. Scores for patellofemoral and tibiofemoral compartment were obtained by 
summing the individual defect scores in relevant regions. Intraclass correlation 
coefficients (ICCs) ranged from 0.80 to 0.95 for intraobserver reliability [209].  
4.2.6  Cartilage volume measurement 
Knee tibial and patellar cartilage volumes were measured on T1-weighted MR images 
by a single trained observer at baseline as previously described [126]. The volumes of 
individual cartilage plates (medial tibial, lateral tibial, medial femoral, lateral femoral, 
patellar and trochlear) were isolated from the total volume by manually drawing 
disarticulation contours around the cartilage boundaries on a section by section basis. 
These data were then resampled by means of bilinear and cubic interpolation (area of 
312×312 um and 1.5 mm thickness, continuous sections) for the final 3-dimensional 
rendering. The volume of patellofemoral and tibiofemoral compartments were obtained 
by summing the pertinent cartilage plates within compartments. The coefficient of 
variation (CV) for cartilage volume measures was 2.1% for medial tibial, and 2.2% for 
lateral tibial, 2.7% for medial femoral, 2.8% for lateral femoral, 2.6% for trochlea and 
2.6% for patella [194].  
4.2.7  Meniscal damage 
Meniscal damage was assessed by a trained observer on T1-weighted MR images as 
previously described [197]. The proportion of the menisci affected by a tear, partical or 
full extrusion was scored separately (yes/no) at the anterior, middle and posterior horns 
(medially/laterally). Anterior, middle and posterior scores were summed to get medial 
and lateral meniscal tear/extursion scores. The intra-and inter-observer correlation 
coefficient ranged from 0.86 to 0.96 for meniscal tear and 0.85 to 0.92 for meniscal 
extrusion [198].  
4.2.8  WOMAC knee pain assessment 
Knee pain was assessed using the Western Ontario McMaster Osteoarthritis Index 
(WOMAC) [204] at baseline, 2.6 and 5 years later using a 10-point scale from 0 (no 
pain) to 9 (most severe pain).  The 5 subscales (walking on flat surface, going up/down 
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stairs, at night, sitting/lying and standing upright) were assessed separately and summed 
to create a total pain score (0 to 45). 
4.2.9  Radiographic osteoarthritis  
A standing anteroposterior semiflexed view of the right and left knee with 15°of fixed 
knee flexion was performed in all subjects at baseline and scored individually for 
osteophytes and joint space narrowing (JSN) on a scale of 0-3 (0=normal and 3=severe) 
according to the Altman atlas as previously described [189]. Medial tibiofemoral or 
lateral tibiofemoral JSN was scored separately, while osteophytes were scored at each 
site of medial tibia, medial femur, lateral tibia and lateral femur. The prevalence of 
medial or lateral tibiofemoral JSN or osteophytes was defined as the presence of 
radiographic osteoarthritis (ROA) [190].  
4.2.10  Smoking 
Smoking status (never, or ever) was determined by questionnaire from the following 
questions: “Have you ever smoked cigarettes on a regular basis?” 
4.2.11  Knee bone size measurement  
Knee tibial plateau bone areas were measured using the software program Osiris as 
previously described [116]. Medial and lateral tibial plateau bone areas were uniform 
in nature and can be measured directly from the reformatted axial images. The CVs for 
these measures are 2.2-2.6% [116, 189].  
4.2.12  Data analysis 
Student’s t-tests and χ2 tests were used to compare differences between subjects with 
and without an increase in PFJ BMLs. Crude and adjusted linear regression was used 
to assess whether PFJ BML changes over 2.6 years were associated with changes in 
knee pain in the different sub-scales over 5 years, before and after adjustment for 
potential confounders (age, sex, BMI, baseline patellar BML, ROA, smoking status). 
Crude and adjusted log binomial regression was used to examine the associations 
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between increases in PFJ BMLs as an outcome, and baseline cartilage volumes as well 
as baseline cartilage defect scores as predictors, both before and after adjustment for 
potential confounders. A p-value less than 0.05 (2-tailed) was considered statistically 
significant. All statistical analyses were performed on Stata version 12.0 for Windows 
(StataCorp, College Station, TX, USA). 
4.3  Results 
4.3.1  Characteristics of the study population 
1100 participants aged between 51 and 81 (mean 63 years) were recruited to the 
TASOAC study. 406 subjects completed MRI measures at baseline and follow-up. MRI 
scans were discontinued after this sample due to decommissioning of the MRI scanner. 
WOMAC knee pain data were available on these subjects at 5 years’ follow-up.  As 
previously reported [210], study participants who did not complete MRI measures were 
similar to the remainder of the cohort in terms of demographics, smoking status, 
cartilage defects, BMLs, cartilage volume and ROA at baseline. 
The characteristics of the study sample grouped by increase or no increase in PFJ BMLs 
at 2.6 years follow-up are presented in Table 1. Subjects who had an increase in PFJ 
BMLs had a higher patellar cartilage defect score and lower patellar cartilage volume 
at baseline and were less likely to have smoked but were similar in terms of BMI. There 
were no significant differences in age, sex, BMI, knee pain and ROA (%) between 
people with increased PFJ BMLs and those without (Table 1). 
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Table 4. 1 Characteristics of the participants 
                                                           Patellofemoral joint BMLs 
 No Increase 
(n=321) 
Increase 
(n=85) 
 
p value 
Age 62.9±7.1 61.8±7.6 0.25 
Females (%) 50 50 0.86 
BMI (kg/m2 ) 27.5±4.3 28.0±4.9 0.38 
ROA present (%) 70 61 0.75 
Knee pain (%) 50 40 0.54 
Ever smoked (%) 50 40 0.04 
Tibia Bone size (cm2) 33.6±4.9 32.7±4.2 0.13 
PFJ  BMLs at baseline (%) 26 30 0.38 
TFJ BMLs at baseline (%) 32 42 0.09 
 PFJ Cartilage defect score at baseline 3.2±1.5 4.0±1.6 <0.01 
TFJ Cartilage defect score at baseline 4.2±1.8 4.4±1.6 0.37 
 PFJ cartilage volume at baseline  (ml) 6.5±1.6 6.2±1.5 0.07 
TFJ cartilage volume at baseline  (ml) 10.4±2.6 10.1±2.1 0.29 
Abbreviation: ROA, radiographic osteoarthritis; BMI, body mass index; PFJ, patellofemoral joint; TFJ, 
tibiofemoral joint; BMLs, bone marrow lesions. *Data are given as mean ± SD unless otherwise 
indicated. Student’s t-test or chi-square test (where appropriate) were used to test for significant 
differences between two groups. An increase in patellofemoral joint (PFJ) BMLs is defined as a change 
in BMLs of ≥1 from baseline to follow-up (vs. no increase). 
4.3.2 Natural history of PFJ BMLs 
109 of 406 participants (27%) who completed follow-up had PFJ BMLs at baseline. Of 
these participants, 49 (45%) persisted, 26 (24%) increased in grade, and 34 (31%) 
improved including 23 (21%) which completely resolved. PFJ BMLs were absent in a 
total of 297 subjects at baseline, of which 59 developed new BMLs (19.7% of knees) 
over 2.6 years (Figure 4.1, Figure 4.2).   
Grade 1 BMLs (≤25% of the region on the same slice) changed most often, accounting 
for the majority of newly induced lesions (76.3%), and lesions that resolved over 2.6 
years (87%). 
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Figure 4. 1 Examples of change in BMLs over 2.6 years 
 (a) PFJ BMLs increases from baseline to follow-up. (b) PFJ BMLs completely resolved from 
baseline to follow-up. 
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Figure 4. 2 Natural history of patellofemoral bone marrow lesions over 2.6 years in older 
adults 
 
4.3.3 WOMAC pain and PFJ BMLs 
Table 2 describes the association between changes in PFJ BMLs over 2.6 years and 
changes in WOMAC knee pain over 5 years. A change in PFJ BML score over 2.6 
years was associated with a change in total WOMAC pain and knee pain when going 
up and down stairs over 5 years, after adjustment for age, sex, BMI, ROA, smoking 
status, baseline PFJ BMLs and baseline cartilage defects. No statistically significant 
associations between PFJ BMLs changes and changes in other WOMAC knee pain 
subscales were observed.  
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Table 4. 2 Associations between change in PFJ BMLs over 2.6 years and changes in 
WOMAC pain over 5 years 
        Univariable Multivariable * Multivariable** 
 β (95% CI) β (95% CI) β (95% CI) 
  Total WOMAC knee pain 0.78 (0.15, 1.40) 0.81(0.17, 1.45) 0.67 (0.03, 1.31) 
  Pain walking on a flat surface 0.03 (-0.12, 0.18) 0.03 (-0.12, 0.19) 0.02 (-0.14, 0.18) 
  Pain going up and down stairs 0.28 (0.07, 0.48) 0.27 (0.07, 0.47) 0.24 (0.04, 0.44) 
  Pain at night when in bed 0.22 (0.03, 0.41) 0.22 (0.02, 0.42) 0.17 (-0.03, 0.37) 
  Pain sitting or lying 0.12 (-0.02, 0.27) 0.13 (-0.02, 0.28) 0.11 (-0.05, 0.26) 
  Pain standing upright 0.13 (-0.02, 0.29) 0.15 (-0.01, 0.32) 0.15 (-0.03, 0.29) 
*Adjusted for age, sex, BMI, ROAand smoking status, **further adjusted for baseline patellofemoral 
BML, baseline tibiofemoral BMLs, baseline patella cartilage defect, baseline tibiofemoral cartilage 
defect and baseline knee pain. Bold denotes statistical significance.  
4.3.4  Cartilage morphologies and PFJ BMLs 
Table 4.3 describes the relationship between baseline cartilage volume, baseline 
cartilage defects, and increases in PFJ BMLs over 2.6 years.  Higher PFJ and TFJ 
cartilage volume at baseline was associated with reduced risks of having an increase in 
PFJ BMLs. This result remained significant after adjustment for age, sex, BMI, 
smoking status, ROA, baseline patellar BMLs, and baseline total cartilage defects, total 
cartilage volume, meniscal tears and meniscal extrusion. Baseline PFJ cartilage defects 
were associated with increased odds of having an increase in PFJ BMLs; this 
association also remained significant after adjustment for age, sex, BMI, ROA, 
smoking status and baseline patellar BMLs and further adjustment for baseline PFJ 
BMLs, baseline total tibiofemoral BMLs, total cartilage defects, total cartilage volume, 
meniscal tears and meniscal extrusion. There were no significant associations between 
cartilage defects at the tibiofemoral compartment and increases in PFJ BMLs. 
Figure 4.3 shows the association between baseline PFJ cartilage defects and increase in 
PFJ BMLs. There was a higher rate of increased PFJ BMLs in those with higher 
baseline PFJ cartilage defects scores especially grade 3 and 4. 
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Table 4. 3 Associations between baseline cartilage volume, baseline cartilage defects, and 
increases in PFJ BMLs over 2.6 years 
PFJ, patellofemoral joint; TFJ, tibiofemoral joint; *Adjusted for age, sex, BMI, baseline patella BMLs, 
smoking status and ROA. ** further adjusted for baseline PFJ BMLs, baseline total tibiofemoral BMLs, 
total cartilage defects and total cartilage volume, meniscal extrusion and meniscal tears. Bold denotes 
statistical significance.   
 
Figure 4. 3 Association between PFJ cartilage defect grades at baseline and increases in PFJ 
BMLs 
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Baseline PFJ cartilage defect grades
p<0.02 for trend
  Univariable Multivariable * Multivariable ** 
 RR (95% CI)  RR (95% CI)  RR (95% CI) 
Baseline PFJ cartilage volume (ml) 0.88 (0.77, 0.99) 0.71 (0.57, 0.87) 0.69 (0.52, 0.90) 
Baseline TFJ cartilage volume (ml) 0.96 (0.89, 1.03) 0.85 (0.74, 0.97) 0.67 (0.49, 0.92) 
Baseline PFJ cartilage defects (per grade) 1.48 (1.24, 1.76) 1.46 (1.22, 1.76) 1.73 (1.38, 2.17) 
Baseline TFJ cartilage defects (per grade) 1.04 (0.96, 1.13) 1.03 (0.93, 1.14) 0.99 (0.89, 1.10) 
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This is the first population-based longitudinal study that describes the natural history 
of PFJ BMLs and the associations with WOMAC knee pain as well as knee structures. 
PFJ BMLs were not static, with over one third participants showing change (both 
increasing and decreasing) over 2.6 years of follow-up. Changes in PFJ BMLs over 2.6 
years were associated with change in knee pain when going up or down stairs over 5 
years, suggesting that changes in PFJ BMLs are clinically relevant. Furthermore, 
baseline PFJ cartilage volume was associated with a decrease in PFJ BMLs and baseline 
PFJ cartilage defects were associated with an increase in PFJ BMLs, indicating a site-
specific effect of cartilage morphology on PFJ BMLs. 
We found that approximately half of the pre-existing PFJ BMLs showed a change in 
size over 2.6 years, with one third of pre-existing PFJ BMLs decreasing in score over 
2.6 years. The regression rate was higher than some previous studies which assessed 
BMLs in whole knee [85, 211], but lower than that in a study which described knee 
joints BMLs in a cohort with symptomatic knee OA over 30 months [72]. The majority 
of the subjects whose BMLs resolved (87%) and those with new BMLs (76%) had 
grade 1 PFJ BMLs, suggesting that milder PFJ BMLs when BMLs have a greater 
potential to reverse. 
Many studies have linked TF BMLs and knee pain [75, 83, 84, 212]. Our team 
previously reported that tibiofemoral BMLs were associated with knee pain [74] and 
patellar BMLs were deleteriously associated with increased knee pain especially going 
up/down stairs [195]. However, associations between knee pain and PFJ BMLs has 
been less frequently reported [44, 213, 214]. The current study found that the change 
in PFJ BMLs over 2.6 years was associated with changes in total WOMAC pain score 
and knee pain when going up and down stairs over 5 years. This model was not same 
time frame but does allow assessment of whether changes in PFJ BMLs over 2.6 years 
predict changes in WOMAC knee pain over 5 years. The results were expected given 
that PFJ structural changes are commonly thought to be the causes of anterior knee pain 
during activities in which the knee is flexed, such as squatting and going up and down 
stairs [215].  
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Previous studies assessing the whole knee suggest that subchondral bone might play a 
role in cartilage degradation and in the early development of knee clinical symptoms 
[216], with subchondral BMLs predicting increased progression of cartilage defects 
and loss of cartilage volume [79, 85]. However, change in BMLs may be secondary to 
the cartilage damage. This finding was in line with our previous finding that baseline 
cartilage defects predicted BML progression in the tibiofemoral compartment [205]. In 
order to confirm this hypothesis in the PFJ, we examined whether baseline cartilage 
morphology could predict increases in PFJ BMLs.  Baseline PFJ cartilage volume was 
associated with a decrease in PFJ BMLs and baseline PFJ cartilage defects were 
associated with an increase in PFJ BMLs over 2.6 years. Meniscal pathology has been 
reported to have a substantially increased risk of both incident and enlarging BML over 
30 months [217], however, in our current study, significant associations between 
cartilage morphology and increases in PFJ BMLs remained unchanged after further 
adjustment for meniscal tears and meniscal extrusion, indicating independent 
associations between PFJ cartilage morphology and PFJ BMLs. The current study also 
found that tibiofemoral cartilage defects were not associated with changes in PFJ 
BMLs, suggesting compartment specific associations. This is consistent with the 
tibiofemoral compartment [61, 205]. Smoking has been found to be related to knee 
BMLs [218] as well as knee pain and cartilage defects [219, 220]. So it was considered 
as a potential confounder. However, no significant differences were made after 
smoking status was adjusted in multivariable analyses. 
There are several potential limitations in this study. First, follow-up MRI scans were 
only available for the current study in 406 out of 1100 participants. However, between 
the current study sample and the rest of cohort were similar in terms of demographics, 
ROA, baseline cartilage volume, defects and BMLs (data not shown). Secondly, BML 
scores were measured by grading the slice with the greatest BML size using a semi-
quantitative scale (0 to 3) rather than a quantitative measure of area or volume, which 
is likely to be more sensitive. Considering the slice thickness (4 mm) and interslice gap 
(0.5 to 1.0mm) of our imaging protocol, some lesions (especially small ones) may be 
underestimated if most of them lies within the interslice gap. Thirdly, we were not able 
to measure knee alignment, which has been linked to BMLs [221, 222]. However, it 
remains uncertain whether this is a cause effect association. Fourth, patella axial and 
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lateral firm were not included in the radiographic examination, which may impair the 
veracity of ROA assessment. 
In conclusion, PFJ BMLs are not static and change is clinically relevant. PFJ cartilage 
morphology predicts increases in PFJ BMLs  
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5.1 Introduction 
OA is a common joint disease characterised by progressive deterioration of the entire 
joint [223]. Although OA has traditionally been regarded as a non-inflammatory 
arthritis, recent studies have suggested that systemic inflammation is involved in its 
pathogenesis [26, 152], albeit at much lower levels than the recognised inflammatory 
arthropathies. Serum levels of interleukin (IL)-6, an inflammatory cytokine, predicts 
radiographic knee OA progression over 5-10 years in women [143] and increased knee 
cartilage volume loss over 3 years in older adults [142]. Similarly, increased serum 
levels of inflammatory cytokines IL-1β and tumour necrosis factor (TNF)-α are 
associated with increased risk of knee OA progression [10].  
High-sensitivity C-reactive protein (hs-CRP) is a circulating marker of systemic 
inflammation.  It is synthesized by the liver and can be up-regulated by IL-6 and IL-1 
[174] and is associated with presence and progression of knee OA [177, 179]. A recent 
meta-analysis found that serum hs-CRP levels in people with OA were modestly but 
significantly higher than in controls, and were weakly but significantly associated with 
knee pain and decreased physical function [224]. However, this analysis was based on 
five cross-sectional studies, so whether these associations are causal is unknown [224]. 
We reported that serum hs-CRP was associated with increased knee pain over 5 years 
in older adults [225].  
Bone marrow lesions (BMLs) are ill-defined hyperintense signals seen on magnetic 
resonance imaging (MRI) scans. They are recognized as an important feature of knee 
OA and play a vital role in disease progression [78, 79]. BMLs are related to clinical 
manifestations [76] and radiographic abnormalities in OA patients [61, 85].  
Histologically, BMLs represent multiple abnormalities including osteonecrosis, 
trabecular abnormalities and bone remodelling, but rarely edema [226]. BMLs may also 
be caused by inflammation in reaction to cartilage breakdown products, or other factors 
in intruded synovial fluid [87].  However, thus far, it is unclear if inflammation is 
associated with BMLs in OA patients. BMLs could be an intermediate factor on the 
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causal pathway between inflammatory markers and knee pain, but it is not known if 
serum levels of hs-CRP are associated with knee BMLs in patients with knee OA.  
 
Therefore, the aims of this study were to describe the associations between serum hs-
CRP, knee BMLs and knee pain cross-sectionally and longitudinally in patients with 
knee OA. 
5.2  Patients and methods 
5.2.1 Study design and patient population.  
These data were collected for an observational sub-study from the Vitamin D Effects 
on Osteoarthritis (VIDEO) Study, which was a multicentre, parallel randomized, 
placebo-controlled and double-blind clinical trial in patients with symptomatic knee 
OA and a low 25-hydroxyvitamin D (25OHD) level in Melbourne and Hobart, 
Australia. The first 192 patients (mean 63 years, range 49-79 years, female 53%) in 
Hobart were selected from the wider VIDEO study population to have hs-CRP 
measurement. Inclusion and exclusion criteria were the same as for the VIDEO study 
[202]. Eligible subjects were assessed according to the American College of 
Rheumatology (ACR) criteria for clinical knee OA [6] with a pain score of at least 20 
mm on a 100 mm visual analogue scale (VAS). They also had an ACR function class 
rating of I, II and III [199], and relatively good health, with a score of 0 to 2 on a 5 
point Likert scale (from 0 indicating very good health to 4 indicating very poor health) 
according to the global investigator assessment of disease status [227].  
Subjects were included if their serum 25OHD levels >12.5 nmol/L and < 60 nmol/L. 
Exclusion criteria included grade 3 radiographic changes according to Altman’s atlas 
[31] severe knee pain on standing (more than 80 mm on a 100 mm VAS), 
contraindication to MRI, rheumatoid or psoriatic arthritis, lupus, cancer, and severe 
cardiac or renal impairment.  
The VIDEO study was approved by The Tasmania Health and Human Medical 
Research Ethics Committee (reference number H1040) and Monash University Human 
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Research Ethics Committee (reference number CF10/1182-2010000616). Written 
informed consent was obtained from all participants. 
5.2.2 Serum hs-CRP measurements  
Serum levels of hs-CRP were measured at baseline and after 24 months using enzyme-
linked immunosorbent assay [203]. The minimal detectable concentration is 
approximately 0.02 μg/ml. The coefficients of variation (CVs) in our hands was 5.8%-
6.3%. Change in serum levels of hs-CRP was calculated as: follow-up value − baseline 
value.  
5.2.3 Assessment of bone marrow lesions  
BMLs in the diseased knee (or of the less painful knee if both knees were affected to 
avoid “ceiling effect”) were assessed on MR images, acquired with a 1.5T whole-body 
magnetic resonance unit (Picker, Cleveland, Ohio, USA) using a commercial transmit–
receive extremity coil at baseline and 24 months later. T2-weighted fast spin echo 
(FSE) sequences were used, as previously described [202]. 
 
BMLs were measured by one trained observer (ZZ) using a modified whole organ MRI 
score (WORMS) [125]. BMLs were defined as ill-defined hyperintense signal areas 
adjoining to the subchondral bone at 6 regions: medial patellar, lateral patellar, medial 
tibial, lateral tibial, medial femoral and lateral femoral.  
 
In the modified WORMS, the medial and lateral tibial and femoral compartments are 
divided into three sub-regions (anterior, central, posterior), and the tibia has an 
additional subspinous sub-region which represents the portion of the tibia beneath the 
tibial spines. Thus, a total of 15 sub-regions were scored for each knee [125].  
 
BMLs were scored categorically according to the maximal percentage of bone area that 
the lesion occupied within the total sub-region. We scored grade 0 if no BMLs; grade 
1 if lesion size =<25% of the subregion; grade 2, 25% to 50% of the subregion; grade 
3, >50% of the subregion [125]. Total knee BML scores were obtained by summing the 
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BML scores of all the sites, giving a potential total knee BML score range of 0 to 45. 
Baseline and follow-up MRIs were scored in pairs in chronological order to minimise 
measurement error [74]. The intraclass correlation coefficients (ICCs) were 0.93-0.98 
for intra-observer repeatability. 
 
Presence of BMLs in the whole knee was defined as a BML score of ≥ 1 at any 
subregion. Changes in BML score were calculated by subtracting total knee BMLs at 
follow-up from total knee BMLs at baseline. An increase in BML was defined as a 
change in BML score of ≥ 1. 
5.2.4 WOMAC knee pain assessment  
Knee pain was assessed at knee level using the Western Ontario and McMaster 
Universities Osteoarthritis Index (WOMAC) [204] at baseline and 24 months later. 
Five items were used to assess pain: walking on flat surface, when going up/down 
stairs, at night in the bed, when sitting/lying and when standing upright; these were 
assessed using 100 mm visual analogue scales. Items were summed to create a total 
pain score (range 0-500). Change in total knee pain was calculated as (follow-up value 
– baseline value of total pain scores). 
5.2.5 Anthropometrics 
Height was measured to the nearest 0.1 cm (with shoes, socks, and headgear removed) 
using a stadiometer. Weight was measured to the nearest 0.1 kg (with shoes, socks, and 
bulky clothing removed) using a single pair of electronic scales (Model 707; Seca 
Delta, Hamburg, Germany) that were calibrated using a known weight at the beginning 
of each clinic. Body mass index (BMI) [weight (kg)/height (m2)] was calculated.  
5.2.6 Co-morbidities 
Co-morbidities (no or yes) including diabetes, hypertension, osteoporosis, asthma, 
bronchitis, emphysema, heart attack, stroke, angina and high cholesterol were recorded 
using the following questionnaire: have you ever been told by your doctor or a nurse 
that you have any of the following conditions? 
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5.2.7 25OHD assays 
In the original RCT study, after randomisation, participants in the intervention and 
control arms were given a monthly capsule of 50,000 IU (1.25 mg) vitamin D3 
(cholecalciferol) and placebo, respectively, for 24 months. Serum 25OHD was assayed 
by Liaison method at screening and month 24, utilizing a direct competitive 
chemiluminescent immunoassays (DiaSorin Inc, Stillwater, Minnesota, USA). The 
intra-assay and interassay coefficients of variation were 3.2% and 6.0%. 
5.2.8 Data analysis 
T tests or χ2 tests (when appropriate) were used to compare means or proportions 
between those with higher (≥ median value) and lower (<median value) hs-CRP. 
Baseline hs-CRP was not normally distributed; hence quartiles of baseline hs-CRP were 
used for subsequent analyses as no other transformations were appropriate. Univariable 
and multivariable log binomial regression analysis was used to determine associations 
between baseline hs-CRP and presence of knee BMLs in the whole knee and an increase 
in total knee BMLs before and after adjustment for age, sex, BMI, intervention arm 
(vitamin D or control, for longitudinal data), and/or baseline total knee BML scores 
(for longitudinal data). Linear regression analyses were used to assess associations 
between changes in hs-CRP and changes in total knee BMLs, and between 
baseline/changes in hs-CRP and baseline/changes in total WOMAC knee pain before 
and after adjustment for covariates including interventions. Associations between 
baseline/changes in hs-CRP and baseline/changes in total WOMAC knee pain were 
further adjusted for baseline total knee BMLs or changes in BML score to see if these 
associations were explained by BMLs.  
A p value less than 0.05 (two tailed) was regarded as statistically significant. All 
statistical analyses were performed on Stata version 12.0 for Windows (StataCorp, 
College Station, TX, USA). 
5.3  Results 
5.3.1 Characteristics of participants  
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A total of 192 subjects (53% female) aged between 49 and 79 years old (mean 63 years) 
were included in the study. The median serum level of hs-CRP was 1.40 μg/ml (range 
0.18 – 27.8 μg/ml). The average vitamin D level of participants at baseline and month 
24 were 45 ± 14 nmol/L and 70 ± 25 nmol/L, respectively. Increases in vitamin D levels 
were mainly attributed to intervention (vitamin D supplement on intervention arm). 
BMLs were present in 80% of subjects. Those who had higher levels of hs-CRP (≥ 
median level) were heavier, shorter and had greater BMI as well as higher knee pain 
scores than those with lower hs-CRP levels (< median level). No significant differences 
were found between groups in terms of sex, baseline total knee BML scores and 
baseline 25OHD levels (Table 1). In total, 108 participants had bilateral symptomatic 
knee OA. There were no significant differences in terms of hs-CRP levels and pain 
score between subjects with bilateral and unilateral knee OA (data not shown). There 
were no significant interactions between knee OA status (bilateral or unilateral knee 
OA) and hs-CRP on increase/change in BMLs (all p>0.40), so patients with bilateral 
and unilateral knee OA were combined for analyses. 
Table 5. 1 Characteristics of the participants at baseline 
 
 
Baseline hs-CRP < median 
(n=96) 
 
Baseline hs-CRP ≥ median 
(n=96) 
 
p 
Age, years 63.0 (7.7) 63.2 (7.1) 0.85 
Women (%) 58% 49% 0.20 
Weight  84.0 (14.0) 88.4 (15.5) <0.001 
Height 170.9 (10.5) 168.1 (8.8) 0.04 
BMI, kg/m2 27.7 (4.2) 31.3 (4.8) <0.001 
25OHD, nmol/L 45.2 (14.4) 44.2 (12.8) 0.62 
Total knee BML score 3.14  (3.1) 3.99 (3.5) 0.08 
Total WOMAC score 103.4 (82.4) 141.3 (78.3) 0.001 
Prevalence of BMLs 76.3% 85.0% 0.12 
Results are shown as mean (SD) except for percentage. Two-tailed t test used for differences between 
means, χ2 test used for proportions (percentages). Significant differences are shown in bold. hs-CRP, 
high-sensitivity C-reactive protein; BMI, body mass index; BML, bone marrow lesion, 25OHD: 25-
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hydroxyvitamin D; WOMAC: Western Ontario McMaster Osteoarthritis Index. Median level of serum 
hs-CRP: 1.4 μg/ml. 
5.3.2 Serum hs-CRP and total knee BMLs 
In cross-sectional analysis, quartiles of baseline hs-CRP were positively associated 
with the presence of knee BMLs, before and after adjustment for age, sex and BMI 
(Figure 1a, Table 2). In longitudinal analysis, quartiles of baseline hs-CRP were 
significantly and positively associated with an increase in total knee BMLs (Figure 1b, 
Table 2). This result remained significant after adjustment for age, sex, BMI, 
interventions and baseline total knee BML scores (Table 2). Significant associations 
were found between change in hs-CRP and changes in total knee BML scores, both 
before and after adjustment for potential confounders (Table 2).  Additionally, the 
highest quartile of hs-CRP (cut-off point: 2.6 μg/ml) was associated with an increase in 
total BMLs in multivariable analyses (the highest vs other quartiles: RR=1.86, 95%CI: 
0.98, 3.57; the highest vs the lowest quartile: RR=1.42, 95%CI: 1.01, 1.99). 
Table 5. 2 Associations between serum hs-CRP and total knee BMLs: cross-sectional & 
longitudinal data 
  
Univariable Multivariable* 
Presence of total knee BMLs PR (95%CI) PR (95%CI) 
  Baseline hs-CRP (per quartile) 1.06 (1.00, 1.14) 1.07 (1.00, 1.15) 
Increase in total knee BMLs RR (95%CI) RR (95%CI) 
  Baseline hs-CRP (per quartile) 1.22 (1.01, 1.47) 1.37 (1.10, 1.70) 
Change in total knee BMLs β (95%CI) β (95%CI) 
  Change in hs-CRP (per μg/ml) 0.18 (0.03, 0.33) 0.19 (0.05, 0.34) 
*Adjusted for age, sex, BMI, interventions (for longitudinal data), and/or baseline total knee BMLs (for 
longitudinal data). Statistical significances are shown in bold. Hs-CRP, high-sensitivity C-reactive 
protein; BMLs, bone marrow lesions; PR, prevalence ratio; RR: risk ratio. 
5.3.3 Serum hs-CRP and total WOMAC knee pain 
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In cross-sectional analyses, quartiles of baseline hs-CRP were associated with total 
knee pain in unadjusted analysis (Figure 2a). The association remained statistically 
significant after adjustment for age, sex and BMI, and did not change after further 
adjustment for baseline total knee BML score (Table 3). In longitudinal analyses, 
baseline hs-CRP was not significantly associated with change in total knee pain, before 
or after adjustment for age, sex, BMI, interventions and baseline knee pain scores 
(Table 3); however, change in hs-CRP was significantly associated with change in total 
knee pain before and after adjustment for covariates (Table 3). This association 
decreased in magnitude and was no longer significant after further adjustment for 
change in total knee BMLs (Table 3). Additionally, quartiles of change in hs-CRP were 
significantly associated with an increase in total knee pain (Figure 2b). 
The significant associations between hs-CRP and knee BMLs/pain remained 
unchanged after further adjustment for the co-morbidities (data not shown). 
Table 5. 3 Associations between serum hs-CRP and total WOMAC knee pain: cross-sectional 
& longitudinal data 
 Multivariable* 
 
Multivariable** 
 β (95%CI) β (95%CI) 
Total knee pain at baseline    
                Baseline hs-CRP (per quartile) 13.8 (2.46, 25.2) 13.7 (2.26, 25.1) 
   
Change in total knee pain  
   
              Baseline hs-CRP (per quartile) 5.21 (-6.48, 16.9) 5.16 (-6.56, 16.9) 
             Change hs-CRP (per μg/ml) 4.71 (0.48, 8.94) 4.24 (-0.24, 8.51) 
*Adjusted for age, sex, BMI, interventions (longitudinal), and/or baseline knee pain (for knee pain 
change); ** Further adjustment for baseline total knee BMLs (cross-sectional/or longitudinal), or change 
in total knee BMLs (longitudinal). Statistically significant associations are shown in bold. Hs-CRP, high-
sensitivity C-reactive protein; BMLs, bone marrow lesions; WOMAC: Western Ontario McMaster 
Osteoarthritis Index. 
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(b) 
Figure 5. 1 Association between hs-CRP and knee BMLs 
 (a) Baseline prevalence of knee BMLs, by quartiles of hs-CRP: (b) Presence of an increase in 
total knee BMLs over 2 years by baseline hs-CRP (quartile). Hs-CRP: high sensitivity C-reactive 
protein; BMLs: bone marrow lesions 
 
(a) 
Chapter 5 – Hs-CRP, BMLs and knee pain in OA 
64 
 
 
 (b) 
 Figure 5. 2 Associations between hs-CRP and knee pain 
 (a) Baseline WOMAC knee pain scores by baseline hs-CRP (quartiles). (b) Presence of an 
increase in total WOMAC knee pain by change in hs-CRP (quartiles). Hs-CRP: high sensitivity C-
reactive protein; WOMAC: Western Ontario and McMaster Universities Osteoarthritis Index 
 
5.4 Discussion 
To the best of our knowledge, this is the first study to report cross-sectional and 
longitudinal associations between serum hs-CRP and total knee BMLs and total 
WOMAC knee pain in patients with knee OA. Our data demonstrated that serum hs-
CRP was associated with the presence of total knee BMLs cross-sectionally, and 
predicted worsening knee BMLs over 2 years in patients with knee OA. Furthermore, 
there were significant associations between hs-CRP and total WOMAC knee pain and 
their changes, and the longitudinal association was partly explained by total knee 
BMLs. These results add to the growing evidence that the clinical course of OA is 
associated with systemic inflammation [26, 142, 224].  
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Several serum biomarkers have been correlated with OA incidence and progression and 
are thus proposed as diagnostic and prognostic markers for knee OA [228, 229]. 
Cartilage oligomeric matrix protein (COMP) is an important degradation product of 
articular cartilage [74] and baseline serum COMP was associated with incident 
radiographic knee OA over 6 years [230]. Serum hyaluronic acid (HA) concentration 
was positively associated with progression of Kellgren Lawrence grade in knees with 
and without OA [229]. Serum levels of kerantan sulphate (KS) is also a potential marker 
of cartilage degradation [231]. As one of the most widely- used clinical marker of 
systemic inflammation, serum hs-CRP has been investigated by some studies regarding 
its associations with incidence [179], progression  [184], symptoms [232] and structures 
[233] of knee OA. Spector et al reported that serum CRP levels were significantly 
increased in women with radiographic knee OA compared with those without, and 
higher CRP values predicted radiographic OA progression over four years [234]. 
Pelletier et al. [235] found that baseline levels of CRP predicted cartilage volume loss 
in the medial compartment, and correlated with worsening of WOMAC pain in patients 
with knee pain. Further, Pearle et al observed a positive correlation between plasma 
CRP and histologic evidence of synovitis (inflammatory cell infiltration in synovial 
membrane) at the time of joint replacement in patients with OA [236]. Our recent meta-
analysis revealed that serum hs-CRP levels in OA were higher than controls, although 
differences were modest; greater hs-CRP was associated with more knee pain but not 
with radiographic OA [224]. However, current evidence regarding the association and 
OA is mainly derived from cross-sectional studies (account for about 75% of total 
studies regarding to CRP and OA) [224], so whether the association is causal is not 
known. A previous study [181] reported that serum CRP measured 3 years prior was 
predictive of radiographic OA progression over 5 years, but suggested that serum CRP 
concentration was not good predictor of individual patient progression because the 
sensitivity and specificity as a marker for individuals were poor. Another study reported 
that baseline levels of hs-CRP did not predict incident radiographic knee OA [230]. 
Besides, there are few studies reporting associations between serum hs-CRP and knee 
BMLs (an imaging marker of knee OA) both cross-sectionally and longitudinally in 
OA patients.  
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One previous study [185] evaluated cross-sectional correlations between hs-CRP and 
bone marrow oedema (the former name of BMLs); it found no differences in hs-CRP 
between patients with and without bone marrow oedema in a symptomatic OA 
population. However, this study is limited by its cross-sectional design and relatively 
small sample size (n=30). Our current study examined cross-sectional and longitudinal 
associations between serum hs-CRP and BMLs in patients with knee OA, and reported 
positive associations between hs-CRP and total knee BMLs, independent of age, sex, 
BMI, intervention and co-morbidities. The associations were consistent: patients with 
higher baseline hs-CRP had greater prevalence of knee BMLs and greater proportion 
of having an increase in BMLs; patients with greater increase in hs-CRP had also 
greater increase in knee BMLs. These findings suggest that low grade inflammatory 
process may play a pivotal role in the etiology of knee BMLs and serum levels of hs-
CRP may be a biomarker of progressive BMLs in knee OA.  
 
In the current study, baseline hs-CRP was not associated with change in total knee pain 
over 2 years. This is inconsistent with our previous findings [225], in which serum hs-
CRP was associated with worsening knee pain over 5 years in older adults. The reasons 
for this inconsistency are unclear, but it may be due to differences in study population, 
sample size and duration of follow-up. In our previous study, a total of 149 subjects 
with 45% prevalence of knee pain were selected and analysed at baseline and 5 years 
later [225] whereas in our present study, 192 OA patients with mild to moderate knee 
pain were included. In addition, the follow up period was 2 years rather than 5 years in 
the present study, which may not be long enough to observe any associations between 
baseline hs-CRP and increases in knee pain. Although the current study does not 
provide evidence of a causal relationship, hs-CRP and change in hs-CRP were 
consistently associated with knee pain and change in knee pain, respectively. This 
suggests potential involvement of inflammation in the symptoms of knee OA.  
 
BMLs have been linked to knee pain in older subjects [23, 74, 195] and patients with 
knee OA [76], and so may underlie the inflammatory involvement of knee pain. In this 
study, we found that associations between change in hs-CRP and change in total 
WOMAC knee pain decreased in magnitude and became of borderline significance 
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after adjustment for BMLs. This suggests that the correlations between hs-CRP and 
total knee pain is at least partly explained by BMLs, which is consistent with our 
previous findings [225]. Serum levels of hs-CRP may reflect the inflammatory process 
in BMLs among OA patients which can be an underlying mechanisms of OA knee pain. 
From a clinical perspective, our results may facilitate the development of new 
therapeutic strategies targeting low-grade inflammation for knee OA.  
 
Obesity can influence serum hs-CRP levels, and BMI is a major determinant of CRP 
[237]. The influence of obesity in the development of OA was revealed to go beyond 
mechanical loading, and obesity-related inflammatory cytokines (so-called 
adipocytokines) are implicated in the pathogenesis of OA [238]. In the current study, 
we also observed significant differences in BMI between subjects with higher and 
lower baseline hs-CRP. However, the statistically significant associations between hs-
CRP and total knee BMLs as well as knee pain were not changed after adjustment for 
BMI both cross-sectionally and longitudinally. This is consistent with most [224] but 
not all previous [184] studies. Our finding suggests that low-grade inflammatory 
process may influence BMLs and symptoms in knee OA, independent of obesity.   
 
A strength of the present study was the longitudinal design, which allowed assessment 
of a temporal relationship between serum hs-CRP and BMLs. There were several 
potential limitations. First, the original study was an RCT study and most participants 
were vitamin D deficient OA patients. Low serum levels of vitamin D may affect OA 
and BMLs progression [239]. However, all longitudinal associations remained 
significant after adjustment for intervention (vitamin D supplementation) or change in 
25-OHD levels (data not shown), suggesting serum levels of vitamin D may not affect 
our results. Second, inclusion and exclusion criteria were applied in the RCT. 
Therefore, the findings may not be generalisable to all patients with knee OA. Third, 
other potential confounding variables such as physical activity and medication uses 
were not recorded in this study. Fourth, the accumulation of BML data at baseline and 
after 2 years may introduce bias due to BML fluctuation over short term [73]; however, 
associations between hs-CRP and BMLs were consistent cross-sectionally and 
longitudinally suggesting this is unlikely. Last, the period of 2 years follow-up may not 
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be sufficient to detect associations between hs-CRP and change in pain; previous 
studies suggest that 5 years may be required to detect the associations [225, 240].  
In conclusion, serum hs-CRP is associated with knee BML scores and, to a lesser 
extent, pain both cross-sectionally and longitudinally in patients with knee OA, 
suggesting that inflammation is linked with BMLs and their associated pain.  
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6.1 Introduction 
Osteoarthritis (OA) is the most frequent type of arthritis worldwide.  It is characterized 
by progressive loss of cartilage, deterioration of subchondral bone and mild synovial 
inflammation [223]. While OA has traditionally been regarded as a non-inflammatory 
type of arthritis, there is a growing evidence that the clinical course of OA may be 
driven by systemic and localized inflammation [26, 142, 224], albeit at much lower 
levels than the recognised inflammatory arthropathies [10, 143].  
IL-6 is an inflammatory cytokine with pro- and anti-inflammatory effects, both inside 
and outside of the joints [150, 151, 241]. Although emerging evidence suggests that 
low-level systemic inflammation is involved in OA pathogenesis [26, 152], the role of 
IL-6 in OA remains controversial. In a spontaneous aging model of OA, mice deficient 
in IL-6 displayed increased levels of cartilage loss, suggesting a potentially protective 
role of IL-6 in the development of OA. In contrast, higher levels of serum IL-6 were 
associated with higher prevalence of osteophytes in older adults [142]. Circulating 
levels of IL-6 have been associated with the prevalence of knee OA [143].  
IL-17A and IL-17F are the prototypical members of the IL-17 cytokine family, which 
are produced by CD4 (+) T-helper 17 cells (Th-17) [163]. IL-17A and IL-17F share the 
most homology at the amino acid level [164], have overlapping but also distinct effector 
functions in a range of autoimmune diseases [165]. The development of CD4 (+) Th-
17 cells is differentiated by IL-6, and stabilised by IL-23 [163]. Produced by antigen 
presenting cells (APCs), IL-23 is a heterodimeric protein composed of a p19 and a p40 
subunit. Several groups have demonstrated that IL-1β, IL-6 and IL-23 promote human 
Th-17 cells differentiation from CD4+ cells, resulting in the expression of IL-17A, IL-
17F, and IL-6 [166, 167]. Thus, IL-6, IL-23 and IL-17 form a new axis through Th-17 
cells, which has an important role in autoimmunity and chronic inflammation [242-
245]. 
Bone marrow lesions (BMLs), observed as ill-defined hyperintense signals in 
subchondral bone of the knees on magnetic resonance imaging (MRI) scans, are an 
important feature of knee OA. They are strongly associated with knee pain [75, 76], 
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and OA incidence [77] and progression [78, 79]. Additionally, BMLs predict knee joint 
space loss on x-ray [79], cartilage defect progression [55] and cartilage loss on MRI 
[80], as well as knee replacement surgery [81, 246]. However, thus far, the etiology of 
BML formation is largely unknown. An experimental study reported BMLs might 
originally correspond to an acute inflammatory response, oedema, contusion and/or 
necrosis, which were eventually replaced by permanent bone marrow remodelling such 
as fibrosis and myxomatous connective tissue [247]. BMLs could be caused by an 
inflammatory reaction to cartilage breakdown products, or other factors in intruded 
synovial fluid [87]. Our previous study reported that high serum hs-CRP was associated 
with increased knee BMLs in patients with knee OA, suggesting that systemic 
inflammation may play a role in the pathogenesis of BMLs in knee OA patients [248].  
Although IL-6/IL-23/IL-17 axis has been implicated in the pathogenesis of many 
inflammatory conditions [164], its’ roles in human OA are unclear. Therefore, the aim 
of this study was to describe cross-sectional and longitudinal associations between 
serum IL-6, IL-17A, IL-17F, IL-23 and knee BMLs in patients with knee OA. 
6.2 Subjects and methods 
This study was a sub-analysis from the Vitamin D Effects on Osteoarthritis (VIDEO) 
Study, which was a multi-centre parallel-group, randomized, placebo-controlled and 
double-blind clinical trial to evaluate the effects of vitamin D supplementation in 
patients with symptomatic knee OA and a low 25-hydroxyvitamin D (25OHD) levels. 
Measures of IL-6, IL-17A, IL-17F and IL-23 were made from the 192 patients (mean 
63 years, range 49-79 years, female 53%) recruited in Hobart. Inclusion and exclusion 
criteria were the same as for the VIDEO study [202]. Briefly, eligible subjects met the 
American College of Rheumatology (ACR) criteria for clinical knee OA [6], and had a 
pain score more than 20 mm on a 100 mm visual analogue scale (VAS). They also had 
an ACR function class rating of I, II and III [199], and relatively good health, with a 
score of 0 to 2 out of a maximum score of 4 on a global investigator assessment of 
disease status [227], where 0 indicates very good health and 4 indicating very poor 
health.  
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Subjects were included if their serum 25OHD levels were > 12.5 nmol/L and < 60 
nmol/L and were randomly assigned to receive either a monthly capsule of 50,000 IU 
(1.25 mg) vitamin D3 (cholecalciferol) or identical placebo for two years. Exclusion 
criteria included grade 3 radiographic changes according to Altman’s atlas [34], severe 
knee pain on standing (more than 80 mm on a l00 mm VAS), contraindication to MRI, 
rheumatoid or psoriatic arthritis, lupus, cancer, and severe cardiac or renal impairment. 
The VIDEO study was approved by the Tasmania Health and Human Medical Research 
Ethics Committee (reference number H1040). Written informed consent was obtained 
from all participants. 
6.2.1 Inflammatory markers measurements  
Serum levels of IL-6, IL-17A, IL-17F and IL-23 were measured at baseline and after 
24 months using enzyme-linked immunosorbent assay [10]. The limits of detection are 
0.49 pg/ml, 1.84 pg/ml, 14.6 pg/ml and 34.4 pg/ml respectively. The proportion of 
participants with IL-6 below limit of detection was 17%. The majority of study 
participants had IL-17A, IL-17F and IL-23 levels below limits of detection, with the 
proportions of measurements below their limits of detection for IL-17A, IL-17F and 
IL-23 were 78%, 60% and 77%, respectively. The coefficients of variation (CVs) were 
5.8%-6.3%. 
6.2.2 Assessment of bone marrow lesions  
BMLs in the diseased knee, or of the less painful knee if both knees (aiming to avoid 
“ceiling effects” of the treatment on disease outcomes when designed in original 
randomized controlled trail (RCT) study) were affected were assessed on MR images. 
These were acquired with a 1.5T whole-body magnetic resonance unit (Picker, 
Cleveland, Ohio, USA) using a commercial transmit-receive extremity coil at baseline 
and 24 months later. Image sequence included the following: Fat-saturated T2-
weighted fast spin echo (FSE), flip angle 90º, repetition time 3067 ms, echo time 112 
ms, field of view 16 cm, 45 partitions, 228×256-pixel matrix; sagittal images were 
obtained at a partition thickness of 2 mm.  
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BMLs were measured by one trained observer (ZZ) using the modified whole organ 
MRI score (WORMS) [125]. In the modified WORMS, the medial and lateral tibial 
and femoral compartments are divided into three sub-regions (anterior, central, 
posterior), and the tibia has an additional subspinous sub-region which represents the 
portion of the tibia beneath the tibial spines. Thus, a total of 15 sub-regions were scored 
for each knee [125].  
BMLs were scored according to the maximal percentage of bone area that the lesion 
occupied within the total sub-region. We scored grade 0 if no BMLs were present; grade 
1 if lesion size=<25% of the subregion; grade 2, 25% to 50% of the subregion; grade 
3, > 50% of the subregion [125]. Total knee BML scores were obtained by summing 
the BML scores of all the sites, giving a potential total knee BMLs score range of 0 to 
45. Baseline and follow-up MRIs were scored in pairs in chronological order to 
minimise measurement error [74]. The intra-rater reliability (ICC=0.93-0.98) and inter-
rater reliability (ICC=0.91-0.97) were excellent. Presence of BMLs in the whole knee 
was defined as a BML score of ≥1 at any subregion. For longitudinal analyses we 
defined an increase in BML score of greater than one between baseline and follow-up 
to be the outcome of interest.  
6.2.3 Anthropometrics  
Height was measured to the nearest 0.1 cm (with shoes, socks, and headgear removed) 
using a stadiometer. Weight was measured to the nearest 0.1 kg (with shoes, socks, and 
bulky clothing removed) using a single pair of electronic scales (Model 707; Seca 
Delta, Hamburg, Germany) that were calibrated using a known weight at the beginning 
of each clinic. Body mass index (BMI) [weight (kg)/height2 (m2)] was calculated. 
6.2.4 25OHD assays  
Serum 25OHD was assayed by the Liaison method at baseline, utilizing a direct 
competitive chemiluminescent immunoassays (DiaSorin Inc, Stillwater, Minnesota, 
USA). The intra-assay and inter-assay coefficients of variation were 3.2% and 6.0%, 
respectively [202].  
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6.2.5 Data analysis 
Student’s t-tests, χ2 tests or Wilcoxon rank-sum test (when appropriate) were used to 
compare means, proportions or median between those with or without baseline knee 
BMLs.  
Baseline IL-6 was highly right-skewed, hence quarters were used for subsequent 
analyses, the other cytokines were dichotomised at the highest quarters. Baseline BML 
score had a right-skewed and zero-inflated distribution, thus multivariable negative 
binomial regression models were used to determine associations between cytokines and 
total knee BML scores, adjusted for age, sex, BMI and vitamin D level. Negative 
binomial regressions were used to address the problems of the unusual distribution of 
the BML score variable at baseline, which was bounded (at zero), highly skewed, and 
with a large proportion of zero scores. Alternative models were investigated but 
ultimately rejected. Serum levels of 25-(OH)D were associated with inflammatory 
markers including IL-6, IL-17, IL-23 [249-251], as well as BMLs [252, 253]; therefore, 
25-(OH)D levels were used for adjustment as p potentially confounding factor.  
Log binominal regression was used to assess associations between baseline cytokines 
and presence of an increase in total knee BMLs, adjusted for age, sex, BMI, vitamin D 
levels and baseline total knee BMLs. Log-binomial regression models were used to 
estimated relative risks where the outcome was dichotomous. Logistic regression was 
also considered for this type of analysis but rejected since the resultant odds rations 
would overestimate the more appropriate relative risks due to the common nature of the 
outcome (an increase in BMLs from baseline to follow-up). Interactions between sex 
and cytokines were tested in all multivariable models. When significant interactions 
were identified, estimates are presented separately for each sex.  
A p value less than 0.05 (two tailed) was regarded as statistically significant. All 
statistical analyses were performed on Stata version 12.0 for Windows (StataCorp, 
College Station, TX, USA). 
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6.3  Results 
6.3.1 Characteristics of the study population at baseline.  
A total of 192 subjects (53% female) aged between 49 and 79 years old (mean 63 years) 
were included.  80% had BMLs visible on MR imaging at baseline. Characteristics of 
the participants at baseline are presented in Table 1. No statistically significant 
differences were found between participants with and without baseline BMLs in terms 
of age, sex, BMI and baseline serum cytokine levels (Table 1).  
 
Table 6. 1 Characteristics of participants at baseline, by presence or absence of BMLs at 
baseline 
 Without Baseline BMLs 
(N=36) 
With Baseline BMLs 
(N=156) 
p value 
 
    
Age (years) 62.2 ± 7.3 63.3 ± 7.0 0.32 
Females (%) 54% 49% 0.42 
BMI (kg/m2) 30.1 ± 6.0 29.5 ± 4.8 0.38 
25-(OH) D (nmol/L) 44.4 ± 13.1 45.6 ± 13.6 0.47 
IL-6 (pg/ml) 1.33 (0.4, 3.7) 1.16 (0.4, 2.5) 0.65 
IL-17A (%) * 20% 25% 0.48 
IL-17F (%) * 36% 39% 0.97 
IL-23 (%) * 17% 28% 0.08 
Two-tailed Student’s t tests were used for differences between means, χ2 tests were used for proportions 
(percentages) and Wilcoxon rank-sum tests were used for differences between medians. Results are mean 
± SD or median (IQR) except for percentage. BMI, body mass index. 25-(OH)D: 25-hydroxyvitamin D; 
IL: interleukin. * Proportions of measurements above their limits of detection. Limits of detection: IL-6, 
0.49 (pg/ml); IL-17A, 1.84 (pg/ml); IL-17F, 14.6 (pg/ml); IL-23, 34.4 (pg/ml). 
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6.3.2 Associations between IL-6 and BMLs.  
Patients in the higher quarters of baseline IL-6 had higher baseline total knee BML 
scores (Figure 1a), and were more likely to have an increase in total knee BMLs over 
2 years (Figure 1b). 
Table 2 describes cross-sectional and longitudinal associations between serum IL-6 and 
total knee BMLs over 2 years. Baseline IL-6 (quarters) were statistically significantly 
associated with baseline total knee BML score, after adjustment for age, sex, BMI and 
vitamin D levels (Table 2). Higher baseline IL-6 (quarters) were statistically 
significantly associated with greater risks of increased BML scores over 2 years, after 
adjustment for age, sex, BMI, vitamin D levels and baseline total knee BMLs, in log 
binomial regression analyses (Table 2). There were no statistically significant 
interactions between sex and IL-6 (data not shown), therefore men and women were 
combined for analyses.  
Table 6. 2 Cross-sectional and longitudinal associations between serum IL-6 and total knee 
BMLs/an increase in BMLs over 2 years 
   Univariable Multivariable 
Total knee BML scores RM† 95% CI  RM† 95% CI 
Baseline IL-6 (quarter)=1  Ref    Ref 
Baseline IL-6 (quarter)=2 1.23 (0.83, 1.83)  1.24  (0.83, 1.86) 
Baseline IL-6 (quarter)=3 1.63 (1.11, 2.40)  1.68 (1.12, 2.52) 
Baseline IL-6 (quarter)=4 1.61 (1.08, 2.39)  1.62 (1.09, 2.42) 
p for the trend  p<0.01   p*<0.01 
      
An increase in BMLs RR 95% CI  RR 95% CI 
Baseline IL-6 (quarter)=1  Ref   Ref 
Baseline IL-6 (quarter)=2 1.21 (0.60, 2.43)  1.25 (0.62, 2.50) 
Baseline IL-6 (quarter)=3 1.36 (0.70, 2.67)  1.58  (0.80, 3.12) 
Baseline IL-6 (quarter)=4 1.74 (0.92, 3.29)  1.90 (1.01, 3.58) 
p for the trend  p=0.07   p**=0.05 
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The dependent variable: baseline total knee BML score in negative binominal models, or an increase in 
total knee BMLs in log binominal models. The independent variable: quarters of IL-6. †Ratio of means 
presented from negative binomial model; *Adjustment for age, sex, BMI and vitamin D levels; ** 
Adjusted for age, sex, BMI, vitamin D levels and baseline total knee BMLs. Bold denoted statistical 
significance (p<0.05). 
6.3.3 Associations between IL-17A, IL-17F, IL-23 and BMLs.  
Table 3 describes cross-sectional and longitudinal associations between serum IL-17A, 
IL-17F and IL-23 and total knee BMLs over 2 years in males and females.  Interactions 
between sex and IL-17F, IL-23 on BMLs were statistically significant (both p<0.1), so 
men and women were analysed separately. Additionally, no statistically significant sex 
interaction was found for IL-17A, however since this interleukin is part of the same 
family as the others and they are located adjacent to each other and exhibit a similar 
cysteine knot configuration, we present results separately for males and females also.  
Dichotomized baseline IL-17A, IL-17F and IL-23 (highest quartile vs others or 
detectable vs undetectable) were not associated with baseline total knee BMLs in 
females or males, before or after adjustment for age, BMI and vitamin D levels, in 
multivariable negative binominal regression analyses (Table 3). In females, those with 
higher baseline IL-17F and IL-23 had 1.9-fold and 2.1-fold higher risks of increased 
BML scores, after adjustment for age, BMI, vitamin D levels and baseline total knee 
BMLs, in log binomial regression analyses (Table 3, Figure 2). However, no 
statistically significant associations were found in male group (Table 3). IL-17A was 
not statistically significantly associated with an increase in BMLs in either females or 
males (Table 3). 
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Table 6. 3 Cross-sectional and longitudinal associations between Th17 cytokines and total 
knee BMLs/an increase in BMLs over 2 years, by sex 
 Multivariable analysis in Males Multivariable analysis in Females 
 Total knee BML scores RM† 95% CI* RM† 95% CI* 
Baseline IL-17A 1.28 (0.68, 1.89) 0.95 (0.57, 1.57) 
Baseline IL-17F 1.31 (0.72, 1.89) 1.05 (0.65, 1.68) 
Baseline IL-23 1.34 (0.74, 1.94) 0.92 (0.55, 1.54) 
     
An increase in BMLs RR 95% CI** RR 95% CI** 
Baseline IL-17A 0.81 (0.13, 1.50) 1.53 (0.79, 2.94) 
Baseline IL-17F 0.83 (0.18, 1.48) 1.85 (1.04, 3.28) 
Baseline IL-23 0.88 (0.19, 1.57) 2.10 (1.16, 3.79) 
The dependent variable: baseline total knee BML score in negative binominal models, or an increase in 
total knee BMLs in log binominal models. The independent variables: baseline IL-17A, IL-23 
(dichotomised at cut-off points of limits of detection), and IL-17F (highest quarter vs others). †Ratio of 
means presented from negative binomial model; *Adjusted for age, BMI and vitamin D levels; ** 
Adjusted for age, BMI, vitamin D levels and baseline total knee BMLs; Bold denoted statistical 
significance (p<0.05). 
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(a) 
 
Figure 6. 1 Association between IL-6 and knee BMLs in total sample 
 (a) Baseline total knee BMLs (mean +/- 95%CI), by quarters of baseline IL-6; (b) An 
increase in total knee BMLs over 2 years by quarters of baseline IL-6. BMLs: bone marrow lesion.  
 (b) 
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Figure 6. 2 Association between IL-17F, IL-23 and an increase in total knee BMLs over 2 
years in females 
 
6.4  Discussion 
This study is the first, to our knowledge, to assess longitudinal associations between 
IL-6, IL-23 and IL-17, and knee BMLs in patients with knee OA. Our data showed that 
higher serum IL-6 was associated with greater likelihood of an increase in knee BMLs 
over 2 years, and that high levels of IL-17F and IL-23 predicted an increase in knee 
BMLs in females (but not males) with knee OA. These results add to the growing 
evidence that systematic inflammation is involved in the pathogenesis of knee OA, 
particularly among females [26, 142].  
IL-6 levels are elevated locally at sites of inflammation, and can activate B cells, T cells 
and other inflammatory cells [254]. Increased IL-6 expression has also been observed 
in subchondral bone and osteophytes of subjects with knee OA [255]. In our present 
study, associations between serum IL-6 and total knee BMLs as well as increases in 
knee BMLs over 2 years were independent of potential confounders including age, sex, 
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BMI and vitamin D levels, suggesting that serum IL-6 is involved in the pathogenesis 
of BMLs in knee OA patients and predicts BML development/progression. This is in 
line with our previous report in which a higher circulating levels of IL-6 was an 
independent predictor of worsening knee pain [225].  
A number of investigations have demonstrated roles for Th17 cytokines in the aetiology 
and progression of rheumatoid arthritis (RA) [256]; the cytokines are expressed by 
rheumatoid synovium and can induce inflammation and osteoclastic bone resorption 
[257]. IL-17A and IL-17F are pro-inflammatory cytokines, and have regulatory roles 
in host defence and chronic inflammation, resulting in tissue damage and autoimmunity 
[258, 259]. However, little is known about the role of IL-17 in OA. Chen et al [171] 
reported a positive association between knee OA severity and IL-17 concentration in 
synovial fluid, but not in serum. Liu et al [172] showed that synovial IL-17 level was 
correlated with severity of knee pain, but not with radiographic severity. These studies 
were limited by their cross-sectional design, small sample size and lack of adjustment 
for potential confounders. In our present study, we found that baseline IL-17F predicted 
increased BML scores in females but not males. Associations between IL-17A and 
BMLs were consistently positive in both females and males, but none reached statistical 
significance. IL-17A and IL-17F are expected to have similar physiological effects 
because they are located adjacent and exhibit a similar cysteine knot configuration 
[260]. However, our findings suggest that IL-17F may play a more important role in 
human knee OA aetiology than IL-17A, but the underlying reasons for this difference 
are unknown. In this study, we also found that baseline serum IL-23 predicted increased 
BMLs in females but not males; this association was independent of potential 
confounders such as age, BMI and vitamin D levels. Combined with the associations 
that we found between IL-6, IL-17F and knee BMLs in this study, these results suggest 
that IL-6/IL-23/IL-17 axis may play a role in the aetiology and progression of knee OA, 
at least in females. Further studies investigating other OA- related features (meniscal 
tears, ligamentous lesions, cartilage defects, etc.) and IL-6/IL-23/IL-17 axis are 
required to provide more comprehensive understanding of the relationship between 
inflammation and knee OA progression.  
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The reasons for why we observed a sex difference for the association between IL-
17F/IL-23 and BMLs, but not between IL-6 and BMLs are unclear. It may reflect the 
influence of sex hormones on the relationships of IL-17/IL-23 and knee BMLs. We 
previously reported that serum levels of IL-6 were associated with hip radiographic 
changes in females but not in males [145], which was inconsistent with the present 
study. This may imply that there are different inflammatory pathways between hip OA 
and knee OA in the relationship with IL-6. 
This study has several limitations. First, the original study was a randomized controlled 
trail (RCT); therefore, results could be affected by the intervention (vitamin D 
supplementation). However, all associations from longitudinal analyses remained 
significant after adjustment for vitamin D levels. Secondly, giving that the majority of 
subjects had cytokine levels under the limits of detection for most cytokines, we 
dichotomized predictors rather than using them as continuous variables. Therefore, we 
cannot completely exclude the possibility that the relationships are model-specific, and 
replications using predictors with higher sensitivity are required in future studies. Third, 
we did not measure ligamentous and meniscal status that may be risk factors of BMLs 
[261]; however, there is no evidence showing that serum levels of inflammatory 
cytokines are associated with meniscal and/or ligamentous status, so meniscal and/or 
ligamentous status seem unlikely to be potential confounders for the associations 
between inflammatory cytokines and BMLs. Lastly, as inclusion and exclusion criteria 
were applied in the original RCT design, the generalizability to the general knee OA 
population needs to be confirmed.   
In conclusion, while serum IL-6 is associated with increased knee BMLs in both female 
and male OA patients, serum IL-17F and IL-23 only predict increased knee BML scores 
in females. These suggest that inflammation is involved in BML pathogenesis in knee 
OA, with the IL-6/IL-23/IL-17 axis having a role particularly in women. 
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is in Appendix 4. The text of this chapter is the same as the published version, except 
where changes have been requested by the examiners. Thus, there is some repetition of 
the methods. 
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7.1  Introduction 
Osteoarthritis (OA) is the most common type of arthritis, with prevalence estimates 
expected to increase dramatically worldwide due to aging and increasingly obese 
populations [2, 16]. There is a pressing need for biomarkers that can identify or predict 
the potential structural abnormalities and subsequent symptoms of disease, which 
would aid decision-making at both individual and community levels. Osteophyte (OP) 
formation is one of the common features of OA [6, 262, 263]. However, there are only 
modest correlations between knee OPs and clinical features [47, 103]. Additionally, 
change in knee symptoms is poorly predicted by OPs on baseline radiographs [264].  
Magnetic resonance imaging (MRI) is a non-invasive multiplanar tomographic tool that 
has been introduced to evaluate knee osteoarthritic changes such as bone marrow 
lesions (BMLs) [265], cartilage defects [190] and cartilage volume [266]. Although 
MRI can assess OPs in locations that are not easily visualised by conventional 
radiography [105, 188], and at greater sensitivity than radiographs for detection of early 
formation of OP [104], few data are available to compare the prevalence of OPs 
detected by MRI and radiography in population-based samples. It has been shown that 
greater size of MRI-detected OPs correlated with higher Kellgren-Lawrence score [63] 
and increased knee pain [110], and cross-sectional studies have suggested that 
increasing size and presence of MRI-defined OPs was associated with severity of knee 
OA [9, 63, 111] as well as presence of pain.  However, longitudinal studies are rare 
[110, 267].   Thus, the purposes of current study are to describe cross-sectional and 
longitudinal associations between MRI-detected OPs and knee structural abnormalities 
over 2.6 years as well as knee pain during 5 years in older adults.  
7.2  Material and methods 
7.2.1 Subjects 
This study used data from the Tasmania Older Adult Cohort (TASOAC) study, which 
is an ongoing, prospective, population-based study that aimed to identify the 
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environmental, genetic, and biochemical factors associated with the development and 
progression of OA. Participants between 50 and 80 years old were randomly selected 
from the electoral roll in Southern Tasmania (population 229, 000) using sex-stratified 
random sampling (response rate 57%). Participants were excluded if they were 
institutionalised or had contraindications to MRI. The Southern Tasmania Health and 
Medical Human Research Ethics Committee approved the study, and written informed 
consent was obtained from all participants. Baseline examinations were taken between 
February 2002 and September 2004, and follow-up measures were taken at 
approximately 2.6 and 5.1 years later.  
7.2.2 Anthropometrics 
Height was measured to the nearest 0.1 cm (with shoes, and headgear removed) using 
a stadiometer. Weight was measured to the nearest 0.1 kg (with shoes, socks, and bulky 
clothing removed) by using a single pair of electronic scales (Delta Model 707, Seca, 
Hamburg, Germany) that were calibrated using a known weight at the beginning of 
each clinic. Body mass index (BMI, weight (kg)/height2 (m2)) was also calculated.  
7.2.3 WOMAC pain assessment 
Knee pain was assessed using the Western Ontario McMaster Osteoarthritis Index 
(WOMAC) [204] at baseline, 2.6 and 5 years later using a 10-point scale from 0 (no 
pain) to 9 (most severe pain). The 5 subscales (walking on flat surface, going up/down 
stairs, at night, sitting/lying and standing upright) were assessed separately and summed 
to create a total pain score (0 to 45). The presence of knee pain was defined as total 
WOMAC pain score of 1 or greater [268]. Change in knee pain score was calculated as 
follow-up value - baseline value. An increase in total WOMAC pain was defined as a 
change in WOMAC pain score of ≥1. 
7.2.4 X-ray assessment  
A standing anteroposterior semiflexed view of the right knee with 15° of fixed knee 
flexion was performed in all subject at baseline [269]. Joint space narrowing (JSN) and 
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radiographic osteophytes (OPs) were scored at the medial tibia, medial femur, lateral 
tibia and lateral femur on a scale of 0-3 (0=normal, 3= severe) according to the 
Osteoarthritis Research Society International (OARSI) atlas developed by Altman et 
al. [31] OP score in the whole knee was the highest score of all compartments of the 
knee. The presence of radiographically- detected OP was defined as the OP score ≥ 1 
on X-ray. The presence of radiographic OA (ROA) was defined as any JSN or OP score 
of ≥1. Each score was determined by two readers (VS & HC) who simultaneously 
assessed the radiograph with immediate reference to the atlas. Intraobserver 
repeatability was tested in 40 subjects one month apart with intraclass correlation 
coefficients (ICCs) of 0.65-0.85 [23].  
7.2.5 Magnetic Resonance Imaging  
MRI scans of the right knees were performed on two occasions (baseline and 2.6 years 
later) and imaged in the sagittal plane on a 1.5-T whole body magnetic resonance unit 
(Picker, Cleveland, OH) using a commercial transmit-receive extremity coil. The image 
sequences were used as follows: (1) a T1-weighted fat saturation 3D gradient recall 
acquisition in the steady state; flip angle 30°; repetition time 31 ms; echo time 6.71 ms; 
field of view 16 cm; 60 partitions; 512×512 matrix; acquisition time 11 min 56 s; one 
acquisition. Sagittal images were obtained at a partition thickness of 1.5 mm and an in-
plane resolution of 0.31×0.31 (512×512 pixels). (2) a T2-weighted fat saturation 3-D 
fast spin echo, flip angle 90, repetition time 3067 ms, echo time 112 ms, field of view 
16 cm, 15 partitions, 228x256-pixel matrix; sagittal images were obtained at a partition 
thickness of 4 mm with a between-slices gap of 0.5 to 1.0 mm. The image database was 
transferred to an independent computer workstation using the software program Osirix 
(University of Geneva, Geneva, Switzerland) as previously described [116, 191].  
7.2.6 MRI-detected OP assessment  
MRI-detected OPs were measured (Supplementary Figure 1) by ZZ according to the 
Knee Osteoarthritis Scoring System [196] where OPs are defined as focal bony 
excrescences, seen on sagittal, axial or coronal images, extending from a cortical 
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surface. OPs were measured using the following scale: grade 0, absent; grade 1, 
minimal (<3 mm); grade 2, moderate (3-5 mm); grade 3, severe (>5 mm). Size was 
measured from the base (distinguished from that of adjacent articular cartilage with a 
normal MRI appearance) to the tip of the OP [188] at each of the following 14 sites: 
the anterior (a), central weight- bearing (c) and posterior (p) margins of the femoral 
condyles and tibial plateaus, and the medial (M) and lateral (L) margins of the patella 
[125].  The worst score of each individual site in the relevant compartment (or whole 
knee) was regarded as the OP score in that compartment (or whole knee). MRI-detected 
OP was considered as present if OP score of ≥1. Intra-observer reliability (expressed as 
ICC) was 0.94-0.97 and inter-observer reliability was 0.90-0.96.   
7.2.7 Cartilage defects 
Cartilage defects were assessed on T1-weighted MRI and graded at medial tibial, lateral 
tibial, medial femoral, lateral femoral and patellar regions as previously described [126, 
129]. as follows: grade 0, normal cartilage; grade 1, focal blistering and low-signal 
intensity change with an intact surface and bottom; grade 2, irregularities on the surface 
or bottom and loss of thickness of less than 50%; grade 3, deep ulceration with loss of 
thickness of more than 50%; grade 4, full thickness cartilage loss with exposure of 
subchondral bone [126].  The worst score of each individual site in the relevant 
compartment (or whole knee) was regarded as the cartilage defect score in that 
compartment (or whole knee). The presence of cartilage defects was defined as a 
cartilage defect score of ≥2 at any site. An increase in cartilage defects was defined as 
a change in cartilage defects of ≥1. Intra-observer reliability (expressed as ICC) was 
0.89-0.94 and inter-observer reliability was 0.85-0.93 [126].  
7.2.8 Cartilage volume 
Knee cartilage volume was measured on T1-weighted images by a single trained 
observer as previously described [193, 194]. The volumes of individual cartilage plates 
(medial tibial, lateral tibial) were isolated from the total volume by manually drawing 
disarticulation contours around the cartilage boundaries on a section by section basis. 
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These data were resampled by means of bilinear and cubic interpolation (area of 
312×312) um and 1.5 mm thickness, continuous sections) for the final 3-dimensional 
rendering. Changes in cartilage volume were calculated as: percentage change per 
annum= [(follow-up volume – baseline volume)/baseline cartilage volume]/time 
between 2 scans in years × 100. The coefficient of variation (CV) for cartilage volume 
measures was 2.1% to 2.6% [193, 194].  
7.2.9 Bone marrow lesions 
Subchondral BMLs were defined as discrete areas of increased signal adjacent to the 
subcortical bone on T2-weighted MRI and scored at medial tibial, lateral tibial, medial 
femoral, lateral femoral, medial patellar and lateral patellar regions using a modified 
version of Whole-Organ Magnetic Resonance Imaging Score (WORMS): grade 0, 
absence of BML; grade 1, area smaller than 25% of the region; grade 2, area between 
25% to 50% of the region; grade 3, area larger than 50% of the region [125].  The worst 
score of each individual site in the relevant compartment (or whole knee) was regarded 
as the BML score in that compartment (or whole knee). An increase in BMLs was 
defined as a change in BMLs of ≥1. The inter-reader reliability of this BML scoring 
system has been shown to be excellent [71, 195].  
7.2.10 Statistical analysis 
Student t or χ2 tests were used to compare means or proportions between those with and 
without baseline MRI-detected total knee OP. Site-specific associations were defined 
as the associations within the same site or compartment. Multivariable linear regression 
analyses were used to examine the site-specific associations between baseline MRI-
detected OPs (independent variables) and knee cartilage volume or change in cartilage 
volume (dependent variables), after adjustment for age, sex, BMI, cartilage defects and 
BMLs. Multivariable log binominal regression analyses were used to assess the site-
specific associations between baseline MRI-detected OPs (independent variable) and 
presences of knee cartilage defect/BMLs as well as increases in cartilage defects/BMLs 
(dependent variables) over 2.6 years, before and after adjustment for age, sex, BMI, 
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cartilage volume (if cartilage defects or BMLs), cartilage defect (if cartilage volume or 
BMLs) and BMLs (if cartilage defects or cartilage volume). Sensitivity analyses were 
performed by repeating the analyses in those without radiographically-detected OPs. 
Standard diagnostic checks of model fit and residuals were made and showed that the 
residuals of baseline and absolute changes of WOMAC knee pain scores were not 
normally distributed. Therefore, multivariable log binominal regression analyses were 
also used to evaluate cross-sectional and longitudinal associations between baseline 
MRI-detected osteophytes and WOMAC knee pain over 2.6 and 5 years (yes vs no at 
baseline, increase vs no increase over years), both after adjustment for age, sex, BMI, 
cartilage defects and BMLs. All statistical analyses were performed on Stata version 
12.0 for Windows (StataCorp, College Station, TX, USA). 
A p-value < 0.05 (2-tailed) or a 95% confidence interval (CI) not including the null 
point (for linear regression) or 1 (for log binominal regression) was considered 
statistically significant.  
7.3  Results 
7.3.1 Distribution of X-ray and MRI-detected OPs 
At baseline, 895 subjects were included for MRI assessments of OP. Mean age was 
62.4 years, mean BMI was 27.7 and 50% were females. 406 subjects completed MRI 
measures at 2.6 years’ follow-up but the rest discontinued MRI measures due to 
decommissioning of the MRI scanner in the local hospital. WOMAC knee pain data 
were available at baseline, 2.6 (n=874) and 5 years’ follow-up (n=751). There were no 
significant differences in demographic factors, cartilage defects, BMLs, cartilage 
volume and radiographic OA (ROA) between participants who completed and did not 
complete MRI measures at baseline [210].  A total of 837 participants had readable x-
ray and MRI images out of 895 baseline participants. The frequencies of OP grades 
detected by radiography and MRI are presented in Table 7.1/Table 7.2 85% of 
participants had MRI-detected OPs at baseline, while only 10% of participants had 
radiographically-detected OPs. 439 of 755 (58%) participants without 
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radiographically-detected OPs exhibited modest MRI-detected OPs (grade 1), and 189 
of 755 (25%) participants without radiographically-detected OPs showed larger MRI-
detected OPs (grade 2 and 3). In contrast, only 2 out of 129 participants without MRI-
detected OPs showed radiographically-detected OPs. Patellar site has the most frequent 
MRI-detected OPs at baseline (data not shown).  
Table 7. 1 Distribution of x-ray and MRI-detected OP scores 
 Total MRI OP scores  
 0 1 2 3 Total  
T
ot
al
 x
-r
ay
 O
P
 s
co
re
s 
0 127 439 132 57 755 
1 0 13 11 22 46 
2 2 3 2 20 27 
3 0 0 0 9 9 
 Total  129 455 145 108 837* 
*Only 837 had readable x-ray and MRI films. 
Table 7. 2 Sensitivity and specificity of MRI detected OP 
 X-ray detected OP  
 No Yes Total  
A
ny
 
M
R
I-
O
P
  
No 
 
127 (16.8%) 2 (2.4%) 129 
Yes 628 (83.2%) 80 (97.6%) 708 
 Total  755 82 837* 
*Only 837 had readable x-ray and MRI films. X-ray detected osteophyte (OP) was used as the reference 
7.3.2 Baseline characteristics of participants  
The baseline characteristics of the participants are shown in Table 7.3.  Compared with 
those without baseline MRI-detected OPs, those with baseline MRI-detected OPs were 
older, and had more proportion of males, higher weight and BMI, and larger lateral 
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tibial bone area. Additionally, participants with baseline MRI-detected OPs had 
significant less patellar cartilage volume, and higher prevalence of cartilage defects, 
BMLs and knee pain. The differences in prevalence of joint space narrowing and ROA 
between those with and without baseline MRI-detected OPs were of borderline 
significance (Table 7.3).  
Table 7. 3 Characteristics of participants at baseline 
 Any MRI osteophytes in total knee p-value 
Absent  Present 
 N=129 N=708  
Age (year) 60.3±6.4 62.7±7.5 <0.01 
Female sex (%) 58 49 0.05 
Weight (kg) 72.4 ± 12.5 78.6 ± 14.8 <0.01 
BMI (kg/m²) 26.3 ± 3.8 27.9 ± 4.7 <0.01 
Patella cartilage volume (ml) 3.4±0.9 3.2±0.9 0.02 
Total tibial cartilage volume (ml) 5.0 ± 1.2 5.1 ± 1.2 0.66 
Medial tibial bone area (cm²) 21.8±16.4 21.0±3.1 0.23 
Lateral tibial bone area (cm²) 11.8±2.0 12.2 ±2.2 0.03 
Any joint space narrowing (%) 52 61 0.07 
Any cartilage defects (%) 17 59 <0.01 
Baseline cartilage defects score, n (%)    
1 105 (81) 294 (41)  
2 18 (14) 215 (30)  
3 4 (3) 145 (21)  
4 2 (2) 54 (8)  
Any BMLs (%) 21 37 <0.01 
Baseline BML score, n (%)    
0 101 (78) 446 (63)  
1 27 (21) 183 (26)  
2 1 (1) 67 (9)  
3 0 (0) 12 (2)  
Knee pain present (%) 43 53 0.03 
Radiographic OA (%) 52% 61% 0.05 
Two-tailed t tests were used for differences between means, and χ2 tests were used for proportions 
(percentages). Significant differences are shown in bold. Mean ± SD except for percentages. 
Radiographic OA was defined using Osteoarthritis Research Society International definition with a total 
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score of >=1. BMI: body mass index; OA: osteoarthritis; BML: bone marrow lesions; MTF: medial 
tibiofemoral; LTF: lateral tibiofemoral 
7.3.3  Associations with structural changes 
Cross-sectionally, higher grades of baseline MRI-detected OPs in medial tibiofemoral, 
lateral tibiofemoral and patellar compartments were significantly and site-specifically 
associated with higher prevalences of cartilage defects, after adjustment for age, sex, 
BMI, baseline BMLs and cartilage volume (Table 7.4). Longitudinally, higher grades 
of baseline MRI-detected OPs were site-specifically associated with greater risks of 
any increase in cartilage defects in all compartments except for patellar site, after 
adjusted for covariates (Table 7.4, Figure 7.1a).  
Table 7. 4 Site-specific associations between baseline MRI-detected osteophytes and 
baseline/increases in knee cartilage defects 
 Multivariable*  Multivariable**  
 PR (95% CI) p PR (95% CI) p 
Presence of cartilage defects at baseline    
N=895     
Medial tibiofemoral      
Grade 0 Ref.  Ref.  
Grade 1 2.70 (1.98, 3.69) <0.01 2.61 (1.91, 3.56) <0.01 
Grade 2 4.51 (3.26, 6.25) <0.01 4.11 (2.95, 5.74) <0.01 
Grade 3 7.06 (5.45, 9.13) <0.01 6.01 (4.50, 8.02) <0.01 
P for trend    <0.01 
     
Lateral tibiofemoral      
Grade 0 Ref.  Ref.  
Grade 1 2.60 (1.73, 3.90) <0.01 2.41 (1.61, 3.60) <0.01 
Grade 2 6.29 (4.11, 9.65) <0.01 4.80 (3.09, 7.45) <0.01 
Grade 3 10.5 (7.18, 15.3) <0.01 7.46 (5.00, 11.1) <0.01 
P for trend    <0.01 
     
Patellar      
Grade 0 Ref.  Ref.  
Grade 1 2.46 (1.72, 3.50) <0.01 2.39 (1.68, 3.42) <0.01 
Grade 2 4.89 (3.44, 6.95) <0.01 4.52 (3.17, 6.44) <0.01 
Grade 3 5.78 (4.04, 8.28) <0.01 5.22 (3.63, 7.50) <0.01 
P for trend    <0.01 
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Total      
Grade 0 Ref.  Ref.  
Grade 1 2.52 (1.73, 3.67) 
8)
<0.01 2.46 (1.68, 3.58) <0.01 
Grade 2 4.20 (2.89, 6.11) <0.01 3.89 (2.67, 5.67) <0.01 
Grade 3 4.98 (3.44, 7.21) <0.01 4.31 (2.96, 6.27) <0.01 
P for trend    <0.01 
     
Any increase in cartilage defects RR  RR  
N=402     
Medial tibiofemoral      
Grade 0 Ref.  Ref.  
Grade 1 1.15 (0.81, 1.61) 0.44 1.12 (0.79, 1.57) 0.53 
Grade 2 1.72 (1.14, 2.59) <0.01 1.60 (1.07, 2.40) 0.02 
Grade 3 1.70 (1.14, 2.51) <0.01 1.54 (1.01, 2.34) 0.04 
P for trend    0.01 
     
Lateral tibiofemoral      
Grade 0 Ref.  Ref.  
Grade 1 1.82 (1.12, 2.94) 0.02 1.81 (1.08, 3.04) 0.02 
Grade 2 2.40 (1.22, 4.69) 0.01 1.91 (0.90, 4.09) 0.09 
Grade 3 2.51 (1.11, 5.67) 0.03 2.61 (1.20, 5.69) 0.02 
P for trend    0.03 
     
Patellar      
Grade 0 Ref.  Ref.  
Grade 1 0.84 (0.55, 1.29) 0.42 0.83 (0.54, 1.27) 0.39 
Grade 2 1.20 (0.71, 2.02) 0.50 1.16 (0.68, 1.97) 0.59 
Grade 3 1.50 (0.79, 2.85) 0.22 1.59 (0.84, 3.03) 0.15 
P for trend    0.20 
     
Total      
Grade 0 Ref.  Ref.  
Grade 1 1.09 (0.84, 1.42) 0.52 1.08 (0.83, 1.41) 0.57 
Grade 2 1.38 (1.04, 1.84) 0.03 1.33 (1.00, 1.77) 0.05 
Grade 3 1.57 (1.20, 2.07) <0.01 1.45 (1.09, 1.91) 0.01 
P for trend    <0.01 
Dependent variable: baseline presence of (yes vs no) or any increase (yes vs no) in cartilage defects. 
Independent variable: MRI-detect osteophytes (per grade). OP: osteophytes; PR: prevalence ratio; RR: 
relative risks; Ref: reference group; *adjusted for age, sex and BMI; ** further adjusted for BMLs, 
cartilage volume; Significant differences are shown in bold. 
In cross-sectional analyses, higher grades of baseline MRI-detected OPs were 
significantly associated with lower baseline cartilage volume in all compartments, after 
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adjustment for age, sex, BMI, baseline cartilage defects and BMLs (Table 7.5). In 
longitudinal analyses, higher grades of baseline MRI-detected OPs were significantly 
associated with more loss of cartilage volume in total knee, medial and lateral 
tibiofemoral compartments, after adjustments for covariates (Table 7.5, Figure 1b).   
Table 7. 5 Site-specific associations between baseline MRI osteophytes and baseline/changes 
in cartilage volume 
 Multivariable*  Multivariable**  
 β (95% CI) p β (95% CI) p 
Baseline cartilage volume (mm3)    
N=895     
Medial tibiofemoral     
Grade 0 Ref.  Ref.  
Grade 1 64.7 (-19.9, 149) 0.13 80.8 (-5.75, 167) 0.07 
Grade 2 99.2 (-31.7, 230.1) 0.14 131 (-4.42, 267) 0.06 
Grade 3 -229 (-362, -96.5) <0.01 -178 (-323, -33.1) 0.02 
P for trend    0.60 
     
Lateral tibiofemoral      
Grade 0 Ref.  Ref.  
Grade 1 6.20 (-72.1, 84.5) 0.88 14.6 (-65.6, 94.8) 0.72 
Grade 2 -42.3 (-182, 97.6) 0.55 -24.2 (-171, 123) 0.75 
Grade 3 -326 (-481, -171) <0.01 -296 (-466, -126) <0.01 
P for trend    0.03 
     
Patellar      
Grade 0 Ref.  Ref.  
Grade 1 -153 (-276, -30.5) 0.01 -129 (-251, -7.19) 0.04 
Grade 2 -373 (-531, -214) <0.01 -288 (-451, -125) <0.01 
Grade 3 -737 (-962, -512) <0.01 -623 (-854, -392) <0.01 
P for trend    <0.01 
     
Total      
Grade 0 Ref.  Ref.  
Grade 1 -259 (-523, 5.62) 
8)
0.06 -217 (-481, 46.4) 0.11 
Grade 2 -172 (-498, 153) 0.30 -43.3 (-374, 287) 0.80 
Grade 3 -813 (-1168, -457) <0.01 -555 (-940, -171) <0.01 
P for trend    0.01 
     
Change in cartilage volume (% pa) β  β  
N=402     
Medial tibiofemoral      
Grade 0 Ref.  Ref.  
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Grade 1 0.61 (-0.98, 2.20) 0.45 0.66 (-0.95, 2.27) 0.42 
Grade 2 -4.88 (-7.57, -2.19) <0.01 -5.0 (-7.79, -2.21) <0.01 
Grade 3 -3.13 (-6.10, -0.17) 0.04 -3.25 (-6.43, -0.06) 0.05 
P for trend    0.01 
     
Lateral tibiofemoral      
Grade 0 Ref.  Ref.  
Grade 1 0.93 (-0.16, 2.03) 0.09 0.98 (-0.13, 2.09) 0.08 
Grade 2 -1.17 (-3.34, 1.00) 0.29 -1.07 (-3.30, 1.17) 0.35 
Grade 3 -5.96 (-8.36, -3.55) <0.01 -5.95 (-8.53, -3.37) <0.01 
P for trend    <0.01 
     
Patellar      
Grade 0 Ref.  Ref.  
Grade 1 -0.21 (-1.51, 1.08) 0.75 -0.16 (-1.47, 1.14) 0.81 
Grade 2 -0.49 (-2.16, 1.19) 0.57 -0.25 (-1.98, 1.48) 0.78 
Grade 3 -0.90 (-3.12, 1.33) 0.43 -0.49 (-2.85, 1.87) 0.68 
P for trend    0.68 
     
Total      
Grade 0 Ref.  Ref.  
Grade 1 -0.03 (-0.72, 0.66) 0.93 -0.01 (-0.69, 0.70) 0.98 
Grade 2 -1.17 (-2.01, -0.33) <0.01 -1.10 (-1.94, -0.25) 0.01 
Grade 3 -0.90 (-1.80, -0.01) 0.05 -0.78 (-1.75, 0.20) 0.12 
P for trend    <0.01 
Dependent variable: baseline or change in cartilage volume. Independent variable: MRI-detect 
osteophytes (per grade). OP: osteophytes; PR: prevalence ratio; RR: relative risks; Ref: reference group; 
*adjusted for age, sex and BMI; ** further adjusted for BMLs and cartilage defects; Significant 
differences are shown in bold. 
Similarly, higher grades of baseline MRI-detected OPs were significantly and site-
specifically associated with greater prevelances of baseline BMLs at all compartments, 
after adjustment for age, sex, baseline cartilage volume and cartilage defects (Table 
7.6). The longitudinal associations between baseline grades of MRI-detected OPs and 
any increase in BMLs at total knee, medial and lateral tibiofemoral compartments were 
also significant in multivariable analyses (Table 7.6, Figure 7.1c). Sensitivity analyses 
showed that these significant associations between MRI-detected OPs and structural 
abnormalities were similar in those without X-ray OPs (data not shown). 
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Table 7. 6 Site-specific associations between baseline MRI osteophytes and 
baseline/increases in BMLs 
 Multivariable*  Multivariable**  
 PR (95% CI) p PR (95% CI) p 
Presence of BMLs at baseline    
N=895     
Medial tibiofemoral      
Grade 0 Ref.  Ref.  
Grade 1 1.51 (1.08, 2.12) 0.02 1.37 (0.97, 1.93) 0.08 
Grade 2 2.07 (1.35, 3.18) <0.01 1.72 (1.11, 2.68) 0.02 
Grade 3 3.85 (2.89, 5.13) <0.01 2.74 (1.96, 3.84) <0.01 
P for trend    <0.01 
     
Lateral tibiofemoral      
Grade 0 Ref.  Ref.  
Grade 1 1.31 (0.93, 1.84) 0.12 1.09 (0.75, 1.57) 0.57 
Grade 2 2.29 (1.44, 3.63) <0.01 1.89 (1.11, 3.21) 0.02 
Grade 3 3.62 (2.39, 5.49) <0.01 2.10 (1.32, 3.35) <0.01 
P for trend    <0.01 
     
Patellar     
Grade 0 Ref.  Ref.  
Grade 1 1.66 (1.08, 2.56) 0.02 1.72 (1.08, 2.74) 0.02 
Grade 2 2.87 (1.81, 4.57) <0.01 2.87 (1.75, 4.70) <0.01 
Grade 3 2.42 (1.31, 4.47) <0.01 2.02 (1.01, 4.05) 0.05 
P for trend    <0.01 
     
Total      
Grade 0 Ref.  Ref.  
Grade 1 1.34 (1.05, 1.70) 
8)
0.02 1.21 (0.95, 1.54) 0.13 
Grade 2 2.06 (1.42, 2.99) <0.01 1.78 (1.18, 2.69) <0.01 
Grade 3 2.93 (2.04, 4.23) <0.01 1.88 (1.24, 2.84) <0.01 
P for trend    <0.01 
     
Any increase in BMLs RR  RR  
N=402     
Medial tibiofemoral     
Grade 0 Ref.  Ref.  
Grade 1 1.27 (0.70, 2.30) 0.43 1.14 (0.62, 2.10) 0.67 
Grade 2 2.79 (1.42, 5.48) <0.01 1.92 (0.96, 3.84) 0.07 
Grade 3 3.64 (2.00, 6.60) <0.01 2.08 (1.12, 3.86) 0.02 
P for trend    <0.01 
     
Lateral tibiofemoral      
Grade 0 Ref.  Ref.  
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Grade 1 0.97 (0.61, 1.54) 0.88 0.86 (0.54, 1.37) 0.52 
Grade 2 1.57 (0.81, 3.07) 0.18 1.02 (0.50, 2.09) 0.95 
Grade 3 3.19 (1.98, 5.14) <0.01 2.04 (1.14, 3.65) 0.02 
P for trend    <0.01 
     
Patellar      
Grade 0 Ref.  Ref.  
Grade 1 1.16 (0.64, 2.12) 0.62 1.11 (0.59, 2.08) 0.39 
Grade 2 1.19 (0.58, 2.42) 0.64 1.32 (0.60, 2.91) 0.50 
Grade 3 1.71 (0.74, 3.93) 0.21 2.22 (0.90, 5.49) 0.08 
P for trend    0.35 
     
Total      
Grade 0 Ref.  Ref.  
Grade 1 0.91 (0.62, 1.33) 0.63 0.88 (0.59, 1.30) 0.57 
Grade 2 1.48 (0.93, 2.36) 0.10 1.11 (0.64, 1.92) 0.71 
Grade 3 2.53 (1.78, 3.61) <0.01 1.56 (1.03, 2.40) 0.04 
P for trend    <0.01 
Dependent variable: baseline presence (yes vs no) of or any increase (yes vs no) in BMLs. Independent 
variable: MRI-detect osteophytes (per grade). BMLs: bone marrow lesions; OP: osteophytes; PR: 
prevalence ratio; RR: relative risks; Ref: reference group; *adjusted for age, sex and BMI; ** further 
adjusted for cartilage defects and cartilage volume. Significant differences are shown in bold. 
7.3.4 Associations with WOMAC pain  
Table 7.7 described the associations between baseline MRI-detected OPs and the 
presence of or any increase in WOMAC knee pain. Participants who had higher grades 
of baseline MRI-detected OPs, particularly in grade 2 and 3, had higher prevalence of 
WOMAC pain and greater risks of worsening WOMAC pain scores over 2.6 and 5 
years, before and after adjustments for age, sex, BMI (Table 7.4). Figure 7.1d shows 
significant associations between baseline MRI-detected OPs in different compartments 
and worsening total WOMAC knee pain over 5 years. The cross-sectional associations 
remained significant after further adjustment for baseline cartilage defects and BMLs; 
however, longitudinal associations were no longer statistically significant after further 
adjustments (Table 7.7). 
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Table 7. 7 Cross-sectional and longitudinal associations between baseline MRI-detected 
osteophytes and baseline and increases in WOMAC knee pain 
       Multivariable*     Multivariable** 
 PR (95% CI) p PR (95% CI) p 
Presence of knee pain at baseline     
N=892     
Total MRI-detected OPs     
Grade 0 Ref.  Ref.  
Grade 1 1.05 (0.84, 1.30) 0.68 1.05 (0.84, 1.31) 0.64 
Grade 2 1.30 (1.03, 1.66) 0.03 1.31 (1.03, 1.66) 0.03 
Grade 3 1.80 (1.44, 2.26) <0.01 1.79 (1.41, 2.27) <0.01 
P for trend     <0.01 
     
Increase in WOMAC knee pain over 2.6 years    
N=787 RR (95% CI) p RR (95% CI) p 
Total MRI-detected OPs     
Grade 0 Ref.  Ref.  
Grade 1 1.20 (0.78, 1.85) 0.40 1.16 (0.75, 1.80) 0.50 
Grade 2 1.07 (0.63, 1.83) 0.80 0.95 (0.55, 1.66) 0.87 
Grade 3 1.67 (1.00, 2.78) 0.05 1.35 (0.77, 2.37) 0.30 
P for trend     0.03 
     
Increase in WOMAC knee pain over 5 years    
N=690     
Total MRI-detected OPs      
Grade 0 Ref.  Ref.  
Grade 1 0.90 (0.65, 1.26) 0.55 0.85 (0.61, 1.20) 0.37 
Grade 2 1.20 (0.77, 1.88) 0.41 1.01 (0.63, 1.60) 0.98 
Grade 3 1.63 (1.08, 2.45) 0.02 1.24 (0.78, 1.97) 0.37 
P for trend     0.04 
Dependent variable: baseline and increases in WOMAC knee pain (yes or no). Independent variable: 
MRI-detect total knee osteophytes. OP: osteophytes; PR: prevalence ratio; *adjusted for age, sex and 
BMI. ** Further adjustment for baseline cartilage defects and BMLs. Significant differences are shown 
in bold. 
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Figure 7. 1 Association of baseline MRI-detected OPs with increases in total knee cartilage 
defects 
(a), changes in cartilage volume per annum (%) (b), increases in total knee BMLs (c), and 
increases in total WOMAC knee pain over 5 years (d). MTF: medial tibiofemoral; LTF: lateral 
tibiofemoral. p values were for trends at different compartments after adjustment for baseline age, sex 
and body mass index. 
 
7.4  Discussion 
In our study, OPs detected on MRI were much more common than OPs visible on 
conventional radiographs, as expected. MRI-detected OPs were associated with knee 
structural abnormalities both cross-sectionally and longitudinally. Significant 
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associations between MRI-detected OPs and WOMAC knee pain were also found but 
these were largely dependent of knee structural abnormalities. These results suggest 
that MRI-detected OPs may be an early marker of the disease process in knee OA.  
Conventional radiographs are known to be relatively insensitive to the structural 
changes of OA [107], in part because of their inability to detect three-dimensional (3D) 
joint structures [107], and inadequate visualization of early and central OPs. One study 
reported that prevalence of MRI-defined OP was 72% among middle-aged women 
[110].  Another study looked at the prevalence of MRI-depicted abnormalities in knees 
without radiographic evidence of OA and found that OPs were the most common 
abnormality, being present in 74% of 710 participants [107].  Our data also showed a 
much higher prevalence of MRI-detected OPs in older adults than the prevalence of 
radiographially-detected OPs (85% vs 10%). MRI-detected OPs also had high 
reliabilities than radiographically-detected OPs. These findings suggest that MRI is far 
more sensitive and reliable than X-ray to detect osteophytes and our data suggest these 
OPs have clinical relevance.  
Structural changes 
Significant cross-sectional associations between MRI-identified OPs and radiographic 
severity of knee OA were reported among middle-aged women [63]. Another cross-
sectional study revealed that MRI-detected OPs was only weakly associated with 
synovitis or joint effusion [270]. There are only two longitudinal studies so far, which 
reported inconsistent results [110, 112]. The first did not reveal any significant 
associations between MRI- defined OPs and knee structural progression [110]. The 
second was a nested case-control study reporting that subjects with 6 or more locations 
affected by OPs had 4.4-fold the odds of being both radiographic and pain progression 
compared with 0-2 locations affected [112]. Our current study reported positive, 
consistent and independent associations between MRI-detected OPs and changes in 
knee cartilage and bone abnormalities both cross-sectionally and longitudinally in a 
community-based older population. These associations remained unchanged after those 
with X-ray detected OPs were excluded. Although the underlying mechanisms are 
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unable to be determined in this study, our findings imply that MRI-detected osteophytes 
could be a precursor of cartilage degradation and BMLs.   
Pain  
The association between OPs and knee pain is still controversial. One cohort study 
reported that increasing baseline OP size was associated with increasing WOMAC pain 
severity score [110] in a middle-aged female population (n=363). Another cross-
sectional study reported a significant association between presence of OPs and knee 
pain among symptomatic OA patients (n=368) only when OPs were located in the 
patellofemoral compartment or when more than four OPs (any grade) were present 
anywhere in the knee [44]. In contrast, Link et al [111] reported that MRI-defined OPs 
were not associated with clinical findings as assessed with the WOMAC scores in 
patients with varying degrees of OA (n=50). A recent systematic review concluded that 
there was limited level of evidence for associations between MRI-detected OPs and 
knee pain [82]. Compared to these previous studies, our study was performed in a 
general population with a large sample size (n=837) and revealed that there was a 
significant association between MRI-detected OPs and total WOMAC knee pain cross-
sectionally, independent of knee structural abnormalities. MRI-detected OPs were also 
significantly associated with changes in knee pain over 2.6 years and 5 years, but these 
associations became non-significant after adjustment for cartilage defects and BMLs, 
indicating MRI-detected OPs may cause OA symptoms through other structural 
changes. Our extensive analyses showed that MRI-detected OP at medial compartment 
had the most prominently and consistently significant associations with WOMAC knee 
pain changes than others (data not shown). This is reasonable as medial compartment 
has the most frequently osteoarthritic changes among all the compartments [271].   
Strengths of this study included the random selection of participants for the cohort from 
the community, with a large sample size and both structural and symptomatic 
measurements. Our results have good external validity, as they can be generalizable to 
all white older adults in the population. Study limitations included the unavailability of 
follow-up MRI scans in 489 participants due to decommissioning of MRI scanner. 
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However, the current study sample is similar to the remainder of the cohort in terms of 
demographic factors, ROA, baseline cartilage volume, defects and BMLs. Second, we 
did not perform MRI scan at year 5 so were not able to assess the associations with 
changes in knee structures over 5 years. Last, different semi-quantitative scoring 
systems were used for OPs, cartilage defects and BMLs which may influence results; 
however, given all measures were highly reproducible, this is considered unlikely. 
In conclusion, MRI-detected OPs are common and appear to be clinically relevant to 
knee structural changes in older adults. 
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Association between MRI-detected early osteophytes and 
knee structure in older adults: a population-based cohort 
study 
 
This manuscript has been submitted for publication. The text of this chapter is the same 
as the submitted version. Thus, there is some repetition of the methods. 
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8.1 Introduction 
Knee osteoarthritis (OA) is a leading cause of pain and disability [2]. Symptomatic 
knee OA is estimated to occur in 10% of men and 13% of women aged 60 years or 
older in the United State [40]. Although osteophytes (OPs) have long been viewed as a 
defining structural feature of knee OA [272] and a fundamental sign of disease 
incidence and progression [273], the correlation between OPs and clinical feature is 
weak at best [47, 103], and change in symptoms is poorly predicted by baseline 
radiographic OPs [264].  
In an observational study, knee pain was reported by 1004 subjects, only 15% of whom 
had radiographic grade 2 to 4 changes of OA [274]. The discrepancy between clinical 
and radiographic OA may be due to the inherent limitations of conventional 
radiography as an imaging tool [275]. Many OA features cannot be detected using 
radiography and some pre-radiographic OA features are missed using radiographic 
assessment. A recent study revealed that about 90% of radiographically normal knees 
had one or more OA-related features on MRI, and MRI-detected OP is the most 
common abnormality among these features [107]. An observational study has reported 
that prevalence of MRI-detected OPs is 72% among middle-aged women [110] and 
another study reports 74% MRI-detected OPs in 710 knees without radiographic 
evidence of OA [107]. In contrast, the prevalence of radiographic OPs was 
approximately 10% in a generally older population (mean age 61 years) [108].  
Given that radiography fails to detect a large proportion of OPs which can be detected 
on MRI, there would be a large number of OA patients who have MRI-detected early 
OPs (MRI-OPs) but are misclassified as normal. Moreover, they represent different 
stages of OA process. To date, the relevance of MRI-OPs for the development of 
structural and clinical abnormalities is uncertain. We hypothesized that MRI-OPs that 
are detected only by MRI can serve as a biomarker in identifying patients at a high risk 
of osteoarthritic progression. The aim of this population-based cohort study, therefore, 
was to describe the prevalence of MRI-OPs in older adults and the longitudinal 
associations with knee pain and structural abnormalities. 
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8.2  Material and methods 
8.2.1 Subjects  
These analyses use data from the Tasmania Older Adult Cohort (TASOAC) Study, a 
population-based, ongoing, prospective study which was designed to identify the 
environmental, genetic, biochemical factors associated with the development and 
progression of OA at multiple sites. Participants between 50 and 80 years old were 
randomly selected from the electoral roll in Southern Tasmania (population 229, 000) 
using sex-stratified random sampling (response rate 57%). Participants were excluded 
if they were institutionalised or had contraindications to MRI. The Southern Tasmania 
Health and Medical Human Research Ethics Committee approved the study, and 
written informed consent was obtained from all participants. Baseline examinations 
were taken between February 2002 and September 2004, and follow-up measures were 
taken at approximately 2.6 and 5.1 years later. This study consisted of 837 participants 
who had knee MRI and radiographic scans at baseline. 
8.2.2 Magnetic Resonance Imaging 
MRI scans of the right knees were performed on two occasions and imaged in the 
sagittal plane on a 1.5-T whole body magnetic resonance unit (Picker, Cleveland, OH) 
using a commercial transmit-receive extremity coil. The image sequences used are 
listed as follows: (1) a T1-weighted fat saturation 3D gradient recall acquisition in the 
steady state; flip angle 30°; repetition time 31 ms; echo time 6.71 ms; field of view 16 
cm; 60 partitions; 512×512 matrix; acquisition time 11 min 56 s; one acquisition. 
Sagittal images were obtained at a partition thickness of 1.5 mm and an in-plane 
resolution of 0.31×0.31 (512×512 pixels). (2) a T2-weighted fat saturation 3-D fast spin 
echo, flip angle 90, repetition time 3067 ms, echo time 112 ms, field of view 16 cm, 15 
partitions, 228x256-pixel matrix; sagittal images were obtained at a partition thickness 
of 4 mm with a between-slices gap of 0.5 to 1.0 mm. The image database was 
transferred to an independent computer workstation using the software program Osirix 
(University of Geneva, Geneva, Switzerland) as previously described [116, 191].  
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8.2.3 MRI-detected osteophytes 
MRI-detected OPs were measured by ZZ according to the Knee Osteoarthritis Scoring 
System (KOSS) [196] where OPs are defined as focal bony excrescences, seen on 
sagittal, axial or coronal images, extending from a cortical surface. OPs were measured 
using the following scale. Grade 0, absent; grade 1, minimal (<3mm); grade 2, moderate 
(3-5 mm); grade 3, severe (>5 mm) [196]. Size was measured from the base 
(distinguished from that of adjacent articular cartilage with a normal MRI appearance) 
to the tip of the OP [188] at each of the following 14 sites: the anterior (a), central 
weight bearing (c) and posterior (p) margins of the femoral condyles(medial and 
lateral), and tibial plateaus (medial and lateral), and the medial (M) and lateral (L) 
margins of the patella [125]. The worst score of each individual site in the relevant 
compartment (or whole knee) was regarded as the OP score in that compartment (or 
whole knee). MRI-detected OP score of ≥1 was considered as OP present. MRI-
detected OPs were remeasured in 40 randomly selected participants with four weeks 
interval by ZZ and WH to calculate intra-observer and inter-observer reliabilities. Intra-
observer reliability (expressed as intraclass correlation coefficients, ICCs) was 0.94-
0.97 and inter-observer reliability was 0.90-0.96. 
8.2.4 Cartilage defects  
Cartilage defects were graded by CD at medial tibial, lateral tibial, medial femoral, 
lateral femoral and patellar regions as previously described [126, 129] as follows. 
Grade 0, normal cartilage; grade 1, focal blistering and low-signal intensity change with 
an intact surface and bottom; grade 2, irregularities on the surface or bottom and loss 
of thickness of less than 50%; grade 3, deep ulceration with loss of thickness of more 
than 50%; grade 4, full thickness cartilage loss with exposure of subchondral bone 
[126]. The worst score of each individual site in the relevant compartment (or whole 
knee) was regarded as the cartilage defect score in that compartment (or whole knee). 
The presence of cartilage defects was defined as a cartilage defect score of ≥2 at any 
site (medial tibial, lateral tibial, medial femoral or lateral femoral). An increase in 
cartilage defects was defined as a change in cartilage defects of ≥1. Intra-observer 
reliability was 0.89-0.94 and inter-observer reliability was 0.85-0.93 [126]. 
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8.2.5 Cartilage volume 
Knee cartilage volume was measured on T1-weighted images by a single trained 
observer at baseline as previously described [193, 194]. The volumes of individual 
cartilage plates (medial tibial, lateral tibial, medial femoral, lateral femoral and patellar) 
were isolated from the total volume by manually drawing disarticulation contours 
around the cartilage boundaries on a section by section basis. These data were 
resampled by means of bilinear and cubic interpolation (area of 312×312) um and 1.5 
mm thickness, continuous sections) for the final 3-dimensional rendering. Changes in 
cartilage volume were calculated as: percentage change per annum= [(follow-up 
volume – baseline volume)/baseline cartilage volume]/time between 2 scans in years × 
100. The coefficients of variation (CVs) for cartilage volume measures were 2.1% to 
2.6% [193, 194]. 
8.2.6 Bone marrow lesions 
Subchondral bone marrow lesions (BMLs) were defined as discrete areas of increased 
signal adjacent to the subcortical bone on T2-weighted MRI and scored at medial tibial, 
lateral tibial, medial femoral, lateral femoral, and patellar regions, using a modified 
version of Whole-Organ Magnetic Resonance Imaging Score (WORMS). Grade 0, 
absence of BML; grade 1, area smaller than 25% of the region; grade 2, area between 
25% to 50% of the region; grade 3, area larger than 50% of the region [125]. The worst 
score of each individual site in the relevant compartment (or whole knee) was regarded 
as the BML score in that compartment (or whole knee). The presence of BMLs was 
defined as a BML score of ≥1 at any site (medial tibial, lateral tibial, medial femoral or 
lateral femoral). An increase in BMLs was defined as a change in BMLs of ≥1. The 
intraclass correlation coefficients (ICCs) for intra-observer reliability were 0.89-0.96 
[205]. The inter-observer reliability of this BML scoring system was assessed by 
randomly selecting 40 subjects with BMLs and having their MRI scans re-read by 
another observer. The ICCs for inter-observer reliability were also excellent (0.73-0.95) 
[71, 195]. 
8.2.7 X-ray assessment 
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A standing anteroposterior semiflexed view of the right knee with 15° of fixed knee 
flexion was performed in all subject at baseline. Joint space narrowing (JSN) and 
radiographic osteophytes (OPs) were scored at each site of medial tibia, medial femur, 
lateral tibia and lateral femur on a scale of 0-3 (0=normal, 3= severe) according to the 
Osteoarthritis Research Society International (OARSI) atlas developed by Altman et 
al. [31]. Medial tibiofemoral (femoral and tibial combined) X-ray-detected OP and 
lateral tibiofemoral X-ray-detected OP were the worst scores of the four sites (medial 
tibia, medial femur, lateral tibia and lateral femur). The total X-ray-detected OP score 
was the worst score of all compartments of the knee. The presence of X-ray-detected 
OP was defined as X-ray-detected OP scores of ≥ 1 in the specific compartment. Due 
to lack of skyline view of radiographs, patellar radiographic OPs were not obtained. 
The presence of radiographic OA (ROA) was defined as any score of ≥ 1 (JSN or OP). 
Each score was determined by two readers who simultaneously assessed the radiograph 
with immediate reference to the atlas. Intraobserver repeatability was tested in 40 
subjects one month apart with ICCs of 0.65-0.85 [23].  
8.2.8 WOMAC pain assessment  
Knee pain was assessed using the Western Ontario McMaster Osteoarthritis Index 
(WOMAC) [204] at baseline and 5 years later using a 10-point scale from 0 (no pain) 
to 9 (most severe pain). The 5 subscales (walking on flat surface, going up/down stairs, 
at night, sitting/lying and standing upright) were assessed separately and summed to 
create a total pain score (0 to 45). Change in knee pain score was calculated as follow-
up value - baseline value. The presence of knee pain was defined as total WOMAC 
pain score of 1 or greater [268]. Worsening knee pain was defined as a change in 
WOMAC pain score of 1 or greater. Regular nonsteroridal anti-inflammatory drugs 
(NSAIDs) use in most days (>15 days) of the last month at baseline were recorded by 
questionnaire. 
8.2.9 Anthropometrics 
Height was measured to the nearest 0.1 cm (with shoes, and headgear removed) using 
a stadiometer. Weight was measured to the nearest 0.1 kg (with shoes, socks, and bulky 
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clothing removed) by using a single pair of electronic scales (Delta Model 707, Seca, 
Hamburg, Germany) that were calibrated using a known weight at the beginning of 
each clinic. Body mass index (BMI, weight (kg)/height (m2)) was also calculated.  
8.2.10 Data analysis 
One-way analysis of variance or χ2 test were used to compare means or proportions 
among participants with no OPs (no X-ray or MRI OPs), MRI-OPs (only MRI OPs, not 
detected by X-ray) and established-OPs (both X-ray and MRI OPs). Multivariable 
linear regression analyses were used to examine the compartment-specific associations 
between different phenotypes of OP (independent variables) and knee cartilage volume 
change (dependent variable), with age, sex, BMI, cartilage defects and BMLs as 
covariates. Multivariable log binominal regression analyses were used to assess 
compartment-specific associations between different phenotypes of OP (independent 
variables) and increases in cartilage defects /BMLs (dependent variables); 
multivariable linear regression analyses were also used to evaluate longitudinal 
associations between OP phenotypes and change of total WOMAC knee pain over 5 
years, both after adjustment for potential confounders. All statistical analyses were 
performed on Stata version 12.0 for Windows (StataCorp, College Station, TX, USA) 
A p-value < 0.05 (2-tailed) or a 95% confidence interval (CI) not including the null 
point (for linear regression) or 1 (for log binominal regression) was considered as 
statistical significance.  
8.3  Results 
8.3.1 Characteristics of study sample 
Of the 837 participants, 422 (50%) had MRI-OPs, 333 (40%) had no-OPs and 80 (10%) 
had established-OPs in the total tibiofemoral compartment of knee. In medial 
tibiofemoral compartment, 205 (24%) had MRI-OPs, and in lateral tibiofemoral 
compartment 446 (53%) had MRI-OPs (Table 8.1). 2 cases had OPs only seen on 
radiographs. We ignored this group as the sample was too small to do any proper 
analyses. In total 422 knees that had MRI-OPs in total tibiofemoral compartment, 155 
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knees had the highest OP score based on tibia, 340 knees  based on femora, and 73 
knees had equivalent highest OP score based on two sites. There were no significant 
differences in baseline demographics, cartilage defects, BMLs, or cartilage volume 
between the subjects who were included in the present study and the rest of the cohort 
(data not shown). Due to lack of skyline view of radiographs, MRI-OPs at 
patellofemoral compartment was not investigated in current study. Follow-up MRI 
scans were only available in 395 out of 837 participants. However, there were no 
significant differences in baseline demographics, cartilage defects, BMLs, or cartilage 
volume between participants who were included in the present study and those who did 
not have follow-up MRI scans (data not shown).  
The baseline characteristics of the participants are shown in Table 8.2. Over the 
observational period, 83%, 69%, and 53% of participants had persistent MRI-detected 
OP scores and 17%, 30%, and 46% of subjects had increased MRI-detected OP scores 
in the medial tibiofemoral compartment, lateral tibiofemoral compartment, and total 
knee compartment, respectively. Change in MRI-detected OP scores were significant 
associated with increases in cartilage defects, BMLs before and after adjusted for age, 
sex, BMI and baseline structural abnormalities (data not shown). At baseline, subjects 
with no-OPs, established-OPs and MRI-OPs were significant different in terms of age 
(p<0.01), body weight (p<0.01), BMI (p<0.01), tibial bone area (p<0.01), prevalence 
of JSN (p<0.01), cartilage defects and BMLs (p<0.01), and total cartilage defect and 
BML scores (p<0.01). Subjects with no, MRI-, and established-OPs were similar in 
terms of baseline cartilage volume and female proportion.  
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Table 8. 1 Frequencies of OP types detected by x-ray and MRI in the studied sample 
 Total TF MTF LTF  
 
x-ray 
OPs 
MRI 
OPs 
n 
x-ray 
OPs 
MRI 
OPs 
n 
x-rays 
OP 
MRI OPs n 
No OPs N N 333 N N 571 N N 358 
MRI-OPs N Y 422 N Y 205 N Y 446 
 Y N 2 Y N 2 Y N 0 
Established-
OPs 
Y Y 80 Y Y 59 Y Y 33 
Total   837   837   837 
OP: osteophytes; TF: tibiofemoral; MTF: medial tibiofemoral; LTF: lateral tibiofemoral; Y means with 
x-ray OP or MRI OP, N means without x-ray OP or MRI OP.  
Table 8. 2 Baseline characteristics of participants 
 No OP MRI-OPs Established-OPs Total Sample 
 N=333 N=422 N=80 N=834 
Age (year) 62±7.2 62±7.5 66±6.8 62±7.4 
Female sex (%) 53 48 48 50 
Weight (kg) 75±13 79±15 86±15 78±15 
BMI (kg/m²) 27±4.2 28±4.4 31±6.2 28±4.7 
Total tibial bone area (cm²) 32±1.5 33±0.5 35±0.6 33±5.0 
Any joint space narrowing (%) 52 58 95 59 
Any joint space narrowing score (n)     
0 160 178 4 342 
1 136 188 18 343 
2 34 45 35 115 
3 3 11 23 37 
Total cartilage defects score (0-4) 1.4±0.7 2.0±0.9 3.0±1.0 1.8±0.9 
Total BML score (0-3) 0.27±0.49 0.49±0.73 1.1±1.0 0.47±0.71 
Total tibial cartilage volume (ml) 5.0±1.2 5.1±1.2 4.8±1.3 5.1±1.2 
Any cartilage defects (%) 32 61 93 53 
Any BMLs present (%) 25 37 68 34 
Knee pain present (%) 47 50 76 51 
Total WOMAC score (0-45) 3.3±6.3 3.1±5.6 6.5±7.5 3.5±6.1 
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One-way analysis of variance was used for differences between groups, and χ2 tests were used for 
proportions (percentages). Mean ± SD except for percentages. Significant differences are shown in bold. 
OPs: osteophytes; BMI: body mass index; BML: bone marrow lesions.  
8.3.2 Associations with cartilage defects 
Figure 8.1a shows a dose-response relationship between baseline OP phenotypes and 
increases in knee cartilage defects in different knee compartments. Compared to knees 
with no-OPs, knees with MRI-OPs were associated with a greater risk of increased 
cartilage defect scores in medial tibiofemoral, lateral tibiofemoral and total tibiofemoral 
compartments, after adjustment for age, sex, BMI, baseline cartilage volume, JSN and 
BMLs in the same compartments. Similarly, knees with established-OPs had greater 
risk of increased cartilage defect scores in total tibiofemoral and medial tibiofemoral, 
but not in lateral tibiofemoral, compartment, after adjustment for relevant covariates 
and the effect sizes were larger than MRI-OPs group (Table 8.3).   
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8.3.3 Associations with cartilage volume 
Figure 8.1b shows significant associations of baseline OP phenotypes with changes of 
total cartilage volume in different compartments. Comparing with knees with no-OPs, 
knees with MRI-OPs had significantly greater loss of cartilage volume over 2.6 years 
in medial tibiofemoral compartment, after adjustments for age, sex and BMI, cartilage 
defects and BMLs in the same compartments, but became statistically non-significant 
after further adjustment for JSN. Associations between MRI-OPs and cartilage loss in 
total tibiofemoral and lateral tibiofemoral compartments were not significant. 
Established-OPs were significantly associated with loss of knee cartilage volume over 
2.6 years in total tibiofemoral and lateral tibiofemoral compartments, after adjustment 
for age, sex and BMI, these significant associations persisted after further adjustment 
for cartilage defects, JSN and BMLs in the same compartments. No significant 
associations were found between established-OPs and cartilage volume loss in medial 
tibiofemoral compartments (Table 8.3).  
8.3.4 Associations with BMLs  
Figure 8.1c showed significant associations between baseline OP phenotypes and 
increases in total knee BMLs in different compartments. Comparing with no-OPs 
knees, knees with MRI-OPs had higher risks of having increased medial tibiofemoral 
BMLs over 2.6 years, after adjustment for age, sex and BMI, and remained significant 
after further adjustment for cartilage volume, JSN and cartilage defects. MRI-OPs were 
not significantly associated with increases in BMLs in the total tibiofemoral and lateral 
tibiofemoral compartments. Knees with established-OPs had significantly higher risks 
of increased knee BMLs over 2.6 years in total tibiofemoral, medial tibiofemoral and 
lateral tibiofemoral compartments after adjustment for age, sex and BMI. These 
significant associations remained after further adjustment for cartilage volume, JSN 
and cartilage defects in the same compartments (Table 8.3).  
8.3.5 Associations with knee pain  
Figure 8.2 showed the associations between baseline OP phenotypes and increases in 
total WOMAC knee pain in different compartments. Established-OPs in total 
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tibiofemral and medial tibiofemoral compartment were positively associated with 
change in knee pain over 5 years, after adjustment for age, sex, BMI, BMLs and 
cartilage defects. In contrast, there was a significantly negative association between 
MRI-OPs in medial tibiofemoral compartment and change in total knee pain over 5 
years, and this association remained significant after adjustment for age, sex, BMI, 
BMLs and cartilage defects in the same compartments (Table 8.4). MRI-OPs in total 
knee compartment were also negatively associated with knee pain change, but this did 
not reach statistical significance. All associations remained largely unchanged after 
further adjustment for NSAIDs usage and baseline WOMAC pain score (data not 
shown). No statistically significant associations were found for OPs in lateral 
tibiofemoral compartment (Table 8.4).  
Table 8. 4 Longitudinal associations of OP phenotype status and WOMAC knee pain changes 
in 5 years 
 Total knee Pain  
 Adjusted * Adjusted ** 
 β (95% CI) β (95% CI) 
OP phenotypes n=646   
Total tibiofemoral   
No OPs  (n=269) Ref. Ref. 
MRI-OPs (n=315) 0.21 (-0.82, 0.86) -0.10 (-0.96, 0.76) 
Established-OPs (n=62) 2.52 (1.01, 4.03) 2.43 (0.84, 4.01) 
Medial tibiofemoral   
No OPs  (n=447) Ref. Ref. 
MRI-OPs (n=155) -1.25 (-2.2, -0.30) -1.51 (-2.50, -0.52) 
Established-OPs (n=43) 2.91 (1.21, 4.60) 2.54 (0.74, 4.35) 
Lateral tibiofemoral   
No OPs (n=287) Ref. Ref. 
MRI-OPs (n=332) 0.12 (-0.70, 0.94) -0.05 (-0.91, 0.81) 
Established-OPs  (n=27) 1.08 (-1.11, 3.27) 0.35 (-1.95, 2.66) 
OP: osteophytes; Significant differences are shown in bold. Results of this table are generated from a 
linear regression model. * Adjusted for age, sex and BMI, ** Further adjusted for BMLs and cartilage 
defects; 
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Figure 8. 1 Associations of baseline osteophytes phenotypes with increases in total 
tibiofemoral  
 cartilage defects (a), change in cartilage volume (b), and increases in BMLs (c). OP: 
osteophytes; Total: total tibiofemral; MTF: medial tibiofemoral; LTF: lateral tibiofemoral.  
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Figure 8. 2 Associations of baseline osteophytes phenotypes with increases in total WOMAC 
knee pain 
 OP: osteophytes; Total: total tibiofemoral; MTF: medial tibiofemoral; LTF: lateral 
tibiofemoral.  
 
8.4 Discussion 
In this population-based cohort study, MRI-OPs at tibiofemoral compartment were 
prevalent, affecting 50% of older adults; in contrast, the prevalence of established-OPs 
was only 10%. Only 0.2% (2 case in this sample) had x-ray only OPs. Both categories 
of OP predicted progression of knee structural abnormalities in a dose-response 
manner, and the associations for MRI-OPs were not as prominent as those for 
established-OPs. This suggests MRI-OPs, which largely represent early OP formation, 
can also serve as a biomarker to predict knee structural progression over time. 
Our current study confirmed that MRI-OPs were prevalent in an older population-based 
sample which highlights the need for an understanding of clinical relevance of these 
common findings. OPs are considered to be the hallmark of knee OA [6] and their size 
and extent are used for defining OA [30]. Despite the development and widespread use 
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of MRI in recent decades, conventional radiography remains the most commonly used 
imaging tool to detect OPs in research and clinical practice [103, 263]. The 
discrepancies of using MRI and radiography in detecting OPs have been reported 
previously [276]. MRI-defined OPs were present in 60% of older persons without 
radiographic OA [110], and were the most common abnormality that was found in 74% 
of all participants without radiographic evidence of OA [107].  
Our study found that MRI-OPs and established-OPs are associated with knee structural 
changes in a dose response manner. Cross-sectional studies suggested that greater size 
of MRI-detected OPs correlated with higher Kellgren-Lawrence score, and increasing 
size and presence of MRI-defined OPs were associated with severity of knee OA [63, 
111]. Another study reported that patients with central OPs detected by MRI had higher 
likelihood of full thickness or near-full thickness cartilage defects than patients without 
central OPs [188]. To the best of our knowledge, there are only two longitudinal studies 
examining the associations of MRI-detected OPs with knee structural changes so far. 
While one did not find any significant associations between MRI-detected OPs and 
knee structural progression [110], another reported that MRI-detected OP was an 
important factor in determining future total knee arthroplasty [277]. Our findings from 
the current longitudinal study were consistent, with OPs detected only by MRI but not 
by X-ray (MRI-OPs) being associated with increases in cartilage defects/loss and 
subchondral bone abnormalities over time. Our results are largely in line with findings 
from a previous case-control study which reported that hidden OPs on plain x-ray at 
femoral inter-condylar notch were at risk for the development of radiographic OA after 
48 months [104], indicating MRI-OPs can serve as a biomarker for knee osteoarthritic 
structural progression before radiographic changes become evident. 
Although knee OPs are associated with pain and predict pain weakly but more 
accurately than joint space narrowing, the longitudinal associations are inconsistent 
[44, 267, 278, 279]. In one prior study, increasing x-ray-detected OP size at baseline 
was reported to be associated with increasing WOMAC pain severity score [110]. In 
contrast, Link et al [111] reported that MRI-defined OPs were not associated with 
clinical findings as assessed with the WOMAC scores in patients with varying degree 
of OA. Neogi et al estimated the relationship of radiographic features with knee pain 
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and found that JSN was more strongly associated with knee pain than OPs [280]. A 
recent systematic review concluded that there was a lack of evidence on the association 
between OPs and knee pain [82], and it is still debatable if OPs are detrimental or 
beneficial for pain [97, 279]. Our data showed that while OPs detected only by MRI 
predicted a decrease of WOMAC knee pain over 5 years, established-OPs (both on 
MRI and x-ray) predicted an increase in knee pain over time. This is unexpected but 
the clinical relevance of MRI-OPs on knee pain progression remains uncertain. A 
previous study reported that removal of OPs from the arthritic compartment 
significantly increased the varus-valgus motion [98]. OPs have been considered an 
adaptive reaction of the joint to cope with instability and may play a compensatory role 
in the redistribution of forces to provide articular cartilage protection [97]. However, 
our data do not support this as both categories of OP were associated with worse 
structural change. 
We employed a combination of WORMS and KOSS for the measurement of OPs. 
WORMS and KOSS scoring systems are two validated instruments which have good 
reliability to assess OPs semi-quantitatively on MR imagines [125, 196]. In our study, 
WORMS was used to divide the whole knee into 14 different subregions as it has one 
of the most complex differentiation of OP in terms of number of locations, and KOSS 
was used to score OP at each site. The reason for making this choice is because 
WORMS grading system has advantage of subdividing whole knee into different 
subregions which includes both marginal and central OPs, but its OP grading scale is 
more subjective . On the other hand, KOSS grading system has the advantage of 
quantitative OP grading scale for each subregion. The reliability of our measures were 
excellent. 
There were several potential limitations in our study. One limitation is lack of skyline 
view to assess patellofemoral radiographic OPs, so we are unable to comment on the 
associations of patellofemoral MIR-OPs with OA progression. The patellofemoral joint 
is a common site of knee pain and contribute to functional limitation among OA 
patients [207, 208]. Future study are needed to investigate whether MRI-OPs in 
patellofemoral compartment have similar relationships with knee pain change as those 
in tibiofemoral knee compartments. Second, using higher field strength magnet than 
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1.5 T might be marginally more sensitive in detecting OPs; however, as reported 
previously [65], the results would not be markedly different as this benefit is modest. 
Third, follow-up MRI scans were only available in 395 out of 837 participants; 
However, there were no significant differences in demographic factors, ROA, baseline 
cartilage volume, defects and BMLs between the current study sample and the rest of 
cohort (data not shown). Last, the WOMAC knee pain questionnaire was not asked 
specifically for the right knee, while MRI scans were taken at right knee. Thus, the 
associations found between MRI-OPs and WOMAC knee pain change needs to be 
interpreted with caution. 
In conclusion, MRI-OPs were associated with changes in knee structures,  and the 
associations were similar but not as prominent as those for established-OPs. These 
suggest MRI-OPs may have a role to play in knee early-stage osteoarthritic progression. 
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9.1 Summary 
OA is one of the leading cause of pain, loss of function and disability amongst the 
elderly. The socioeconomic burden of OA is expected to increase dramatically in the 
coming decades as our society is increasingly aged and obese. Knees are the most 
common joint affected by OA [40]. Despite the high prevalence and heavy 
socioeconomic burden, the aetiology of OA remains unclear. Subchondral bone 
abnormalities have been recognized as a hallmark of knee OA, and studies have 
suggested that subchondral bone abnormalities may precede cartilage damage. This 
thesis has focused on two common subchondral bone abnormalities in knee OA: BMLs 
and MRI-detected OPs, and investigated relationships between cartilage morphology, 
systemic inflammation and knee BMLs as well as examining the predictive value of 
MRI-detected OPs on knee OA structural and symptomatic changes.  
Chapter 4 was the first study to describe the natural history of PFJ BMLs. It also 
investigated longitudinal associations between PFJ BMLs changes, knee pain and knee 
cartilage morphology in older adults over 2.6 years. In this population-based sample of 
community-dwelling older adults, 27% had PFJ BMLs at baseline. Of these participants 
who had PFJ BMLs at baseline, PFJ BML scores increased in 24%, persisted in 44%, 
decreased in 32% and resolved completely in 21% of study participants. Incidence of 
PFJ BMLs in participants without PFJ BMLs at baseline was quite high over 2.6 years 
(26%). This suggestes that PFJ BMLs are not static. Change in PFJ BML score over 
2.6 years was associated with changes in total WOMAC pain and pain when going up 
and down stairs over 5 years. These significant associations remained after adjustment 
for age, sex, BMI, smoking status, ROA, baseline PFJ BMLs and baseline cartilage 
defects. Participants with higher patellar cartilage volume at baseline had reduced risks 
of having an increase in PFJ BML score, and greater number of patellar cartilage 
defects at baseline were associated with increased risks of progressing PFJ BMLs; these 
associations were independent to structural abnormalities. The study suggests that 
changes in PFJ BMLs are clinically relevant, and PFJ cartilage morphology predicts 
increases in PFJ BMLs.  
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OA has traditionally been recognised as a non-inflammatory form of arthritis, driven 
by progressive deterioration of the entire joint [223]. However, increased numbers of 
studies have suggested that systemic inflammation is involved in its pathogenesis, 
albeit at lower levels than the established inflammatory arthropathies [154]. Chapter 5 
described the cross-sectional and longitudinal associations between serum high 
sensitivity hs-CRP, BMLs and knee pain among patients with knee OA. Baseline serum 
levels of hs-CRP were associated with the presence of knee BMLs and total knee pain 
score in multivariable analyses. In longitudinal analyses, higher baseline hs-CRP level 
predicted increased BML score. In regard to knee pain, change in hs-CRP was 
positively associated with change in total knee pain score, but this was not independent 
of changes in BML score. These findings show that serum levels of hs-CRP are related 
to knee BML scores and knee pain both cross-sectionally and longitudinally, suggesting 
systemic inflammation is involved in the pathogenesis of BMLs and BML-associated 
pain. This adds the growing consensus that the development of OA is partly driven by 
low-grade systemic inflammation, but the underlying mechanisms are yet to be 
clarified.  
Chapter 6 investigated the cross-sectional and longitudinal relationships between knee 
BMLs and IL-6/IL-23/IL-17 axis in patients with symptomatic knee OA. Baseline IL-
6 (quartiles) were significantly related to total knee BMLs as well as an increase in 
BML score, independent to serum vitamin D levels. This is in line with our previous 
report [142] in which a higher circulating level of IL-6 independently predicted 
worsening knee pain. Baseline Il-17F and IL-23 (highest quartile vs others) was 
associated with increased BML score in females, but not in males. Combined with the 
associations that we found between IL-6 and BMLs, these results suggest that IL-6/IL-
23/IL-17 axis may play a role in the aetiology and progression of knee OA, at least in 
females.   
Although MRI can assess OPs in sites that are not easily visualised by conventional 
radiography [105], and at greater sensitivity than conventional radiographs for early 
detection of OPs [104], longitudinal studies about the predictability of MRI-detected 
OPs are rare. Chapter 7 described the prevalence of MRI-detected OPs in older adults 
and evaluated longitudinal associations with knee structural abnormalities as well as 
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knee pain. 85% of participants had MRI-detected OPs at baseline, while only 10% had 
radiographically-detected OPs. Longitudinally, baseline MRI-detected OPs predicted 
increased cartilage defects and BMLs, and loss of cartilage volume in a site-specific 
manner in multivariable analyses. Medial tibiofemoral and total OP scores were dose-
dependently associated with total knee pain change over 2.6 and 5 years but these were 
not independent of baseline cartilage defects and BMLs. These indicate that MRI-
detected knee OPs are common in older adults and may be an early marker of the 
disease process in knee OA.   
Chapter 8 described the prevalence of OPs that can be detected by MRI but not by X-
ray (MRI-OPs for short) in older adults and investigated longitudinal associations with 
knee pain and structures. 837 participants (mean age 62 years, 50% female) who had 
both MRI and radiographic scans at baseline were included. The prevalence of MRI-
OPs was 75% while the prevalence of established-OPs (OPs detected by both MRI and 
X-ray) was only 10% in total knee at baseline. This is largely consistent with previous 
reports [107, 110], indicating MRI-OPs are highly prevalent in generally older 
population. Compared with participants without any OPs, participants with MRI-OPs 
and/or established-OPs had greater cartilage volume loss, increased cartilage defects 
and BMLs over 2.6 year. Unexpectedly, presence of medial tibiofemoral MRI-OPs 
predicted decreases in knee pain over 5 years, while established-OPs were associated 
with increased total knee pain in multivariable analyses. These findings show that MRI-
OPs predict knee structural changes in a dose response manner. Unexpectedly, they 
predict lessening of knee pain over time, but the clinical relevance of this remains 
uncertain at this time. 
In conclusion, this series of studies indicate that subchondral bone abnormalities such 
as BMLs and OPs are playing pivotal roles in the pathogenesis of knee OA. More 
importantly, systematic inflammation may be involved in the aetiology of BMLs in 
knee OA patients, particularly in women. MRI-detected OPs are common in older 
adults and can predict knee structural changes. Persons with knees that have OPs 
visiable on MRI but not radiographs may also experience knee osteoarthritic structural 
progression over time. Some recommendations for the future direction based on 
projects in this thesis are provided in the following section.  
Chapter 9 – Summary and future directions 
125 
 
9.2 Future directions 
This thesis presents several novel findings using participants from an population-based 
observational study of older adults, and a randomised controlled clinical trial of 
participants with symptomatic knee OA. The studies investigated the important roles 
of MRI-detected subchondral bone abnormalities in knee OA.  
Chapter 4 was the first population-based longitudinal study that describes the natural 
history of PFJ BMLs. This study indicated a site-specific effect of cartilage morphology 
on PFJ BMLs. Additionally, the majority of the participants (87%) whose BMLs 
resolved had grade 1 PFJ BMLs, suggesting that mild PFJ BMLs have the potential to 
regress. Future work could further investigate which biological factors contribute to 
development and regression of BMLs and recommend therapies for those at risk. These 
factors could include physical activity, diet, genetic factors, knee alignment, 
medications, body weight, occupational factors, traumatic history, etc. The PFJ 
compartment is a common sourse of pain and functional limitation in OA patients 
[208], therefore, it is very important to fully investigate PFJ sources of pain and 
understand the underlying aetiology [207]. Future studies should focus on this 
particular compartment in order to better understand its role in knee OA.   
Inflammation is now strongly implicated in the development and progression of OA 
[26, 142]. Chapter 5 investigated the relationships between serum levels of hs-CRP and 
knee BMLs as well as knee pain amongst knee OA patients. The findings suggest that 
higher serum levels of hs-CRP may reflect the inflammatory process in BMLs which 
in turn can be an underlying mechanism of knee pain. However, mechanism 
investigation is something that beyond the capacity of the current study, but is an 
avenus of furture research. 
 Chapter 5 was a secondary analysis conducted on a RCT; thus the findings may only 
be generalizable to patients with symptomatic knee OA but not general population due 
to the inclusion and exclusion criteria of the RCT. Moreover, the follow-up interval of 
2 years may be insufficient to examine associations of serum levels of hs-CRP with 
knee pain. Observational studies suggest that associations may take 5 years to manifest 
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[225, 240]. Therefore, future investigations could benefit from studies including wider 
range of study participants with longer period of follow-up. If the link between hs-CRP,  
knee pain and knee BMLs are further confirmed by epidemiological studies, 
randomised controlled clinical trials targeting low-grade inflammation will be required 
to determine the effects of anti-inflammatory drugs on knee OA.  
A number of investigations demonstrate roles of Th17 cytokines in the aetiology and 
progression of rheumatoid arthritis (RA) [256], a disease characterised by high levels 
of inflammation. OA is known to involve low level inflammation; experimental studies 
reporte that BMLs may originally correspond to an acute inflammatory response to 
cartilage breakdown products [87, 247]. Thus, it is rational to hypothesize that the Th17 
cytokine family plays a role in the formation and progression of BMLs. Investigations 
in chapter 6 were the first study to assess longitudinal associations between IL-6, IL-
23 and IL-17, and knee BMLs amongst knee OA patients. The data showed that higher 
serum IL-6 was associated with greater risk of an increase in knee BMLs over 2 years, 
and high levels of IL-17F and IL-23 predicted an increase in knee BMLs in females but 
not in males. This study demonstrated that OA is an inflammatory disease, and that 
inflammation is important early in the disase process, even before cartilage 
degeneration is visible [18]. Since there is a huge disability burden among patients with 
OA, DMOADs at the early stage of OA seem to be promising. Our improved 
understanding of the inflammatory pathways incuding the onset and progression of OA 
could advance development of targeted therapies. The reasons for the discordant 
findings between men and women in this study are not clear. Therefore, further studies 
should investigate interactions between gender and inflammatory processes in 
progression of OA. Additionally, the association between IL-6/IL-23/IL-17 axis and 
OA progression are also to be validated by other cohorts, and further investigating the 
relationship between other OA-related features such as meniscal tears, ligamentous 
lesion, cartilage degeneration and effusion-synovitis and IL-6/IL-23/IL-17 axis will 
provide a more comprehensive understanding of inflammatory processes in OA. Once 
the role of IL-6/IL-23/IL-17 axis in OA progression is disentangled, further clinical and 
experimental studies can be conducted to screen out effective drugs aimed at 
interference this axis and thereby to modify the development of OA.   
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Conventional radiographs are the current standard for establishing a radiographic 
diagnosis of knee OA [30, 281]. Hallmarks of OA include the presence of marginal 
OPs and joint space narrowing [6, 262]. However, associations between radiographic 
abnormalities and clinical features of OA are poor [282]. Despite the widespread use 
of MRI depicted structural abnormalities of OA, longitudinal studies looking at MRI-
detected OPs and OA clinical features are rare. Chapter 7 demonstrates that MRI has 
much higher sensitivity than did conventional radiography for detection of OPs. MRI-
detected OPs are associated with knee structural abnormalities both cross-sectionally 
and longitudinally. MRI-detected OP could be a very useful clinical tool to monitor 
treatment response once MRI-detected OP is confirmed as an important OA biomarker 
in other epidemiological studies. Since the natural history of MRI-detected OPs has not 
yet been described, future studies can investigate the natural history of MRI-detected 
OPs and to examine whether MRI-detected “early” OPs are important in terms of OA 
structural and symptomatic progression. Dose-response associations between MRI-
detected OPs and WOMAC knee pain were observed but these were largely dependent 
of knee structural abnormalities. Oveall, these results suggest that MRI-detected OPs 
may be an “early” marker of the disease process in knee OA; thus “early” OP formation 
may be an useful predictor of disease progression.  
Previous studies indicate that OP formation may precede cartilage damage [104, 276], 
but longitudinal studies are needed to confirm whether radiographically normal knees 
with MRI-detected OPs can induce cartilage damage and exacerbation of pain. Chapter 
8 showed the prevalence of OPs visiable by MRI but not by standard X-ray (MRI-OPs) 
was much higher (75% vs 10%) than the prevalence of established-OPs (OPs detected 
by both MRI and X-ray) as expected. This is largely consistent with other studies [107, 
276]. This study focused on “early OA” population, which has not been well defined. 
The definition of “early OA” using MRI as a imaging tool besides clinical 
characteristics remains to be developed and validated. This study provides evidence 
that MRI-OPs can serve as a biomarker in identifying patients at a risk of osteoarthritic 
progression. Development and validation of a comprehensive early OA diagnosis 
system so that this group of patients can be identified earlier and more effectively is an 
essential goal for future work. Total knee arthroplasty (TKA) is an important outcome 
in end-stage OA, both from a research and a clinical perspective. Prevention or delaying 
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of TKA represents the ultimate clinical goal for any therapeutic attempts. It will be 
interesting to examine whether MRI-OPs can be used as a prognostic marker to predict 
TKA occurrence in long-term follow-up studies in the future.  
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WOMAC Questionnaires _VIDEO Study
Site Number:        Randomisation Number: 
Subject Initials:           Study Selected Knee  
2 Rate the following today.  Place a mark on the line: 
3 Referring to your knee, Do you have (This is not in questionnaire but is 
implicit) 
PAIN     none                          severe 
Walking on a flat surface 
Going Up and down stairs 
At night while in bed 
Sitting or lying 
Standing upright 
STIFFNESS 
After first awakening 
Later in the day 
4 FUNCTIONAL DEFICIT 
Descending stairs 
Ascending stairs 
Rising from bed 
Rising from sitting 
Putting on socks 
Taking off socks 
Bending to the floor 
Lying in bed 
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Walking on flat 
Getting in/out of bath 
5 Standing 
Sitting 
Getting in/out of the car 
6 Getting on/off toilet 
Heavy domestic chores 
Light domestic chores 
Shopping 
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